var title_f40_61_41936="Alleged renal agenesis ectopic ureter and Mullerian defects";
var content_f40_61_41936=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F86776&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F86776&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Alleged renal agenesis in females with ectopic ureter and M&uuml;llerian abnormalities",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 404px; height: 367px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pathogenesis of&nbsp;alleged renal agenesis in females with unsuspected M&uuml;llerian abnormalities consisting of a duplex vagina and uterus with a left obstructed hemivagina and ectopic ureter from a small dysplastic kidney or renal nubbin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_61_41936=[""].join("\n");
var outline_f40_61_41936=null;
var title_f40_61_41937="Bleeding sessile polyp APC";
var content_f40_61_41937=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F62421&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F62421&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Argon plasma coagulation for postpolypectomy bleeding in the colon",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 317px; height: 327px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFHAT0DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5UqxY2k19crBbJvkb9B6mo4YnnlSOFC8jnCqByTXpfhnRY9Ltld1BuWX94+c8+g9h+prKrUVNHRhsO60rdCfQ9GjsLJYUJ5OXfux/z0rfayFpMY5yA6HDDPKn0+tUlnaQiOEfKP4uwqxHBjG5sk9zXnTk3qz3oU4xXKiV5IwRtGTg9elRwZYEjODVuOEDtwRzTQgLkdFHFZmil3I2Uk7o8ggevWmxs4fLg59assSqc5IU8UAb/wCHn1o1sSpK4yInOMnn3q2oYnA/marOmACMe9T27MxAYk1DZooprQlSE9s/nU0fmxHuRSZZeo/CrETO/wB7pWTbLSQMsV0nBKyDt0qNYp48hlYgdwasywI2GU7cDqO1SWlz5bbJ/nT+/wCn1rPmKsrWKpRdo2sR9TUFza7sk5weOtbUlnv+aIDB9DVeSLb8kgOelUpXM5R7HB+KPD6ahZtE4IYZaJuvlt/geM15JfWk1jdSW1ymyVDgjrX0Tcw71ZSMH+dcR4w8MjVIt0ARLxOFY9GHPyn0r08NXcdJbHk4zDqfvR3/ADPJaKc6sjsrgqynBB7Gm16J5AUUVYsrWS8uFhhA3Hkk9APU0DScnZFrRNMk1O7VAGEKkGRx2H+NenafCtpbJDboY4kGBzWTo1vBp9sqLwqnJ9WNascktxu25VTziuGtJzfkfQ4KhGhG7+JljzsHdg7jwMGkbzGJJyDnoKkECIFHVsDmphCANzZHrXM2kegmRwxEgLv2596tLauS4J6ds0luy72CkbQe/U/StW1ZNpxjJ96zlJobfQpHTnMYYA5z1BphWWB8kEk85z3rctni3qZ1k8lT8wjOGI7gZyAffmlvIoJHdoQ6xE/IHYMwHuQACfoBWbmyoPXUo2rmVMkGrsSMNpGQe4zTLe2MZU9FPStOFB5Y3DKjnmsZNdDoQLEjoCWPPvWbe6b5ZMkedp61vWoWOMoyBwTnmnNGGUoVxnoKxhUknZjempzUMfzBHJ5pZ7V4GdgW2nnjpV+9tHjYMGJA54FJFIskQC5ODzW176o0i7GTLcCGBXYkIO4P6VyPjPw9Br1r9t07/j9jU8YxvA/hPofT/OOv1q2CWUuwZX7xX6elJqO1LHSb5LyOW4uFaKWMOpKgHjCBQQPUkkkntXTSk4+9Hcmth6dePs5rRnzyylGZWBDA4IPY0jEEkgYHpXpXj7wr50b6lYoFlRC86f8APQD+Ie/tXmlevSqqrHmR8VjcHPCVHCW3R9z0HwjoAs0F1eAfaG6A8+WP8a33YzSlVO1e7Y6+1F7L5MZVT95sCiyT5AS3Hc45rhlJy99ns0qcaUeSJbtgoIWPhcc+9WUCjJZgQPWqkZK58oZB71HLHOzBd27PXj+lZ2uzdGvG7NnYBjHrUKXg3MAuR03Y4qlC1yInAB25xnjipYLUomAzBj97BpNLqSlbVmj5isylmGPUUjXUak7W3Y9Bms2PfDIFm+Zc46VoRYckRfKfQ1PLYmSSEaRZYiVHXjipLVWBBXAI6g0JEIwWVRuzyPWp4W8yQ/NsYDkGlJKxUZPoTqy5CvhWPQVbWIEAhhz2qEQ+ZEQSDn1q3bKEjCsMAdyKwloWtWQNHIpIY7oxzgCrUCK8eDge2alU5BJI9qfEOQDgKeAw7Vk22arXQhhL2cg8ony/QnpV6UxTJuP3v508xDa2cAY7VWCsm5R9ztRuHkzPnj2yrjcVORz2qvcWwlGGxn171qCIHKP949OODVeeEwSAk4yMc1tTqPZmNWijynx94e85ZL+3UCeJf3igY3qO/wBQPzArzevoHxTbj+x9QY4/495P/QTXz9Xr4Wo5xafQ8HG01GSa6k1pA9zdRQR/fkYIM+pNd5Ho8ejQBEy7uPnc/wAR9PYVyfhRPM8S6WnrcIP1Fe2NpSTwSW8q5J+YEc8+tRisR7KSi9j1Mmwca1OdS2q0OAhYk7mySOnpWpbXmxCo5JHNU76zltLho5PkKnByOhqBI5JH2wo0kh6KilmP4Dmqspq5rPmovlaOigukPJOWIAHNWGnaYGOEYXu1c/DvChyvydN3bPpmtzS7jgKAASawnBIuM20C2kmAdxVh2PenJJLaT4ZuvINbixq/zkDHTAqJ7WNxjb1PSs+a61Ep6kMNwx5VzjHT3rU02Qbdr/dxnnmst7Vrdcxsp749afFKChwQrjqp4NYyinsdVOppY6WEiVlBUH0NSTYh2hd3zD7uM1k211IpVXZcfrVzzxLwcH0PpXLOLidMJJmwI5oVgW5haFpU8yLLq25c9flJx9Dg+1J5jK7hhzxj6Vl2sgjV0ZVXPIZRjn1+ta1k0buiPg5Wp06GiT6jWRZYCmD3xWBdRPazkEkMf1rqJYgmEBHPSs3W7YlCfvHsccilGVnqaRWtjLaNbm0ZJMhuc1yNwnk3DEBY7iFguVJywx1xXVW7yKAN2d3BJ6ior/TUktNRkLR/ao9kqbuCVJCkA9+v4V1U3Zm1NpPUqwsLmzjU58xRw/fPoa838WeEGOqPLp5RBKS7xscBT7ex5r0WC1urCa4srlfKuAduGwQfRlPQj3qd7U3Sq8ygTD5XGe4q6VV0pXWxONwdHEwtUWhxt+xF2mR8pJNWrf5gMZGP1puu2ximjlA43EVJaHKKc10XvBNHgy0k7l6MFVIVefrTkG0klhn0pY1Kx/NnPUelPVA8nBz3NYtgtWJEpKAHgeue9SqAVwDyKeF4Y8ZNRv8AJtbBwOOPSoKbvoRupMgEgU7hjAosHJuHi+VmAHOe1G5GfdyD61AzMX3xYWReM+1aLYjTZmqxYjaFC5PI3Zx9DUiIwcFAD2qvYs1xGCzKrg45FaMatkB1BwOMDFYylrqaKFie1IIOfv8AoR0qYD5cbcn0z2pBb7OUA+briraxFkU7eR0PpWbaY9ncIQvCgfQZoRvLZkYEf0p9rhXKkZ96dcxjGfLLe46isy0tblmzl81QHxuUY6U24jMZyFJjAqjaOBMMkkE/Kc4zW6V8xBwOmKNmaSiuhQ8kSREEjOeCO1U7wDb5bjLqMg+taSKIspg7l4OOciqU0IltXlzuJJ2kdh2q1uTY5zxN8+g6gcci2kz/AN8mvnSvozxNDJFomoBuv2WTPv8AKa+c69fBfCzwMzjaaOh+H6eb430NMZ3XcYx/wKvqGXS1OU24bqCOOa+Zfhiob4h+HlPQ3sX/AKFX2bJp6NHnB9uK4c0jecfQ9bIMQqVKSfV/oeXeIPC66nb8psuEHyN0/CvNpYb3Rb8tG0tpdwkgSxvsZcjnBHTI/OvpEWi3KuoADJw31rjvGHhcXqHcgMoGM4xkVz4fESpaPVHs1qdPF+7tI8OAYjaoOwdh0FWbeSVTgEAirl3pctldFZlYoDgMB+hqv5ZV+659a9VSjNXR4lWE6EnGSsadnqsi4jlAx0zW1bXaMjcge/rXIufmUAHr1qa3nkhbJyVHYVnKnfYcZJo69/n2s6e9QGEmXzV6jhag03UEmZUc49Aa0yFdtycr6Yrld4vU3hoQrHmJnQAP3+lLBM8ZCuowBVlVCxsQfwpmxSqSqrZBwyj0rOS5kaq8dUSxT5fb94+hq9ZzCNgeePUVh3syRMzQBioOT2OPXFXbSXzY9+c8dc81i421OuLutDpoLlDKuVVi38XpU8irIhB546VjWmRIm7OT0x0Nan3fu8PWLRrGxj3lv5TDjgnrUF5bfbrQx7c4P6VrX4DhVAHPPPrUNqgVsc5PBrWD6F3a94xJ7a5lZZJy8jxqEDE/dUdBVe+aVZd0eAWHPfNda67ZCuPlPUetc9rRjivDkYBAIFWr3ubqpzaMytcsDcWsygfNyy/WuT02UI/7zKgHBHoa99v/AAxYQxyyXCiVlY52EhR9K871L4b6lqF3Lc6Q0EVqxyPNc/MPYAGowmY0WnGo7LuzwsTRvapDU5+N1dQwYY9KeZY1kVQRx1rpdO+E2uGEPc6nZwk/weU8g/Piuf8AE/hPV/D1xtlj+12/BFzbqSv4r1Brpp4vDVZezp1E2ctmt0TrtKNyMntSldyjPGOwrno7qSJiWfp1UjBH4Grceq7lXIOM4JFbeyadwbujTeL5vmXA68d6bbwiR89B296mheOSIkElTxvI4+melOgZS+FIAB6jnP0ok7Iziu4x4vKZWTgg8jpxWnCQxBViV681VkjDNnOQetOt2FrIMnKEfdrCa5jpi+htxtuQjj65p8QcKdxwR2qEFWClDye9Tbyow/PNYSKW4gfbcqDlfXI61e3IyEAkEc8VTnClcjO5eRUtm2+PJ7/pQveWhdtLjpYA0K7Dzmr2nS43x5yw4+tQSL0VcKB8xqJWZW81OGzz9Kpw6FRd1qaDxMtzvwDuHT6VGoBMyEj3HofSlhujIwjYHO7J9qcyoshC4w3P/wBetYUrqxE5JGF4pjWXQNQLgAi2k5/4Aa+W6+o/ER36HqoPOLWbGfTYa+XK9LBR5U0eHmcryidN8NGKfEDw+yjcRexnH/Aq+7NIWG7tVZWyevHaviD4MoJPit4UQ9G1GEf+PV913OlNpc/m2qjyTncorgzRuNSMulh4CrH2cqd7O90QSaXGkpaNQGJ3HHeq13pnngh0+Xsa6ax8u6iEn8Q6GpZ4VKtkg8ZPHSuSKT1OhYycJWe6PHPGHgaKWB7iEOLgL2xhvqPSvKLvS4Immju4Xj2/xxjO0/7Q9K+m9Rd47aQBPMGPlI7fh3ryPxFpRubiZ3jG9jgjGDj3rVyULOB9Nl1b61Bwranjrxn5chsE9aNoIfC4UdT2rZ1exS0uCsUgYkcoR8yfUVmwRCW7H2jzzCTmZolDOi92APBxXdTrKSuZYrKnD3qbKjM0cigk4rSsdSkiOD86/WodVgs4pJVsL43Uavtjd4SgkT+8Dnr9RVOJd3POevFaPlkjy5QqUnaR1tndi4+7g8c1ct2Ic5XC46HvXLWs5gYMA3Tt0rdjvobi2ByVcdB3zXNKHKaxk29CbVbRJbZnj3BsHpVHw7e/ZbkxXMay5XYNxxj3/CtC3uFeZYxnjrnvWTqtuBex+UNplbA56Go0knBnVFNI7UWgto0laXJPIHrVovvCHGQy5zWNpru0S28zFlTjB61rRkDaFbGOBxn8K8+zi9Top3tqRxuHikDHkHH4UltyQD+GKY7KlwFU9evvSPJ5TpjHPTFarub7o01cvO0eB93cT121ia5bq90pdCeOOM10Gnx/umkK/vCeT6jtVLUbRJ5gx64qr2Lha5318S8LIiEFhjIrT0jyfs6xROHdAAU7r7VALclQT07e1P04w6fdSXEq/K6gE+mP6V83jcLen7vQ8io1KDitzTa1d43ZVOQDge9Zc2iS3UCyNKYpe7IAR/8Aqrr4HSe1LxgYYfKfUetTxW0b/KiqWCjI9B7illGF57ymeWsbKlfoeQ6p4ajufOTVNOgv4cYLICrfUEHINeW+K/BEulQG6055bm1z8yMv7yH0zjqPevqi4sUVfkQZx25BrntY0oSLJsRVkIxnGQw9DXvYepKk7027dun/AADoWIpYnSSs+58n2V7c2skRhmdBG4lVd3G8dGx0z710E+pvqd7NeTbVluCGdYwVAOOSMnv1o+JPh/8A4R3VFmtoiLG4JHXIjfuv0PUVztldbTuDcevpXsK1WHPHqZNOE+WW5133ohjjHGe9KqgkEjofrWWuqRrEAeue3erltdCRcjgelc7g0a3NCN2hkyMGPHQdqsrP5rjjgDHBqqZFZQEGCaapJBRRhgc5rFpM2jLQ0TMBGY25PqO9W9PZRBlsZ6VhqxLHOSw6kVsWbEBDtGPQ+tEY2LbVi42SATkA8dKjvXaFSyAEEbc1YiIKMg9OPaqykTv5POAfnJ9q3SuQtGM06UmVhJ24rXKA4YnkjkVi2wLXSFlI5ww9BW7DyjiT+HhcVrHYdVaXMPxRCF0HUD2+yS4/74NfKtfVvixSugamzcA2kmP++DXylXdh3dM8HMU1JHb/AAS/5K74Q/7CUP8A6EK/RiSJXUggEV+c/wAEv+Su+Ef+wlD/AOhCv0drSpSjUVpHnp2Odu7KWwla4sk3xMd0kXv6irdte2k6giVAe4Y4IrWZQRXDeMrGaxu0vLeMSWUwK3EJ6b+zD0PavExOFlhb1IaxPRw1sVJU5uz6Pv5f5GxqNvFPE2OVPTbXl3xBtJ7ZllsvNa5kBO2M52/4Guq8OahHFFIks7OhbhSclfaq2pySXSahBEvmNJGyBF+8SRjrzjHWuSNWNRHuYBVMHXs9UjwzxCLM21mltNeGYx7riO6wxSUHBCt3XH1965+3nudOvori2klgmjIdWU7SV/kQfxFd5FOEs7vSr21srccCRfLwzsvGQxJw3sAM1gavp8qWkSysdsRwisOgP6/56VvColofa8imuV/8Ov6/A5xojd3lzcIIIUllZhE/Cjcc4GOn1qncRT2cxW4iKN+hHqCOtbD2zRSiOQYIwTgg8ex+lbV1p/h14N9ld38kjFdtveqoS3XPzb5Bw+e2AuM11Rra3Z5uKy7mSjG/y1ORRww6554qTldrDr3FdR4+8OWmkvZX+lI9vBPDva1l3buDjeu4Z2n/APVXI+aAnv1rfSWx8+4SpPU0rS6beCTyeM1d1xvMs7coASTz7Yrn45jFIhBz3q/dXhaJQOB1K/0rKVP3k0dEZ9DpNDdnVA3U98810RCRKc/w9wetcTo900bKUH3ema17zUnjt9wJO4cetctSm+Y6IO6JY7jdduQc84A7VPKd98iKQcDOc1h2c58ssx6c5/pXReH7czTPM44Y5ANJxS3OhI6S1TFoAVODjPPSszViI5EG4rnPetV8xAEHqentXLa2Zrm7zGwRV4571ne5tTjY9xSBVjJIO0+tV5bZAcuoweBmtKFRIMMe/Si5ty4OCMCsY0+bc+VVVqVmyvpc8vlCJh+7U7S2MYHYV0UCKlvKA7urYYoOcH2xz+HSuVKSwNvjzjuo6H6itO0vlFrLPJIgEGAwL4cA9wPT/CqoQdFtLZmWJpOfvRN9Y32x702yHqoYYA/z2pLi2QqM4DE9fX2qlpt9FJP5KN8zZI6nP41rSzCOMqxwQMHNOm6dKE3N2X3nmTU6crHmnjfwxFqdtMHhjlXILwuuVce9czpPw80PSj9pt9PTMnVZsyhfYbs4/CvTdT3XFx9nUsFkG4OOh9q0V0yEWyiUJk4AJ6Z7CuXCueIg5J2T7M9X62oQj7RXf6HzV8UfCkEVuupaJaRwCEEXMMC4BHZwo4474rzuwvyoHRh1HvX1nrWmxwzb402sp7DlT715Z4s8CaTf6zDeJb/ZBLJ/pXkHYHz/ABAdA3vXbRx9OlH2VR3t16+jN1S9raVHbscHa3QkG5Tk49aswTr5gJAFdsnwq06ORfJ1G8WJzw4cFlHoRjBrk/Hfg+bwo6XVnfvd2MjbB5qgSI2M844xTpYzDV5ckJak6rdDshpUOAAeDWnbdAnZTxXM2tw1xaF0OGUZrW0md2hSQnO6ujlcTWLT0N0Ptc/d47DvUkC7oHIADs27NQWgJY57+vetOKNVGCecdKlysaxWlihcQmFfMAwCMsferVnueQtICqFePen3bBrOQdQQQc1DZOy2kLrkjbhwR+lOnLS7NJR92xH4oTf4Y1MKoI+ySnn/AHDXyNX1x4mfb4W1Ft337OXj0+Q18j16eE+Fnz+aq00jt/gl/wAld8If9hKH/wBCFfo7X5xfBH/krvhD/sJQ/wDoQr9Ha6zygpksayoUdQynggjINPopSipKzBOx534o0W1sIrqe2cxyod4iYcMnfH/165zSE1C41EXlrubyNrSMvHy+uO+K9W1u0N3YTxqM70KnjJ/CubjsJ9Js4bqW8trTTYCJZVRDukx1Xk8A8ev4V81WwUoVmorTc+kweY3oOMtZPTXX5aLqeRfEfR7a21/c0hhF0vnPI4yOSfmX2P4c153IWdmO5mGc/Mf1rq/GetPrOr3N1uco7nbvOSFzwPwFcqFO484FTDqz9DwNOpChCNR62QzyjkYXBqRogflkUMMZORwPrXT+FNO029aaPVL6O02rui3IT5zf3A3RSaTWE0iOFWsneOWQlJreMEmJO4yepz2/Wq5mW68faezs7+mhn+ItZin1sTCSbUI47MW3mXDli56k5PYHtXA6jaTW0fmoplg6l0BO32b0rp5LNtu9GR1KGUYPO0HHI9faq6TPCDsOCRgjqCK6qVVxd9zhxWW069NQXQ5BLkM4J4q5EZHO9AHX7uM8/XFdfa22j3M0RubBGYHc2zKhx6deK0WsbK50pltkQTAFtoGGIHQGtpYuL2ieJ/ZNWnvI5CzuTDwy/Qmpri6M0oIJPGAPSrurQWlwyPp8YttkQEkOSwLjqwz0Hsan0HT7Zv3jyK5H8JOD/wDXolKPxExozi+UsaPZPc+WSAEBzz0NdvZtFaQKZCqRgYyaxIYyiZiVkCk7AOST7jsKfey/aYDEzEqoDMqnn/drgqSbZ6VKjfc0bzVI13srhlTGSOw9aw76cmUOqklhnj07VTJufLkVoQAi+Z1wAvYe9Fm17cRjyWRQoGWI+8Tn19KSidnsUkfS6RHsOM1LHHvYlvvdhUwiZdu3lc5IqQRsfmwBznp3pRdmfnMqhDDZh1OQc9MGqFxpscc7sqDeRgnHJFdFDwpB+93FI8aBCWzt7mlKXRmccTKMjkopL/SpJZrBkZ3wWR1yrAevfOM4x6810T3wv7WKfy9qFdwB5I+tR3sAb5lQspHTOKLKAJbCM/KoHyn19jXk5k8ROj7Gm/db1RtVqQqJTa94yVvWubyWFfkmt8MEYYDKe49R71vWt2XiIkAbnoO1cjrGn3H9r2dxZvDG+0hnYby0XoPT8a6awO5VER4I53V24SD9koQ0LxVOnyRlH/hhL9kMe1Iic8k4rmNU0xZCW7N2x0NdpJG5U9cDrnvWXcwD0YEHOT2NeRjsHiYVOdPT0Jwtf2b908+l+16X88MjNFn545ece6n+lVdXhttU0+WPVIvtFtKvJIwUPYj6etdhq0CzK4AXA9sbq5rTyC1xakZKdc+hruwVO8ff0l+J7cJKtBya9Twa8sb3Stbe0tQbiB/9XMeEKHux7EV1WkRrawRQ7lkEYxk9zXa6poVrJMEaPMT8bv7vvXGX9q2m6rcWatvVCNr+or2IYlVnydV+JhKi6Xvdzas2G9R6elaDZZcDr64rIsHCsoIzmt+2TcODtz196qaW5rTKSwNIWLYCqc4zVNHYuYFBxuyeeK6B41jDEcg9KyzEouVZTgE81MHodEncp+Lk2+GtRVgf+PWXGD22GvkmvrHxs7Jo9/GCcG0lOfT5DXydXq4L4WfNZt8cfmdf8IZ/svxP8Lz8fu7+JuTgcNX39Y+LrSXat1iB+4LZH4Hoa+BPg5Alz8VPCsEoykmoQqR7Fq/Qix0G0gjkiaFXUnIJHb0rHGxxTqR+ruyOWg8Oqb9qnfyNaCaOeMPE4ZT3BqSs+HTI7WRXsibcbsuifdce49fek864tsm7dSu7hgOorZ4qVKKdaL9VsYOnGT9x/wCZenkWGJ5JCAijJJ7CvBPiHq0uo6pdASu1tn5Ezx04r2TxZdLaaDPcOgkjUZaMnAcHjH6189azcedKxAOc5xXl5pWlKoqa2Pq+FcKpTlXa20OcmUEkHGcdKrhc+YRtTaM7Sfvew/8Ar1dmG6ZWOOBULx5J/XmuSMj9ATH2s20qrgNGDuZT39uKfqM1s168lhaCG2YcxFi20+xJzj6802K3Z1kERGUQuV7kd8Vf0awgmjvri5uEiS3i3bA2Hcngbc9aL21M5yjH330/XyMQEOogYjYTkEqODWl4fsbZtds7PU7cS2kzbchiASeOo54qjbIryr5owp4OOorVj0xU1KK2uWmmtXXerRHbIF9R2yM1qpWYVmuVxva6ZD4u8Oz+GddS2MU0ccgJj80glsHBwR1Hp3rpvA62F7FFZpHGt6z4aWYhEx6FscH09TxUOrapcf8ACRy2nic2uqSwW32W1lb5UtyRlZDt/ixjOc81DYeHZH8O/wBrozyea/ltaJkSNg8sMdQMd+K050pX3R5kpOWHjGvK0nazWzb28/vsU/irBosN9ENAd5drNFJLjCuR1x6jpz35rh7VlglXzkVozwwz2/pXW+MbSzjvIRp95PeLLj/WoR5Zx93d3/pVTRfD32zV/Iea3KoMuNu4EY6ex962U+bRKwoUI06Sm23p13Kkd/Oi+VskkU8QTnIYA9AfUVrFR51tNGjNczZTyYj1NUNS0SWzuTKJy1tHMI8BsMBxx7da6KfTTperIlvbSW88yARxSP5hijPUg89f61lUVtS4NbITTLI+bMjsZTGMyt/CWPRR7ChtHnmu5YbfhIAq5zgEkZrelS2tIorSzBMz/KcAYAPUk5659vyqTRYWtmulmZpmZw28DGeOlZcmplLENRcl8v8AM9p8wiHcuN/6GkSOUOzldxbnGcCuE+JviuTwt8PtUvrYn+0JFFtZYXJM8h2pgYOSM7sd9tQ/ALxddeIvD+qafrN/9v1bRr17eS5aIxGeFiWilKEDaCMgDGflrd0G485+b1H7N8p6Pbk728wYJ9afcw+dFs3YBNOAJUsx568ilGSe4rCcboyb1uhGUkduKp3cLSRAKMDuK0AOOaCAUIFCoqW4Rm4u5zt3Ch8qGXeBLlCI1yx47Duam0WWxQNbQSTMIfkYTja4I7Ef41HqiukbSIT5iDK46g+3p9a5/WLe7VBNp06W95Jh2eRN+713DufeppJUdIrVu56tOmq8eRytf8ztTcFUCiHawyCyfdHPHXrkU0bZQUIwE5965601xEiWO4YySIAWO3r74qxLq0YYrb5Bcc11TqRqK7Od4SpF2sQajbqSwToeMVyU8Yt9RbaCxYqSDxx3rpLu9VBgHnFYE22e4NwTgBcED17VwVKUaab7ns4NSinzbF/xBJax2RFs4mlKgjAxg+leSa3kagJpRwzbGHoa9GvLgEDLg7Rx7VxPimNDZSSqQcEHj1zUYbDRoTTj1OqFLlp8rM+DJuAV5xxW1bzmLbx161jacFUA5znnjmtEqGQggjvgdq9CTXUcYlq6vwWwpyUBwO1NsASdxwB1yaqArHAT0d8jPtS2jZtgucDPSnFDmVfFsXmaPqMhyzfZZfw+Q18oV9XeJpgnh7Ugo62sv/oBr5Rr0cDsz5vN/iidv8Ef+Su+EP8AsJQ/+hCv0dr83vg3NHb/ABV8KTTNtjj1GFmPoAwr6y+OXjnUNPn8K2/hvUriAXt40dwto8SyumzIAaRWVee5FdNSvCnJRk9WeZClOavFXR7Y7hMZ6E4okVXjIcAqRzmvKPg34t1DxR4A0661m+Se9QyQ3txIqxhnV2HG35SAMDI4OM8Zr0Oewl8nFtcyp8v3WOR+X+FcUsXOTnFRuka+x5UnJ2uU9b0u51pfsRuEisDHlisZJLZ4AJOO1eJeMtFm0LUWtrocnlHHCuPVa9w8U3FxYeHJ5LNmR40HzLgFR6814b4i1rUtReMX17POYiQhbA2569AOteZjXSulZ8/fofW8Ne3bbi17Pa3W/fb8zmZhkjI9ulR7M8DkVZlTDlSQeav6Alq+qW32/ebISfvgmNxX0H44rli76H2s6nJBy7GQEeLDrlHByGBIIqPywygqMkevavQ/iKnhsx28nh+R/OA2vFsITb65YZz9M154HAkPJyPatJx5Xa6foZYPEfWaSq8rjfo1ZjYlw/I5Bro9CuZWuYo7SEy3KWroihdxdSeePXt7Vz6ksxDct16YrstKsf7C/se9uY5JYdSWRMxttUrtPyluq84OfShak4ycYws9W72XfRv8iXU5PD0t/af2PBZQWMVt5oljI8+WY9YievBHfnPQ4o8EavJD4qsI2uPtUl5uZlVd5hkbquDj5gOtcxKJbiI28KPc3KqVMgwgKryFBHXAHQ9azI4ikDSGMzyAgxDZuAPcmtYTXPzmCwMZUXSlK91bXV6317+fQ7n4p6JaR+N9L0+2ligsZk2zTvLtitzySXb+HjscZ4x1rm7y5l068sY4LyO7t7EG3tpRAFV1IzuHQuOcfNzxXS6V4l1zV430GEWrzXKsgm2iNeUJYswUjO0HrzWDqkEv9h2TYhErFSJ9gKtGeAfb68Gulzjy3irHHhqVWny0sRJNxVl1ve+u19dUWfBmlxnW9KWa4v8Abc+curNOQLeWP7yeXjnk9Vaut8V2M1h4kj1FU325jEUPTa0YGeOwqh4YS+tdW0otEDc7yV+0grGygffjOMEfWt/xPrSi9tjbwLqUnmGIWpz8z4PA28+4xwapz5oK+hw1eeGKXJqmnfXzf3bW7HCaYI7zWr5o7lYopjhZZuEjOPvHHYVq2Wo2cVsoNzEoyVDM2d2DjP0qa60aPS1sovLtLZ72yMlzBCxkEcityzFuhOcbegKmuPg0ddYvbt0AEMZCIQoweuSPas3Hlslqz0Kc6WKi53aiv00PeLW1sr82zXtrb3RtphPF50YfypB0dcjhhk4I55robTTdPhvri/gsbWK+uVVZrhIlEkoUYUMwGWA7Z6V8sfs5fFUzS2/hfxFcSvcswSwuXIwwA4iY+vHBP09K+odOu1Foi3Dn7SO4BCufYc4rdwcG4Sep+fYhKqvaQ2ZptwOgpily/KgKOnPNOSVHAwQTTfMBcqMnHU44rKceqONJ7WHtx1pokBB2kH6VKqhoDliVbnI9KzY5PKjAY8BiMnvWtSjyWd9yoR5rle8eIXLDgM68+9Yl26yz7VYAoOmKtalL5kp2kbyOD2/GsFFllnxOFEg+R2j6Y7c1zygkezhqNldsSdBDKpXIPJA9R3zWFqMr21wbne6qeCP4R9a6q+JCbuNoGMisXWbA3UYUgNF1IPGaxcX0PUwtVXXPsUbfUfMiPnEq3uO1Qz3SiNij9zkZo8k+WoKBSFIPtWZf2SzRBwzRyDIV42K/nUu+zPQjCF7oytQ1KZi8aDI6Fu4rMvHkvEi3YMSHcAvGfc1oGLymcSbTgcn0pixKcgFcHoK0hoFVNhZIoXgDj0q+uCM4UCqKkxt8oBx61OZcrllPpx2qnqcr0YrReY4PACcc1VJ8qZgCPXNTPdpGpXI+lYl5f5clRk9F5raEehjOYni26RPD2olpFUfZpBljjqpFfMNdx8QfGDaw/wBgsJGFin+sPTzmB/8AQRxj8/SuHr1MNSdOOvU+ZzCvGrUtHodR8MIhP8RPDsRYIHvolyTgDLCvsjXPCVrOttBd6XY6jbrP55F1bK4Rtu0/MwPGP4fWvhFGKMrIxVgcgjgg19UfBf4y6jrunDRdRC3GuQREpO+M3CD+Iju6jqO4GexrlzGi2lVXTsb5ZXkn7FW16PY+gNHtNKtLCKNI7W2t4OIUgQQpHgfdVR/hW7OHlgzbS7G6qcbgfqK8ljv3SD+1JF82KQjeyygvn2B616Po+pC7sIZbWEoGX5Y2YdPXivOoYhNOEkbY7AzoWmndXt0svI868Z6hfNfCC63eXCc+STgN7kjvWDq+iXF/aNqFrFhMZeMcFceg71640WlXrJJqEMMk5yN4BZQT79se9TzaRaW1oPsyhEA+8Dn8a5/qspXnzXPSo5zHDRhGMLNfc+5803CFG+YEUkWC7ZIAUbyu7buA/hz2Jrc8bQvBqjq0KxJkhSi7VbnriuXkbOc5rOOqPu6E/bU1NdTvdQOg/wBivG0ptbmSASxKiFyZP+eZ9B/tHFcJkFgxA+hqNWO0+/frSl+xwexNaW8gw+H9imuZu/c0NPjNxdhZA7lyAcHluexr0zxnfiGfw1bTxv5tuyh48gttBByoHJJAAz+Fcz4WjsdG02fVNRVLifKi3jALhGxnLY6fU8Co/GesfbNPsJoPPlvRulMpj2YB+6FOcnvzgU+m55eIi8TioJL3Y3V/Nr8v1KdsZxqlwllKkOlw3Uk8sxUJmM9Ad3RscYqv4W8QxeG/FU2oxWzy2QVwbeTHmFT0PPvXrvgLSdAudEKaYbXUJWIW4uHjKM+cEnaeoH9KzPG2g6Pp0V1BFaxS3E3zBGXJQH+Ic57Ec8D0rtjh5wjzpo4VmtCrWnhKkHrp2bXVvr+QzRLmy8M+Bvscssct9qjmW1MNuZDcM5yEXg5YZ/SuHbULX+170NpzPJCrRJbSAszydCzr1XHPHXOK2tP8NRf2Xp+rajfyTaHY3RC2wdgEz95gRzkHuD24q1oFvbadHq+tpbL9j1KYw6c0wEmyMZyxLEnk5PIq5N1Vyy0sTTdOhKpJNycn6a329UtWraa2YvhO5XTfMmvdNGo3WxUje8uCTEuMbVUqdq/SqulXw07X7m/M4itdJja7kRjvIBBWOPceTktjPWs/z2s9KvLi7eUvseQmPlio7KPXFFz4V1bUQLi1hF1p1xbRXJkhnQxsuDjLEjcykHIHTI9aj32lypuxpOlQUp+1aSlprt8ruy628yjaWl7r0d3qd/NtlvHMrrGAoc/T0GAPwrotLW3tNNtoSAjogDAnvVfTLrStC8J6nqOp3SeVY7ZFh8zaZUON2B16ccdzXy7438c6n4h1qWa0ubq20+NmFtAshBRCf4iMZPTk+lbUcPKbucGZ5pTwydJLRPRLTp/Xz+Zx6MyMGRirA5BBwQa+sPgD8VX8R2seha5N/wATW1j+SVm5ukHf/eA6+o59a+TasWN3cWF5Dd2UzwXMLh45EOGVh0INelXoqrG3U+Nw9d0Za7Pc/SuyvY3iBBBHQEVPBMIZxvLC3Offn/Cvl7w3+0Xp0Ok2ya3p+oG/CBZmt1Qox/vDLAjPXHat0ftJeFDEEex1z3xDFz/5ErzlRqp7HZP2PSWjPoa8u1jb9yxPoDxWNLd+ZI/uP1rxWb9pHwfKo3WGuZAx/qIv/jlVB+0R4S5P2LXA3tDF0/7+UpUKrd7DoyoRWsj2cB2YsQBnsaEZY3LORz0GK8Y/4aI8JD/lx1w/WGL/AOOU2X9obwk+AbLXMD/pjF/8coeHqfynV9ao7OR68bpJcpjvhhinzXEQfywV9weuK8Wm/aA8JkHyrDWQT/0xj/8AjlVP+F9eGicmz1ck8M3kx5I/77rCWGrdEdEcRhn9ux7FOFZ2KAbT1NZN2gBbOcZ4rzaT49eFyMLZawOOvlR//F1Tuvjp4clQhbHVt3qY4/8A4upWFrbcp1Usww8d5o7G9Yic5BwR0FR26hvlxtxyfWvO7j4xaDJKrLYanjvlU/8Aiqgm+L2hkkx2OpA9jhP/AIqtVhaltjSeZYZ7TR6XKqLHwSQeM5qKWUJGqs1eat8XtIMSr9g1AsOpITn9arT/ABY0x2JSxvvTnZ/jWn1ap2OWWPofzHb6nd7M7FyWPSvI/iB4mZt+lWMhGDi4dT/44D/P8qf4g+IEd9p0sOnwXEFw3AlZhkAnk8d8cD0rz0ksSSck9Sa7KGH5dZHl43Hqa5Kb3EooorsPICprW4mtLmO4tpXhniYMkiNtZSOhBFQ0UBsfWXwh8aWvjy0SLVFhi1WzXMyIMGXpiQAdR6+h+or1qHQ44LlJ9OvZrRz96Jzuic/7v+FfAvh3Wr7w9rNrqmlTGG7t33Kex9VI7gjgivoy2/aG8Pz2kKanpWp7toZ1iCMEfHIUlgSM9CcGvFxOAtK9NXT/AAPeoZnKpBRqStb7n8trntcPiRtLuDb3tqgG4/NEMrj6dRSeJde02400PaXrRTZJwgbKn19K8HuPjj4aXUEubO11gL/EkkcZx9DvP61vQftEeEUi2Pp2sMMYwYIiP/RlcqwmIacWjpnWwUJRqxd31s/zTTItSuLi+Du87Tup+YE84PeqNpDvO05yeDxWR4h+Lngu9ZZdP03VoJs/N+6jAP8A4/UeifF/wrZylrqw1SQY6LFH/wDF1msFXXu8p9PDiHBKjeMreRvXOmzxRq/lsVPTaKpEFCRtw1Xrr48+D3UiHS9VXjGDDHz/AORK469+Kfh+7vGka11GONskkRIT9AN/61o8HXj9m4YbiTC1P4slE6q1huZAwt/M+cc7ScMPQit3+yb1LEySQvKXACsWxsA7AVy+nfGbwbY2qRx6dq7SKMljDH8x+u+p7/486BcQJHBZanDg/NiGM8en36f1Kr1RjU4jw8ppQatfdnoXgrURpbLeNdx/bog0X2V/l2pn7wPc1Q8beKrrVZZCY04OEkVSMjH3ef4c/nXETfG3wiyfLpWptIOhaGPr9d9ZUXxe8NTeZJqFlqcrknbGI02qPb5/pWzw9fl5LaHPSzLL3WeJm1zf1t/X3ns2japp03hlHuLWS4trSPdJbMdsanu2BVPU7iw1m2gOkQ3NvZRg4MpzuP8AsjsvWvL4fjF4UWAxyWGquvoYY8H6/PTJfjVoMduBaWOo+dnHzIgUD2+erVCs1aUTOOYYKNRzhU1vpq7a+R6PcSqx2CM3GY8onfHTp1wOpPauU1jVINEn1HTZL22vfs3lyadc2u02su7mTzHJ429Bjjjn0rkh8bl065vbrQ4bqK7vLcWrTSRruhQZIMeGwGyTyc9uOK838S+KE1CxisNNtjaWSdQTlm9j2xnmt6eFfVf8D8Tnr5zTg24zvFbJbt/dp5k/j3xneeI5hamTFhA5Kqp4dv7x9fauQzSUV6MIKC5YnyOIrzxFR1aj1YUUtS2tvLdXEcFvG0k0jBURepNUZJX2IaK9Y0j4d2b20aXQaaYDMsquQob+6vqPet2H4b6BsAa1lZu585q5HjaaPUjk2Iau7L+vQ8Kor35/hx4aUDFjKeP+e7/401Pht4cKbjZS4z/z3f8AxpfXqfZjeTV11X4/5HgdFe8t8PPDSn/jylP/AG3f/GkT4d+Gz1spMH0uH/xp/XKfmL+x6/dfj/keD0V74Phz4a2ljZyYHbz3/wAaYfh34bDEfYpT/wBt3/xprGQfcX9k1+6/r5Hg1Fe9j4c+G/4bGVv+27/40f8ACufDWPmsZR7+e/H60fW4eYv7Jrd1/XyPBKK97b4c+GxnFlKT6ee/+NQt8OPD7LlbSVef+e7U/rUPMX9lVu6/r5HhVFezTfD/AEVWAFvKP+2zVSuvAmloMxwy4/66mn9ZgS8srLqv6+R5NRXd6t4SgW3ZbFGS4zld75B9q4Z1KMVcFWU4IPUVrCansc1bDzotc3UbRS44z2pKswCiiigAoq5pOn3GqX8VpaLulkP4KO5PtXqdt4D0S2s1+3LPNeEhViViAw7sSDx24wevUd8p1Yw0Z00MJUrpuOx5BRXssPgDRWyHtZc57TNgUXHgLQ1HyW0uR6zNU/WIm6y2q9rf18jxqivbYvh9oDRAi1mY9yZmGad/wr7w/sJNnNx/03al9ZgH9m1e6/r5HiFFe2/8K/0FQN1pLz0/ftxRJ8PdB7W0qj185qaxEBf2dV7r+vkeJUV7T/wgOhDrZykevnNVmPwB4cbGbKYH089qHiIoay2q+q/r5HhtFe8/8K68NkDbZzf9/wBv8aePht4cdAVtJVYc489yD7dan61Ar+y63df18jwOivpXSPAngaZ44L7QzFMeNwupirfju4Psa3W+E3gqV4YLfRHe5nJEUSXUu6TAJOMvjgAmpeMgnazKWU1bXclb1/4B8m0V9MXfwo8KywrJZWDFD/ELmT+p65rgvHXw0S0szNoUDLLDlpIjIW8xcZ+XPceneiGNpzdth1cnxFODno/T/hjySiil4x05rrPKHRq8jqkalmY4AAySa9W8AeF2sF+0XIZbyVPmXoY1Pb69M/lVP4eeFvLCX+oR/vicwof4R/ePv6V6bDDHbuuDglfWvNxmI/5dx+Z9LlGX8tq9Tfov1JYV8qIJsGRyBWlGQFwPTk1nQu7Sc5+Ud+n0q5y49sc151j3ZNIcSmeBx3NRyTFPlQZ9hTyNqcfexxjtUYhKIXbB/nmtFEwcrEZB4MmAT2FIfL3HOM1WupVEoGTuPamlGfB+b8DVcpDdibcWICjA7mp4o2IBC5HrVeHIGDkDPU1qWK/N0yPY1rypIzTbdh8VuxQ/yqUQMFUjDfzHsa0DD0AUg1IsKgEg/hWLkkbRp3M6K2VjtbhutK1qSGVgMjkH1FXngcEc8H05q39lDRhgeg6GkpXKcLHIXVnld2MEevaqM9rvB/vL04rrLm3yrHbgEcistrYkZxuK+h61aZm4HG3tmCMOuG7VwPjPw21xm7s0zcKPnQf8tAP6ivXdQtdwyBn1GK5u/g2kgjHfNdFKo4u5w4jDqpHlZ4LSV23jDw7zJf2KIiqpaaMcZ9WA/nXE16UJKSuj5qtSlSlyyCp7O1mvbmO3tYmlnkOERRkk1EiszBVBZicAAZJr2bwH4Yh0DTjqGoLnUJBt29dmf4R7+p/Coq1VTV+prhcNLETstupqeD9Fj8GWi7UiuNVnQljIodBkYztII45xnvzWlZ2vlksctIfvM5yfzqaytjM/mStudu5/l9KvrEC5Cjgd685zd9T6WnSjGKjFbFWOMnIUEg8D3p62oI+cHPWtS1twqkkDPbNK6LxtH5Cs5SdzZQRVihCquBn+lDQlVLHAGeh5q3tVfvNk+uKqSnk5Jx7DpTTE43I2zkbUJ9qiaMylV5Bx6VciXdyScA/pTgmXyrYWtY2OeV1sQxxgSAHOW655qyLUFWHBB7Him70BzyD05FWVcmMA9MflQ7iS6lIRmL5WyB64q1BDmP5D+PanOFON3zU2OVYmIHK44HvUNXNVqV3VxJhlFbNjqDQRxJMhnhQ7l5w8X+0p9fyrNnYNtbHOO1TWJ+YqevcmoehvA7mOa31G2hkjdDIBtZ1UASdwTj+LnBPU96zNT04SAgrtIGR/jWLD5tpOfsrlGxkgfdb610EOoNPbsREJZlTPkl9oJ9m7fWs3FPVGsPc0Wx86fFzwG1lJLrOkwYhPN1Cg4Q/89APQ9/Q89Dx5NX2xrtlDOjrETNAyj/WxbG5zlGU9cevQg9K+ePGnww1BNZeXw5bpLYzfMIQ2DCe689R3B/DtXdhsTb3Kj2PAzLLv+X9BaPdW2O7sT5ZJYEHOPrWjIwL7mGFUVRj2hgSOQ1W3Ysq7QMselcHLc+icuUuWkf7vdyc1ZLbCQemOKjSQQQDkZqqZXlfnA55NVGFzOU0ONyI23AZI701pJJBnoDSxRAvyuQPyqc8DAAGK0asY8zbuVjbAYYgZPU1YRegbBAqQNvAVQMgU2V/K2/KCR1AHWlFahJu2onl7wDtG0e1SK5tpQVORRAxK8/dJ5Iqy8KSoQNoYdq0kZwL1vcbyrH9elTxS5lKkjaay7VGxhsflWjAoLY6kd6wlBM64SNe1ALfOMVYmOzgDIPWs62uPLZUkHGfStL5JU24yB3rFpo00epQvVDKO4P6VQghyp4xjoa1JYiykDlR39apgBJmGCCeRVJ6WGomZdwjcem3+tc5qtoF4OMdq7i4thIg3AfNyQOM1h6laZUggD0NXCXQwqw0ueaeI4Aml3wJO7yJCCP8AdNeJV9CeK4B/Yt8QAMW8nf8A2TXz3Xq4Z3iz5nNFacTY8Hp5nirSE/vXUY/8eFe73LmfURCozBCNqnHVu9eDeE3MXifS3UZZblCB+Ir6FsbfyYY93L4zk9SSeTWOLdpI68oV6cvUuQRHooy3Q1pRW6oFOMn39adaRrhcjn17ir7Kqkbhx1xXC2e0loVto2EE4Y8c1DIAGwrZwMZFWJeVbgAZ4AqPCJGW6HpTUQehXaRVUAnJ71SmkXJOMCpLiTccKoz61GEDgKeKuMdTOTsiB5jKMICVHHpinfatiBWQkjvU62ycEdR1oMKlzldwArZWZzzlbUhSYS9Bge9X1kG0flwap2yKJGwhHtVoQvjJGPQ02rEpqW5aYKUw3UcVVlhXkklTip0cEMp4Yj8KmKgou4YyMg+oqLF+hm7sYDnBz+NSwMfNIX055qS6iV0OMZHeq8JG7OPbBpNXNoyNuJ96jf17c1ehhOFMbEMOeO1ZFs+SBjpW7bnEavjjvXO00dUUmWYZ/tEDW7YDA7ugyfx649qw7y1CztgH/CtCdSQksX3hyvP6GpYYvtkSyxd/vZx1o5b6otNR0Z5S+VY44w3ANXbAGWQEgjbUcylw5AyQc1bs9sSZIPIwPet4q6OScnezJJTlD+nFRgsvyjqeDxSmTPQ8AdqEYl9x6VUYEORZj3BNqjnvQXyDyMinr8wGzKnHOT3pPs5JJ70WVxK4RuqgHI59f6VHKdz5JNOMXIwMgDpShPnJZRjt9apRS1FKTFhJLDAOD6DvV62GxyxAIx0qFIyCHHUVaX5ifk5PvSktAiSGJlwUTAPOBU8atIw29e9LHtI2sfn7HNCvtm5zt9jWVjeLsXIYupd8ED0zUkbtG+RggcexpAVEZKYwetSxIDk43HHQ1m0ap21JopfMjxjafX1pnlK5DAgEH86SZVTJBOFGRmpLVfMVkXknkDPWs2ramia3JhGrLlhwBWVq0AYZQYHpitSNlIyDlPSq99jyzjk+1Sm09Acb6Hmni1FXRtSVQf8Aj2kzn12mvmuvqHxnb/8AEm1J8gYtpP8A0E18vV7GE+Fnyubq04mv4SGfFGkj/p5j/wDQhX0da4eaMHoBXzr4KG7xdo4xnN1H/wChCvoq3XFzgdRzWeL+JHVky/dy9Teg6YUDaOnbFTggHJ59z3qC1JVCMjninFWyqnmuA9ohuWaMk5OBVVmdsEjNXWhJ6noetMlQIOnINaLzIkyk8WOccUKAOMc9MYqcJvKjJJPQDqTUcyeUSGBBB79qtIxkmyN0LArnB68VHkoMHnI9KGLbAVPAOTTVZCxYn5h1FaxizN2H2xDMQTtPcmrCyhBtGWOOKihWJxkAZqXy0VUOccdqpq5noiIgygmMj/dHrVuC4/dbHQAgADjrVXd5bktgE85HSrEbq+T8ucVDTRrFrYHyAQBkk/lVR/lbgfWrxU5w3Kkc45FVJItqHnkcVCepolYtWigEmt2AZRcEjNYdp8jrzwa27cjaMYz6Gokup0U5dCwybNyD04J71nrcz2E8otyWSTBwexrUuPlRST2qlcRrOQ3APftUxlbYua5lqcbfWRiJIzwazGLs2xcjHXNeg6hYq+4MvPQjHWuS1eyNtITgAZ5owtXm0Zni6WnNEzUJXn+AcgCrluWxu/HHTFUkfccAcgYGa0V2MFWMAEdSe9drWhwQepetSWICgYI7VdMHynJ5PXPaqdm5jYEAfXHSr6SqwJYhaxaOiIwQgkLk89yKfJbncyeSG75Aq+0YAiDcBlyB3UU54v8ASiLWOWQFQFTYSxPfgc/lQuwSt8TMI5UMAT17+lTxY4IbBHr2qWW3ZYmbGXyd2KiVQVKge9U7EJ2JoiTLnsetTSRlRvOWJz9KrqwUlcgGraOGiwOc8njpWbVjVMIMvMFd930q/EpU4PQe9ZyQsrhowWC8kDqKtRyGRvvVnI2iy6ULqRn5QKrzKYmIVsHrU8D7QvPy5xn1qO+kB4C5PWsrGyTvoJHIHRQDyOvpS3K7ouTx7VFbGNEVV4yMnPrU7MGhAIyaTWprc4nxmcaHqWQQBbS9P9018r19Y+M4Smj6jxx9ml7/AOwa+Tq9PBfCz5XPP4kfmb3gMZ8aaIB1+1x/+hCvo3YVuGbJxnGM186fD/8A5HfQun/H5F1/3hX0vdW4S5bjGeeKnFfGjbJv4Un5lnTwZG45rT+z+WAQOo5qvoIXO5uAvPNXL2ZWX5DjNcMou57MXcz52waq3D5XrnHPSrUaF1ZiCF7VBJCpXvkHritYxREmyvFIqgMPvDse1QO/myMxP0p7owbB7fyqGY4wMfL2rS1jF9ycJwAMjtjvSLDtZc8Coo5RlcFj2qykoXBB+Y1aMxPJGSCcEc1r6Bp4v7kQNbXF2FhZzHbsqSKBj58twQM9D1zWbCVcsHbac+netK1Z0DNF5gVU+ZoyQdp4PNNMzqJtWRmTrG6tsYMOn/66pZMLDdyh966HXrye+8q6u3aQIotkmMe1eOQmQAM98dawZFZkwxG09Diq5ehMZNepZVgCoDEK3OPWkuR5gJGBj1qhE7gDdkkGr0TeYSeCCMEYzWcotbHRGdyRJGWzaJkUMHD7sfNgentWvps6iVJfLRwByj9GrMhKuHibiU4CuxwFI7H69KsaexjuHTGwjGFBztB7ZqHG5rCSNVmJt2Vm6jrVVC3J5NWA6FgpHB65qtLiMjbkA88c1jax26WOlv7cMHZAeG9K53XLJZ0+7yRjp0Nejz2Kx2nltyetcrqdqCxVRyKwp6bHHhsQqi5Tyl4TC7Ky4xkZ96s2qZ29M9ateIontgxC5TPzHHOKpwTRPDE67yCeRnke1eqryimck17Oo4mmoZXxxxxxViPucnJwCKrW0gZgMn/gXWrIIwTuBx79fpWdjRSNK1XdudmJZjznrVuNfnQb18xTuLN0HpWTBKMAiQoTxUhuR5wDBc4GSP4vc+9RYt2NPUI7R72GaNPtNswLTWzkrubupxzjOCMVjSxbJWaM5XOf90Z4H4dKtWE8LatbtewvPp6hjJBGQHlYjAU5IwvOSevFU1klV2W5jWNyzERx8qgycKPXAwPwrWzUTnUrztYdIBwQuaFYc7DnHcVEp67hhV5PNQpMquwUEc8A1nJXVjog7M1UuQWTcAAoIyKdEwYMSc4/XmsyFi7DJOa0YMbSv8qwkrHXT1J1JHzEbeOM0SSuAwPVhg/SmMDtUZIIOOewpTtARzIDg4xis1udFi3CkbQKXTa4ByRk7/TPpinqMY9B3pkThQGJzzgU4uFwWGVzxVPUlaHL+Nn3aJqLYPFtKP8Axw18kV9b+NSBouprnLfZpfoPkNfJFehg1aLPmM8d5x+Z0nw4QyePdAQdTeR4/wC+q+rr233xhwuGHGK+WfhMN3xL8ND1v4v/AEKvsfVLEwymZVyh+8B/OsMdK00zfJJx5JQfVnJ6c4UmM8HPBq5Jjp696bf2ZhcSxDKdeKrWtwJJCZOOcVjF8yuj1JJwfkW3OIiBwBVGXIPOM1aaQSO2eQKzLp1DAds9BRbUd9Bkkm3Axn3qlLkqxzUlxIuQT8vp71AjD5gM/XtW0UYyY9HAXa2Qf61JDISR94gVGx6DAyevFPQ7duAOeOtNakPQ0baVcgAAkEZVzwfepluFiM0bR/M4B4P3TnNYs0yoGLfw9Riks7ppSGGBng5Ga0SuiLo7TSLpW8L+J7VgqxLb+fnJDTPg/J9OB0BrjxKsluDG27K/NirtpZzy2t7NbKXS2j33DZH7tD3569O2TVCNFi4iUYPNW9jKKjzPXW5DLLgBsYx1xU2ny7pApYISerNgD61HdgAHA455qK2YAqQAc/LyOhpKNy78uzNi9U210Y3IJU4JAPp71Y011N25O/lAOfX/AAqtfK8uXJDNGCCd2cADrml0cqWeQ5xjGazastTWGr0NiRhG4JIweMU75X5YA1FJGH2swFWEVQgBGa52j0Iu56xqNpJ5bFQSuOlctPAwdyy/NjpXocqhxiuY12HEuVAznms401F6HzWBxLvys8v8T2h2TOFJWJd5OeDzjBrjLq3eCSJkgeGSZd8fykbx6j1FenaqslxZanGuI2MO4kjqoOeK851NDJavJJI26PBjB6AnqPpXdh5aWO/G6tPqRrcI+wkEHHzZPfvUscv3lU59MGsi8kjkcCFTEhwTGzltjY55PJBpouvLdtpIVex54711OlfY4oYlrRm3Fcu6ggcjtViO6YctFvP90ms63kWTo2eByDVuKT5unIrnlCx2xq3VxReGMDeDtPvUnmb2DoAAfemFVaPjHPPFCsNqqo59KB7skDlnyflwOmetIX+UEjBI4qGZgqH170kThwAx57YrJrU3Who2p2rkDOeue1aFqPyHvVCDd8oxye5q9DOF4Ax6+9c81qdlN2RLKpJLsPfFNmSRrVJNmATgUhnGV6ge1SxyOIDG7Axdee1ZuLtoac1x8OXCAYB9KWZhE37wBu+M1FA+4iRBhUzj6+tLdSxSW9t5UQSaMMJZP+ehJ4/KtEgk7GD4sUf2NqZQZzaynOeB8hr5Kr668QJu0HVCAAv2SUD/AL4NfItehhtmfMZyvfi/U674R/8AJTvDH/X/ABf+hV93vGskZBAYd6+EvhAm/wCKHhdc4zqEQz/wKvujUEurWGSRCojjwS23JI9MVxZjfmTMcv1TSetznb6yNtIw2boG6/7NYOqaSWXdbjHfI7+1ehNZySQA3UbwsANyEcjPTOKz7jSntDhhmJuhz0+tcdOTiz3aeLjJcsnqeWzzPA7Jjkdc9qryzfITgH1rsNc0MTK7phJOeRXA3yy2lwYZsg9QRzxXdSan6lVE4rmjsV7ppDdod2F/ujoasxOxQ5UY71AWVnQt2OMj0qVGRQSG9s10NaWObmT1LOcpjqajdRjlh0z+NReb8hAPzZ4IFJ5jEgNycelJKwOQ5wHTBHzdjU1qSq/dAOKrqT3OKni3SbtmMIpZj6Ada0SuZyehozgw6YiXFi4muH862v2JUPFgZQLjDjvkHjNV4uEwcc8gd6rC5uoo1tbh2ELKJo4y25VB6ED+HjsKQS89z6CqqR6GNGSC/J2Ng1Dbf6ljgcc81He3QLkYGDS7kjgBUjJXuc5NQk0jfnT6mi82LUg87xtHNaWlQFlRSuBwT7isrS1RiHmG7j5Fzjn1NdHZEKdzfnWdTsdFBN6l6WMrHhgFyc8VGVK4wuRirMf+khSSPlPQUsqnzGVBwvBya5md6VtD2S7lMS5ArlNbufKWWRnG4gYXPNdNqbBRk5wBmvP/ABrfxiIRR58wjHA6VNtWfNZdT5pLQn0rUNOt9NEt9JH57szbc/MAK81vXjmu7uG2gjvDdLmMN8nksCTwe5x1rSsdNnvZo1mLIjDIYgnjPXitSbw5Bb4Mc8MoHPmlSpYfRup/CtU1Sd5M9KqoSk1G7b+48+t7R57q3DeXOZiyqu/YVI7MzcAg8gHrVCFLuwxfRJJGu9oxKBggjhgDXWm1k0vUI72zhjbLEKjgOh7HINYd9qDQWlzYXVuPs63DzxRjLJE7Dkf4Gu2NVz80ebPD8vkZ9vNHEq569RnvVwTCRCeQvqOawl/0qXYHERYYQu2Bn3NXPOaGUwTApIvBDHj8PWtJQ1KhUVrGtFIACDz65oMqh+hrPNyVBG7P4VC1yectwO1ZuFzeM7GlJOp+XbipInC4x19KzIHDMCenpVyBw5YhsAVm4WN41LmzBcAEcEHFSCcYJyRk96xhcKGwG9s+lSRzHLbGJrGVM64VdDWFxg4Izip4ZC2W5A9BWVGdvzM34Vo2TIQdxJz7Vm0jaMmy/EpeP5MqueuKc0SLGELfL2zThOoAVexxx3p1wqpEsjc59Ki/Y1ab3MDxM4Ggakgz/wAesuc/7hr5Jr6t8SwzXGl6hFAAzm1lIUDtsNfKVd+GVkz5rOnecTtfgqM/FrwkPXUof/QhX6JmBdpXH6V+dvwT/wCSt+Ef+wlD/wChCv0YUg1nioqTSZ5EW1sV4reOFNqIAvoBxUM9nG6FcZHoavkZpu3J964XStsaKpJO9zjdS0sojAIdv05FcL4g0eK4BEiE88HGD+Fe0Txqw2tt59awtS0COVHfeD39MUKnJPQ9nB5ko6VD5+1jQ7uywyo0sHJDAfoawUn2sRzx617lfaK4DpComiK7mVeoA715v4u8PJYqbpZP3LtjLDlSR0P+NdlKrf3ZHVWpxa56TOY+0ocYJz7VJ9pygGc/pVI6c7RvJEM7ehD9PrUDIQ4VpcHGSW6A+ma61CL2OGVSSNeOcEDB4/Okmm328iKRl1KkEHGPwxWTyJQ0Lo8AYHa+fmHoQOfyNJctNHmRsBWJIwCAPbnn86tQRDqPZnYeJdZTWLyynVnKxW4j2zbS6MD93cqqGGMY449ayZplCEgk+9c75s33mlAJHAzUnnEw/wCsO/GW4qnTREKllZF24lVgCSQB0qv58jzkgMQOq9gPpUCMwGCCT15NPhj8xwWkK7uDiqikgm5dDe0/UgjxJ5bE5wSTwa7XSdRaCTMcRk3AqI+oOf6159bR5IZQFjRtue5/Cu08Kxzz6hDECcIcZyVw39DXJWit0ejg6j1jI6OAbCzFCoYfKOmKikzKfkJwOp9TV/WMK+yLAJ+UDtUOwQxxpznHODXCz14y91M7j4ha5baDp8l3fSrDaRJueQ5PJOAMDkk8YFcV4RS28Z3c5drq18oozx3MLwSMDnBG4DIODyK1vjBosvifTP7OtZRFcB0lhdhlQ6NkBh6dql8GnX9Ptrn+3otOjuPkEQsy7eudxYDg8dBxQ3GN5dT5+hOpSopQ0bX9ehH4h0Y6M8ElhJthL+WqyvtKE9lOPmz9Kvw6XDJPJGn7s3CKPLmiLGNh1ZW5IY9wa6e9hjv7eKe9hf5BkIrcZqilrJLPa3Fsp8hvvAHdj69+Kz3lYUMU3BJvVehwmveHlNpc2121xFIAQssI2lOeq9m/GuO8VQqb+71S2kt3l8pPtVo0Ji4UbQUz8rscAkA5ya9916wS4tw5X50HUenvXnWr6LHqpkQOqNG4LP8A/X7E/rV83sJ8rehvTxH1qlfqeMPbgxQSlU2OGIwQWUA8h16qfQN17VVvrYQzwtEmzzWUR5I2nPA9hXoXjK3t7DTRYGyMN7C/mRSAj5B1yfc+h4xXDeICiWtjqE90JlvITcXEaRsxtm3lPn2jCo2AQTivSw9V1LaHHWpcl0x1xarbSTWOYmnRtrTs+AH7qpBII96y8TM+2OPcw5wK01sLmO+Nv5VzZXUKjMMqFHAYcEA9j61oJpNzFqstiYhJeDEYUH+I85B6HIquZrcFFcqaehzgkmjb+ONs9TxitN2hSxgCPeSXrMTOzsnlEc42j7+7pnPHWu0l8Gat9iH2ixW2ncjyvMlVi475VSfw71zeohLRmtLtF+0wOUZRyQfrU+1jLRFKnJ2ne6/Ar2TxR/65cnsavpPEBlFIB6GuemdRN+5JweoI/lWxoUf2q4ji4y5xuJwAaynHqehRaeli08m4bsDI9KuWcnYEt6+9SS2y21w8MqqXQ43DofepbKNUkJUYBPT0rndjtjdbl60Qp87ZPPftUiJNqEqRW/J6nPQfWl3AJsC7i3Awa6PRLAWdtll/eSfeINZ3V7suc7RKGq2Nvp3hnVMYMhtZSznqTsNfDdfcPjjf/YOpKgP/AB6y8D/cNfD1deFle58/nEbcj73Oz+Dbbfir4VYdRqMP/oVfe2v+MtM8Oy2EOoi6ae+LLbxW1s87yFQCwCoCeAc18C/CE4+KHhc+moRf+hV9m+LtI1bVNd8Mapov9nvLpE00jRXkrxq+9AoAKox9aWItzq55tOnzU20eh+HNasPEWkxajpNwtxbOSuQCpVgcFWU4KkHsQDWky4rlPhp4bl8NaPfC8uIp77Ur+bUrkwKREkkpGVQHnaAB1rrW5U4Ga09nFx0MXuRSKHQqe9VRv4VwCy+vcf1q1vXBJOMdcjGBWbfrMZPOSVTFtwuOMH39R7Vy1Fyu7NqSu7Mratbu0MxBjVdueB0rkTp1vdQeZeTqkJfbIzgBMdsk11wuhcw3EZyZBHyrDlgK5TUEWNo1SMqepR84kHsexrnqSs7o9nAuaThezOK8UeHLGCcQWRBCITmPgHP8zXHweH7m7u0iSKSQKNzKW2lvbODg/ga9U1O1MbMiwiMHgNvwfpg5/mK5TUw+nTZgkT7YcbTG+9T3x9aqnWmmetGhSqU9d/67HHX2lXGnXBSS08twcgJJjaPoeSaoanjUGETkeai/Md5yfrnrXr13cafc3sJV0lLRYmkA4z6j1/nXEeKtDSdJryxtFiBPLZIUDHYDseuetdVPFa+8cc8E3C8EcLFZh5rgSTRhUiMgaQlQ5BHyJjjdzkA4HFJbulu8u6NZkaMouWI2E/xcdceldFFZSafJdQva78qCqXJBaMEdTgAFuuMdsVg3EfltjaQBz1zmuh4hSdjmpYK65uhJ5E5ClVDfLnDdxSbJ1O5lKgdNq8CnxXEtu4K8jHQ8iuhVtS0vTjMsU0dxLMJRcCQFUjK4KCPGM99/XqKv2hE6Ti/MXQYDfHYtwbckYduQGHocdq7nw3bvp9n5xZQpzhW+8W/vE1xHhdpRdiUqBHKcHjt3xXceclzlACkCfyrjrTd7HpYWimuZonifcXnkxx93d3qo7SXDk5IAprzNdThIhtjHt2pt7qdvYOkI37gMnaN1c8V1Z3TfKc/+zT8Uf+EnvY/D/iy88zWI1xZTy8G5QDlGPdwBnJ6j3HP0j9likLMME9AfSvzBsL240++gvbGZ7e6gcSRSxnDIwOQQa+7f2e/izB8Q9E+w6gwTxLZRhrpQoVZlzgSpj8MjsT6Gu+ph4yfkfDOrOS1ex6cYZJUe3YvHxkSKMflSWp+xIEuPmf7pl6b8dCavNuB4/lUM4juYmiJBb68g1z8kafwu0l36+Q1O+j2M/UtTjCuiqrx7fv8AUKe2favMZ7yGS/dJ9pUyeeIjwCydMgcEZ5ANdLrOlXdpcKVukXzOhPAzXH6rpN/ewyOXtzKWwJQxRlI7ADORXBKpKVS83qfQ4KjSp024u6ZzvxBmkupo7qGQl1wwAHcHIJ9TXI6ZearY315LazXEZuRtuvK+5KCMHcMYP5Vo3k01tq8UGsC4t7eNsSqY8OV/2T0pker2yFkRAqMSOmDjtXo0k4x5WrmdVxm/cdiL7deRahFcSSySShTH5jjMjD/aPeuw0CfULrUkurKJ1uDEY/NkGDs7hR3+prAsLU6myRxoFGdsaE8475Ne2eEPDsZgS6QtEsiAbl+8QOML7e9dSoxqK8kc7r+xWruvPUpwafqS27wpcTLdzIDHgFGjH8WQM5U+p/CuY8R/Dy5vE8zYV1F5MtMWLCUY6Edq9ns7OCzQrbpt3HLEkkk+5NWMU4UqcHeKOOrmE53VtD5P13w1eaHeJDqlp5ErgmNcgh1B5KkfyODUGmKwnKxKRlvlHcV9CfFTQhrHhmWeCESX1lmeHA5x/Eo+oz+IFeK6NaKZ45YiDuwQBzmqrxThzo6svre0917mhNayBQ7LuYcEkYqHbjPy7ce1dVeWvkWQRWDE/Mfb2rk7252syqOc+leXzH0NKN43Njw9Es10Zn5EZwPrXXbxGoIOSeOlcvohWG1Ve55Jx3rifjD8Sv8AhFbD+z9KlRtcnXI43C3Q/wAZH949h+PpWWspWWrMsTy04889EjB+PvxHFuk3hvRZUe4lXF5PG+TEM/6oY/iPf06etfO1Pkd5ZGkkYu7kszMckk9SaZXq0aSpRt1PksViZYifM9uiJ7K6nsruG6tJXhuIXEkciHDIwOQQa+xvgx8TbfxppHk3jpFrtsg+0wjgSDgeao9D3HY+xFfGVaXh/Wb/AMP6vb6npNw1veQHKOBke4IPBBHBBp1aaqRsyaFZ0ZX6dT9HdO1Iqg3EEH9a2re7SVQeAa8S+Gnj6z8YaCl9bbo54yI7mA9Y5MZ49VPJB+vcGu+t9SwAdwxXn87pvle56VTCRqx9pT2Z2Lsr8gnKnOQcfhVeXb5TBsAkktjoPpWB/apUFg+Tn1qhd6/GrbXZhngkc/8A6qmdS+5nTwNRuyLt7ZSx3ttdxeYpiJZX5CkkEYPr9KrzTW08WdRi3zA5LjgsfUiszU/EUk8tv5krSWsT7miT5DIMdNw6Vd0y5gvAGnK7yxLBVwFGeAPoOKV4vSOx6PsakIKVRbdiG4tJtRD+WuUxxuGQK5bUNKhszNGXvIY5I2Ja7gimhd+wUIA6n/aOcV7PBbQxwBEQAEdR1/OvPPHdvvnMdnOLS9glEsM9uuxwcZAY/wAQz2PWt5UVSjzGeDxf1ifstl/W/wDwzOPttFK2cN7bXNnLKufMTeWVSDwFYDDHHJBwRkcVoWOpW8ljJb3KRq0o2Btu4Z9CKi8SavO+qXFzADb3E9ottcIgASVhySR356E8gZHSubsMyTiHbtjMZLFiFUEdtx4Fck5xcvd1R7VGhVlT5qvrv/wCLxFaCG6cbpWyAFJG4kYxj3HpXEXO8OxZfkxwCOtdzri3jn7TdShfNXO1AM4HHA7dK5idJHTzLaJiyuG8xyGymMbAhHJJ53dvStKL6sqqmoqKMy3tn+zNNIQAcgLnn6itpNeT+y0smRd6ReWCBg49T6k+p5qtdRXMkDSOzKjH7qDbkDtx2qtbWsYWSa4BG7hc963dSMlZnKsNNSTsbNjdGO1hVFIVTnOO1b9vdNeCOGLA2nHLBR+JPA+prItGVoScMGYYGR0A71Il4sMxtbGMzXDYxGo/n/hWdrs6XJQRuX17HYJFBbustxIpbB+RUxyzM54CKBkv0xXg/iz4r61DqjweEtTuLC1jJEtxBIQ14/8Az0bPQDooHb61B8SvGLSNe6RZXCXTTNtu7soOiniGI/wqCOWGC2cHgc+ZV2UaStzM+YzHHOo/ZxehJJGUcqDnvmtHw3rupeG9ZttW0W6ktb63YMjocfgR3B7g8Giiulo8k/Qf4P8AxBtPiP4Qj1a3ha2uo28m7gOSI5QATtPdSCCPrzXb7RnoKKKVhsztZ0pNTgMbvtHVeM4PrXB+JNFu9PSN4AkJRWLTRNhZfUFc8GiiuSthKUk5W1PSy7FVIVI01schrmqx6vpMkF1ZWctxDCYYjIrA7jjDsw6lRk45ya5y40Ozto4b6xumks3lNurvHtfcF3E7eQB+NFFefSqyjdX2PocThqaUWlb+rm54Ohtj4usbDz/P+1SFgShXgLkj9K9+hgWLIThcYC9gKKK9mm26UT5rMPdrOC2RNRRRVHABAIIPNeReItNt9P1O6t4Y40EbbkCLjarc0UUpawaPTyp2r2MC6uvLVgXJz93PauQu7xZdTKZ5B5460UV5bXvH10naI3xl4yTwpoRuAolu5G8u3jYHaW9W9gOfevmXV7651LUri8vp3nuZ3LySP1JoorqwcEoufU+XzmvOVVU3skU6Siius8YKKKKAN7wd4mv/AArrkGo2EjHaQJYdxCzJ3U/54r6y8L+L7fXdJtr+3MgjmTcFYYKnoQfoaKK48ZFOKl1PbySpJ1HTe1r/AJHQQ6juxgE575qvOwZmYnnPAFFFeafTRgovQLbUFeTZMg564HWr6SpGu+MED9KKKIu4V6cYtWNS38U3drbiLdlQOC3JA9qw7u9admkfJZuSc85oorSVSUtGzKlhqUHzRVmyoZohLBIUR5EcHY65VgD0PsaxNQeNASXJO4kqowMk+lFFYTSuejRikyg9xblHWFMueDu7mseS+eKReFJXhuO9FFWkrlTlZtFfUNVlliCvLzjjjpWbHcoz+ZdPuRPuqM/maKK3gjirVHYnGqtOHETeWrnBbv8AQVx/xG8UtpNjFp2lP5d3dR7ppACHjQkgc9Mt1yOg9D0KK7KcFdHgZhXmqTs7HkFTQQ+YCd4XHqKKK7Yq7PnD/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Sessile polyp at hepatic flexture; (B) Immediate bleeding following polypectomy; (C + D) Bleeding controlled with the argon plasma coagulator.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jerome D Waye, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_61_41937=[""].join("\n");
var outline_f40_61_41937=null;
var title_f40_61_41938="Elbow lateral view";
var content_f40_61_41938=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F61667&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F61667&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Normal elbow, lateral view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 623px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the normal small anterior fat pad (black arrow), and the normal alignment. The radiocapitellar line (white line) extends from the midshaft of the proximal radius and bisects the capitellum. Dislocation or displaced fracture of the radial head or capitellum will disrupt this alignment. The anterior humoral line (black line) extends along the anterior of the humerus and should cross the middle of the capitellum. A supracondylar fracture can disrupt this alignment.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_61_41938=[""].join("\n");
var outline_f40_61_41938=null;
var title_f40_61_41939="Bladder exstrophy prenatal ultrasound";
var content_f40_61_41939=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F64600&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F64600&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 602px\">",
"   <div class=\"ttl\">",
"    Bladder exstrophy fetal ultrasound at 31 weeks gestational age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 582px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of: Dr. Joseph G Borer.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_61_41939=[""].join("\n");
var outline_f40_61_41939=null;
var title_f40_61_41940="Metaxalone: Drug information";
var content_f40_61_41940=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Metaxalone: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?40/33/41491?source=see_link\">",
"    see \"Metaxalone: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F193793\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Skelaxin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F193794\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Skelaxin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F193805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Skeletal Muscle Relaxant",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F193796\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Muscle discomfort:",
"     </b>",
"     Oral: 800 mg 3-4 times/day",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F193802\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children &gt;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F193797\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F7292032\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use caution in patients with mild-to-moderate renal impairment; contraindicated with significant impairment. No specific recommendation are provided in approved labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F7292033\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use caution in patients with mild-to-moderate hepatic impairment; contraindicated with significant impairment. No specific recommendation are provided in approved labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F193774\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 800 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Skelaxin&reg;: 800 mg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F193760\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F193776\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be administered with or without food. However, serum concentrations may be increased when administered with food; clinical significance has not been established. Patients should be monitored.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F193775\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relief of discomfort associated with acute, painful musculoskeletal conditions",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F193812\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Metaxalone may be confused with mesalamine, metolazone",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Skelaxin&reg; may be confused with Robaxin&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F193803\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness, drowsiness, headache, irritability, nervousness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash (with or without pruritus)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Gastrointestinal upset, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Hemolytic anemia, leukopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Jaundice",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Hypersensitivity (including rare anaphylactoid reactions)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F193779\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to metaxalone or any component of the formulation; significantly impaired hepatic or renal function, history of drug-induced hemolytic anemias or other anemias",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F193764\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment; routine monitoring of  transaminases is recommended. Contraindicated in patients with significant impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment;  contraindicated in patients with significant impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Muscle relaxants are poorly tolerated by the elderly due to potent anticholinergic effects, sedation, and risk of fracture. Efficacy is questionable at dosages tolerated by elderly patients; avoid use (Beers Criteria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Females: An increase in bioavailability and half-life have been observed in female patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy have not been established in children &le;12 years of age.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F10096444\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (minor), CYP2C19 (minor), CYP2C8 (minor), CYP2C9 (minor), CYP2D6 (minor), CYP2E1 (minor), CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F193769\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F193790\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Food: Bioavailability may be increased (may increase CNS depression).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herb/Nutraceutical: Avoid valerian, St John&rsquo;s wort, kava kava, gotu kola (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F7292029\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal studies. There are no adequate and well-controlled studies in pregnant women. Use during pregnancy (especially first trimester) only if benefits outweigh risks.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F4298405\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F193781\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administration with food may increase serum concentrations.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F193780\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Metaxalone Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     800 mg (100): $489.10",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Skelaxin Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     800 mg (100): $544.04",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F193782\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Skelaxin (CA)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F193763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Precise mechanism has not been established; however, efficacy appears to result from disruption of the spasm-pain-spasm cycle, probably by a general CNS depressant effect. Does not have a direct effect on skeletal muscle.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F193778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: ~1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: ~4-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : ~800 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic via CYP1A2, CYP2D6, CYP2E1, CYP3A4 and to lesser extent CYP2C8, CPY2C9, and CYP2C19",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Not established; food may increase",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 4-14 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: T",
"     <sub>",
"      max",
"     </sub>",
"     : ~3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (as metabolites)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/61/41940/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Toth PP and Urtis J, &ldquo;Commonly Used Muscle Relaxant Therapies for Acute Low Back Pain:  A Review of Carisoprodol, Cyclobenzaprine Hydrochloride, and Metaxalone,&rdquo;",
"      <i>",
"       Clin Ther",
"      </i>",
"      ,  2004, 26(9):1355-67.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/61/41940/abstract-text/15530999/pubmed\" id=\"15530999\" target=\"_blank\">",
"        15530999",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9691 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-200.131.240.2-B63444C5D6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_61_41940=[""].join("\n");
var outline_f40_61_41940=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193793\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193794\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193805\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193796\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193802\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193797\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7292032\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7292033\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193774\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193760\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193776\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193775\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193812\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193803\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193779\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193764\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10096444\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193769\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193790\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7292029\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4298405\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193781\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193780\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193782\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193763\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193778\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9691\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9691|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?40/33/41491?source=related_link\">",
"      Metaxalone: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_61_41941="Pseudofolliculitis barbae 2";
var content_f40_61_41941=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F69365&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F69365&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pseudofolliculitis barbae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Tight, curly hairs that have been sharpened by shaving penetrate the skin. Inflammatory papules and pustules that resemble acne are evident.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP, MD. Goodheart's Photoguide of Common Skin Disorders, 2nd ed. Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy;2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_61_41941=[""].join("\n");
var outline_f40_61_41941=null;
var title_f40_61_41942="Parasternal long axis color flow Doppler I";
var content_f40_61_41942=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F57208%7ECARD%2F68945&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F57208%7ECARD%2F68945&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 476px\">",
"   <div class=\"ttl\">",
"    Parasternal long axis view with color flow Doppler",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 456px; height: 355px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The long axis parasternal view with superimposed color flow Doppler mapping of the left ventricular inflow and outflow tracts was obtained during diastole. The color bar in the left side of the image indicates that red designates flow towards the transducer and that orange shades of red indicate velocities at the preset Nyquist limit of 0.75m/sec; blue identifies flow that is away from the transducer. Normal diastolic mitral inflow from the left atrium (LA) to the left ventricle (LV) is color coded in shades of red. At the point flow crosses the mitral valve (MV) plane it becomes bright orange, ie, flow accelerates as it crosses the narrower diameter of the mitral valve ring, reaching a velocity that is at the upper limits of the instruments ability to measure. There is a small diastolic signal in blue that arises from the central portion of the coapted aortic valve leaflets and represents mild aortic regurgitation (AI); at its point of origin, this flow is characterized by red, white and blue dots that, by convention, identifies the flow as being \"disturbed\" or chaotic and high velocity. As the flow decelerates it becomes blue identifying it as flow that is away from the transducer.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Parasternal long axis view with color flow Doppler mapping",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 384px; height: 285px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Seen is the long axis parasternal view of the left ventricular outflow tract during systole; a normal color flow signal (red-orange) is seen in the left ventricular outflow tract. The occasional blue patches in the signal represent aliasing and suggest that the signal is at or exceeds the Nyquist limit.",
"    <div class=\"footnotes\">",
"     Ao: aorta; IVS: interventricular septum; LA: left atrium; LV: left ventricle; MV: mitral valve.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_61_41942=[""].join("\n");
var outline_f40_61_41942=null;
var title_f40_61_41943="Isoniazid hepatotoxicity";
var content_f40_61_41943=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Isoniazid hepatotoxicity",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/61/41943/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/61/41943/contributors\">",
"     Anne M Larson, MD, FACP, AGAF",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/61/41943/contributors\">",
"     Amy L Graziani, PharmD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/61/41943/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/61/41943/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/61/41943/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/61/41943/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/61/41943/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40279?source=see_link\">",
"     Isoniazid",
"    </a>",
"    (INH, isonicotinylhydrazide) is a synthetic antibiotic that is bactericidal against replicating Mycobacterium tuberculosis. The drug acts by inhibiting the oxygen-dependent steps in the synthesis of mycolic acid, a component of the mycobacterial cell wall. INH has been associated with two syndromes of hepatotoxicity: mild INH hepatotoxicity and INH hepatitis.",
"   </p>",
"   <p>",
"    The pathophysiology and prevention of INH hepatotoxicity will be reviewed here. The clinical use of INH is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/13/9432?source=see_link\">",
"     \"Treatment of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/21/19802?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MILD INH HEPATOTOXICITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild, nonspecific hepatic injury occurs in up to 20 percent of patients taking",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    (INH, isonicotinylhydrazide). This is typically subclinical and evidenced only by mildly elevated serum aminotransferases (usually &lt;100",
"    <span class=\"nowrap\">",
"     IU/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Liver biopsy in such patients usually demonstrates minor, focal hepatocellular damage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/1\">",
"     1",
"    </a>",
"    ]. Adults are more likely to be affected than children; men and women appear to be equally vulnerable. There is no relationship to race or the rate of hepatic acetylation of the drug.",
"   </p>",
"   <p>",
"    The prognosis for mild INH hepatotoxicity is excellent, with an overall mortality rate of only 0.001 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/4\">",
"     4",
"    </a>",
"    ]. Virtually all cases are self-limited; INH therapy can be continued with careful clinical and laboratory monitoring.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INH HEPATITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;INH hepatitis is a less common but more serious liver injury syndrome than mild",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    (INH, isonicotinylhydrazide) hepatotoxicity; it is typically symptomatic and may be fatal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. The features are generally indistinguishable from viral hepatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/5,7-11\">",
"     5,7-11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Prevalence and risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;One meta-analysis of studies published between 1960 and 1980 noted a cumulative rate of hepatotoxicity due to INH and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    of 0.6 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/9\">",
"     9",
"    </a>",
"    ]. Subsequent studies observed the risk of hepatotoxicity associated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    prevention therapy for latent tuberculosis was 0.1 to 0.3 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of INH hepatitis varies among different patient populations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/7,10,12,13\">",
"     7,10,12,13",
"    </a>",
"    ]. Age is an important determinant, as illustrated in a surveillance study of 13,838 patients receiving INH monotherapy as treatment for latent tuberculosis in the 1970s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/7\">",
"     7",
"    </a>",
"    ]. The following rates of hepatitis were observed:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      20 to 34 years &mdash; 0.3 percent",
"     </li>",
"     <li>",
"      35 to 49 years &mdash; 1.2 percent",
"     </li>",
"     <li>",
"      50 to 64 years &mdash; 2.3 percent",
"     </li>",
"     <li>",
"      Over age 65 years &mdash; 4.6 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A similar relationship to age was observed in a survey of 11,141 patients treated between 1989 and 1995, although rates of INH hepatitis were lower [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/10\">",
"     10",
"    </a>",
"    ]. The overall rate was 0.15 percent in those completing treatment and ranged from no cases in children &le;14 years of age to 0.3 percent in adults over age 65. Among children, age is an independent risk factor for development of hepatotoxicity; severe hepatotoxicity has been described in children less than five years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other risk factors include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/7,8,10,15-23\">",
"     7,8,10,15-23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Regular alcohol intake [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/7,15\">",
"       7,15",
"      </a>",
"      ]. In one study, for example, hepatitis developed in 2.6 percent of patients who drank alcohol daily [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Concurrent use of medications that induce CYP (P450) oxidative enzymes (",
"      <a class=\"graphic graphic_table graphicRef76992 \" href=\"mobipreview.htm?9/45/9950\">",
"       table 1",
"      </a>",
"      )",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      are hepatotoxic",
"     </li>",
"     <li>",
"      Previous INH intolerance (eg, headaches, dizziness, nausea)",
"     </li>",
"     <li>",
"      Concurrent liver disease, such as chronic viral hepatitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/25,26\">",
"       25,26",
"      </a>",
"      ], may increase risk of hepatotoxicity. In one study of Vietnamese patients with hepatitis B e antigen (HBeAg) positivity, INH treatment of latent tuberculosis infection was associated with asymptomatic aminotransferase elevation and overt hepatotoxicity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/26\">",
"       26",
"      </a>",
"      ]. Patients with HBeAg were more likely to require discontinuation of INH and to develop severe INH toxicity than patients with HBsAg positivity who were HBeAg negative. However, others have suggested that chronic viral hepatitis is not a risk factor for INH hepatotoxicity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A history of peripheral neuropathy or presence of risk factors for peripheral neuropathy (eg, due to diabetes mellitus or alcoholism)",
"     </li>",
"     <li>",
"      Pregnancy and the immediate postpartum period",
"     </li>",
"     <li>",
"      Active injection drug use",
"     </li>",
"     <li>",
"      Female gender (particularly if nonwhite) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/28\">",
"       28",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There may also be a genetic predisposition to INH hepatotoxicity. The possible role of acetylator status (slow or fast) and cytochrome polymorphisms are discussed below. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Mechanism of hepatotoxicity'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most cases of INH hepatitis occur within the first 2 to 3 months after initiation of therapy, although manifestations can occur as late as 14 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/8,10,29\">",
"     8,10,29",
"    </a>",
"    ]. The clinical features are indistinguishable from acute viral hepatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/30\">",
"     30",
"    </a>",
"    ]. Most patients complain of fatigue, malaise, anorexia, or nausea, with or without vomiting. Approximately one-third of patients have generalized flu-like symptoms, and some have right upper quadrant pain. These symptoms generally appear days to several weeks prior to onset of jaundice, which is the presenting feature in approximately 10 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/8,31\">",
"     8,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The physical examination is largely nonspecific. Jaundice and abdominal pain may be present. Fever, rash, lymphadenopathy, and hepatomegaly are uncommon. Laboratory evaluation demonstrates elevated aminotransferases and variable elevations in alkaline phosphatase, bilirubin, and prothrombin time.",
"   </p>",
"   <p>",
"    INH hepatitis may be anicteric and brief or it may be progressive with the development of severe liver failure and massive hepatocellular necrosis. The latter cases may be associated with ascites, edema, and encephalopathy.",
"   </p>",
"   <p>",
"    Histopathological changes range from focal to diffuse necrosis to multilobular, bridging, and massive necrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;INH hepatitis is suggested by the development of elevated serum aminotransferases (transaminitis). Other causes of elevated aminotransferases should also be considered, including viral hepatitis and toxicity to other medications or herbal therapies. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/18/34090?source=see_link\">",
"     \"Approach to the patient with abnormal liver biochemical and function tests\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of INH hepatitis is supported by resolution of transaminitis within several weeks after discontinuation of therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Discontinuation of INH and other potential hepatotoxins is the most important aspect of therapy. The management of INH hepatotoxicity otherwise largely consists of supportive care. In severe cases liver transplantation may be required [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/29,33\">",
"     29,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Normal baseline liver function",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40279?source=see_link\">",
"     Isoniazid",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?30/34/31269?source=see_link\">",
"     pyrazinamide",
"    </a>",
"    should be discontinued immediately in asymptomatic patients with normal baseline liver function who develop aspartate aminotransferase (AST) levels &ge;5 times the upper limit of normal (ULN) and in symptomatic patients who develop AST levels &ge;3 times ULN [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/34\">",
"     34",
"    </a>",
"    ]. Additional evaluation should include testing for acute and chronic viral hepatitis (A, B, and C), if not performed at baseline. The patient should also be interviewed carefully regarding alcohol use",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    exposure to other potential hepatotoxins.",
"   </p>",
"   <p>",
"    The risks and benefits of continuing versus deferring treatment should be reviewed. If treatment is continued, the regimen should be adjusted to minimize hepatotoxicity. If the AST level decreases to &le;2 times ULN and the patient is asymptomatic, the first line medications may be reinitiated with caution. They should be resumed one at a time with close clinical and laboratory monitoring of liver function tests (every two to four weeks for the first few months and as necessary thereafter). Alternatively, other antituberculous agents to consider include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/7/12406?source=see_link\">",
"     ethambutol",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/10/40102?source=see_link\">",
"     kanamycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/16/34056?source=see_link\">",
"     amikacin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/59/11189?source=see_link\">",
"     capreomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/51/33584?source=see_link\">",
"     moxifloxacin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/13/9432?source=see_link\">",
"     \"Treatment of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Abnormal baseline liver function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with baseline aminotransferases &ge;3 times ULN,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?30/34/31269?source=see_link\">",
"     pyrazinamide",
"    </a>",
"    should be discontinued immediately if there is more than a two- to threefold increase above baseline or if there is jaundice or mental status change [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/32\">",
"     32",
"    </a>",
"    ]. Additional evaluation should include testing for acute and chronic viral hepatitis (A, B, and C), if not performed at baseline. In addition, the patient should be interviewed carefully regarding alcohol use or use",
"    <span class=\"nowrap\">",
"     of/exposure",
"    </span>",
"    to other potential hepatotoxins.",
"   </p>",
"   <p>",
"    The risks and benefits of continuing versus deferring treatment should be reviewed. If treatment is continued, the regimen should be adjusted to minimize hepatotoxicity, with close clinical and laboratory monitoring of liver function tests and coagulation parameters (every two to four weeks for the first few months, and as necessary thereafter). Alternative antituberculous agents to consider include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/7/12406?source=see_link\">",
"     ethambutol",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/10/40102?source=see_link\">",
"     kanamycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/16/34056?source=see_link\">",
"     amikacin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/59/11189?source=see_link\">",
"     capreomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/51/33584?source=see_link\">",
"     moxifloxacin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/13/9432?source=see_link\">",
"     \"Treatment of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overall case-fatality rate in patients who develop clinically apparent hepatitis is approximately 10 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/8,38\">",
"     8,38",
"    </a>",
"    ]. Elderly patients or those who present with INH hepatitis after taking the drug for more than two months appear to have a worse prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/3,8,39,40\">",
"     3,8,39,40",
"    </a>",
"    ]. Some studies have found a higher case-fatality rate among African American patients than other patients, as well as a higher case-fatality rate among African-American women than African-American men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     MECHANISM OF HEPATOTOXICITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanism of liver damage due to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    (INH, isonicotinylhydrazide) remains incompletely understood. The histopathologic appearance closely resembles viral hepatitis; direct toxicity of the drug or a metabolite is probably responsible for hepatocyte death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/8\">",
"     8",
"    </a>",
"    ]. The syndrome is unrelated to serum drug concentrations or autoantibodies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/3\">",
"     3",
"    </a>",
"    ], and there is no evidence that allergic or other hypersensitivity reactions play a role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/31,41\">",
"     31,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Metabolism of INH creates numerous metabolites, including isonicotinic acid (INA), hydrazine (HZ), ammonia, N1-acetyl-N2-isonicotinylhydrazide (AcINH or acetylINH), monoacetylhydrazine (AcHZ), diacetylhydrazine (DiAcHZ), and oxidizing free radicals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/42\">",
"     42",
"    </a>",
"    ]. These compounds are formed via three predominant reactions:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hydrolysis &mdash; forming INA and HZ",
"     </li>",
"     <li>",
"      Cytochrome P450 oxidation &mdash; forming HZ, ammonia, and free radicals",
"     </li>",
"     <li>",
"      N-acetyltransferase (NAT) Activity &mdash; forming AcINH, AcHZ, and DiAcHZ",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hydrazine, AcHZ, and toxic free radicals are the drug metabolites that have been most consistently implicated in the pathogenesis of INH hepatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. INH is first acetylated via NAT in the liver to form the inactive compound AcINH, which is then hydrolyzed to form AcHZ and INA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/42\">",
"     42",
"    </a>",
"    ]. Acetylhydrazine is usually further acetylated to the nontoxic derivative diacetylhydrazine and excreted in the urine. Acetylhydrazine is also oxidized, mainly within the liver, into ammonia (although muscle, kidney, and brain also contribute) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/42\">",
"     42",
"    </a>",
"    ]. Acetylhydrazine also can be oxidized by the cytochrome P450 pathway to form toxic reactive acetyl free radicals that can form covalent bonds with liver cell macromolecules, interfering with their function, leading to hepatocellular necrosis and cell death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/3,38,43,45-49\">",
"     3,38,43,45-49",
"    </a>",
"    ]. Cytochrome isoforms 2E1, 2B1, and",
"    <span class=\"nowrap\">",
"     1A1/A2",
"    </span>",
"    have been implicated in this process [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because rapid acetylation of AcHZ should theoretically reduce the formation of toxic acetylhydrazine oxidative metabolites, the relationship between a patient&rsquo;s acetylator status and the risk for developing INH hepatitis has been evaluated. Data on the association between acetylator phenotype and risk of INH hepatotoxicity are conflicting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/17,19,39,48,52-59\">",
"     17,19,39,48,52-59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Studies demonstrating a higher rate of toxicity in slow acetylators suggest that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    metabolism can be diverted into an alternate CYP pathway that results in the development of a hepatotoxic metabolite. Data that show a higher risk of hepatitis when INH is combined with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    and other CYP inducers support this theory [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/54\">",
"     54",
"    </a>",
"    ]. In one study, for example, N-acetyltransferase (NAT2) and CYP2E1 testing was performed in 89 patients receiving INH for treatment of latent TB [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/60\">",
"     60",
"    </a>",
"    ]. NAT2 testing was not predictive of hepatotoxicity, but the CYP2E1",
"    <span class=\"nowrap\">",
"     *1A/*1A",
"    </span>",
"    genotype (but not CYP2E1 overall) significantly correlated with the development of liver enzymes (odds ratio [OR] 3.4). Others have shown that those carrying the CYP2E1",
"    <span class=\"nowrap\">",
"     C1/C1",
"    </span>",
"    genotype are at greater risk for hepatotoxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/57\">",
"     57",
"    </a>",
"    ]. This genotype carried a 3.94-fold increased probability of hepatotoxicity in rapid acetylators and a 7.43-fold increased probability in slow acetylators. INH may also promote the development of hepatitis by inhibiting CYP2E and CYP2C, which could increase levels of other hepatotoxic drugs that are metabolized by these enzymes (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"     Rifampin",
"    </a>",
"    is seldom hepatotoxic when used alone but increases the activity of the CYP system and thereby can increase the production of toxic metabolites from INH. Toxic hepatitis is seen with the combination of INH and rifampin more frequently (5 to 8 percent) than with either drug alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/9,53,61,62\">",
"     9,53,61,62",
"    </a>",
"    ], and hepatitis occurs sooner, mainly during the first month [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/62\">",
"     62",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/26/24998?source=see_link\">",
"     \"Rifampin and other rifamycins\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no effective preventive measure for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    (INH, isonicotinylhydrazide) hepatitis. Use of INH should be limited to appropriate clinical circumstances and patients should be screened for early detection of hepatitis. Fatal hepatitis has been reported in patients who did not have a clear indication for the drug, emphasizing the importance of carefully reviewing the indication for and duration of INH therapy for each patient at baseline and during the course of therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/29,63\">",
"     29,63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients should receive detailed information about the signs and symptoms of hepatitis every month and should be told to stop INH immediately and call their healthcare provider if they develop nausea, vomiting, abdominal pain, fatigue, or other symptoms of liver dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41943/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    No single monitoring plan reliably predicts early serious disease. Nonetheless, baseline and monthly clinical and biochemical monitoring should be performed in patients who require INH therapy because early detection of INH hepatitis and discontinuation of INH may prevent severe sequelae. Monitoring for patients on INH is discussed further separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/44/19142?source=see_link&amp;anchor=H17#H17\">",
"     \"Isoniazid: An overview\", section on 'Monitoring'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/6/23651?source=see_link\">",
"       \"Patient information: Toxic hepatitis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2810569\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40279?source=see_link\">",
"       Isoniazid",
"      </a>",
"      (INH, isonicotinylhydrazide) is a synthetic antibiotic that is bactericidal against replicating Mycobacterium tuberculosis. INH has been associated with two syndromes of hepatotoxicity: mild INH hepatotoxicity and INH hepatitis. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mild INH hepatotoxicity refers to hepatic injury that is typically subclinical and evidenced only by mildly elevated serum aminotransferases (usually &lt;100",
"      <span class=\"nowrap\">",
"       IU/L).",
"      </span>",
"      It occurs in up to 20 percent of patients taking INH and has an excellent prognosis. Virtually all cases are self-limited; INH therapy can be continued with careful clinical and laboratory monitoring. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Mild INH hepatotoxicity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      INH hepatitis refers to a serious livery injury syndrome due to INH. The syndrome may be anicteric and brief or it may be progressive with the development of massive hepatocellular necrosis and severe liver failure and. The overall rate of INH hepatitis is less than 1 percent but risk increases with age and other factors including alcohol use, concurrent liver disease and administration of other medications that induce CYP450 enzymes (",
"      <a class=\"graphic graphic_table graphicRef76992 \" href=\"mobipreview.htm?9/45/9950\">",
"       table 1",
"      </a>",
"      )",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      are hepatotoxic. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'INH hepatitis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Prevalence and risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most cases of INH hepatitis occur within the first two to three months after initiation of therapy. The clinical features are indistinguishable from acute viral hepatitis. Clinical manifestations include fatigue, malaise, anorexia, or nausea, with or without vomiting. Approximately one-third of patients have generalized flu-like symptoms, and some have right upper quadrant pain. Jaundice may be present. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of INH hepatitis is suggested by the development of elevated serum aminotransferases, and is supported by resolution of transaminitis within several weeks after discontinuation of therapy. Other causes of elevated aminotransferases should also be considered, including viral hepatitis and toxicity to other medications or herbal therapies. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most important factor in the management of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40279?source=see_link\">",
"       isoniazid",
"      </a>",
"      -associated hepatitis is the early recognition and early discontinuation of INH and other potential hepatotoxins. Isoniazid,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?30/34/31269?source=see_link\">",
"       pyrazinamide",
"      </a>",
"      should be discontinued immediately in asymptomatic patients with normal baseline liver function who develop aspartate aminotransferase (AST) levels &ge;5 times the upper limit of normal (ULN) and in symptomatic patients who develop AST levels &ge;3 times ULN. Among patients with baseline aminotransferases &ge;3 times ULN, isoniazid, rifampin, and pyrazinamide should be discontinued immediately if there is more than a two- to threefold increase above baseline, or if there is jaundice or mental status change. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Use of INH should be limited to appropriate clinical circumstances and patients should be screened for early detection of hepatitis. Baseline and monthly clinical and biochemical monitoring should be performed in patients who require INH therapy. Patients should receive detailed information about the signs and symptoms of hepatitis and should be told to stop INH immediately and call their healthcare provider if they develop relevant symptoms. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/1\">",
"      Scharer L, Smith JP. Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid. Ann Intern Med 1969; 71:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/2\">",
"      Byrd CB, Nelson R, Elliott RC. Isoniazid toxicity. A prospective study in secondary chemoprophylaxis. JAMA 1972; 220:1471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/3\">",
"      Mitchell JR, Long MW, Thorgeirsson UP, Jollow DJ. Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy. Chest 1975; 68:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/4\">",
"      Salpeter SR. Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis. West J Med 1993; 159:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/5\">",
"      Garibaldi RA, Drusin RE, Ferebee SH, Gregg MB. Isoniazid-associated hepatitis. Report of an outbreak. Am Rev Respir Dis 1972; 106:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/6\">",
"      Lauterburg BH, Smith CV, Todd EL, Mitchell JR. Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans. J Pharmacol Exp Ther 1985; 235:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/7\">",
"      Kopanoff DE, Snider DE Jr, Caras GJ. Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978; 117:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/8\">",
"      Black M, Mitchell JR, Zimmerman HJ, et al. Isoniazid-associated hepatitis in 114 patients. Gastroenterology 1975; 69:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/9\">",
"      Steele MA, Burk RF, DesPrez RM. Toxic hepatitis with isoniazid and rifampin. A meta-analysis. Chest 1991; 99:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/10\">",
"      Nolan CM, Goldberg SV, Buskin SE. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA 1999; 281:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/11\">",
"      LoBue PA, Moser KS. Use of isoniazid for latent tuberculosis infection in a public health clinic. Am J Respir Crit Care Med 2003; 168:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/12\">",
"      Stead WW, To T, Harrison RW, Abraham JH 3rd. Benefit-risk considerations in preventive treatment for tuberculosis in elderly persons. Ann Intern Med 1987; 107:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/13\">",
"      Chan CH, Or KK, Cheung W, Woo J. Adverse drug reactions and outcome of elderly patients on antituberculosis chemotherapy with and without rifampicin. J Med 1995; 26:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/14\">",
"      Ohkawa K, Hashiguchi M, Ohno K, et al. Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patients. Clin Pharmacol Ther 2002; 72:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/15\">",
"      Gr&ouml;nhagen-Riska C, Hellstrom PE, Fr&ouml;seth B. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis. Am Rev Respir Dis 1978; 118:461.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Core curriculum on tuberculosis. What the clinician should know, 4th ed. .S. Department of Health and Human Services, Public Health Services; Atlanta, 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/17\">",
"      Holdiness MR. Clinical pharmacokinetics of the antituberculosis drugs. Clin Pharmacokinet 1984; 9:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/18\">",
"      Maddrey WC. Drug-related acute and chronic hepatitis. Clin Gastroenterol 1980; 9:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/19\">",
"      Dickinson DS, Bailey WC, Hirschowitz BI, et al. Risk factors for isoniazid (NIH)-induced liver dysfunction. J Clin Gastroenterol 1981; 3:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/20\">",
"      Acocella G, Bonollo L, Garimoldi M, et al. Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease. Gut 1972; 13:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/21\">",
"      Snider DE Jr, Caras GJ. Isoniazid-associated hepatitis deaths: a review of available information. Am Rev Respir Dis 1992; 145:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/22\">",
"      Ungo JR, Jones D, Ashkin D, et al. Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus. Am J Respir Crit Care Med 1998; 157:1871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/23\">",
"      Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000; 161:S221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/24\">",
"      Pande JN, Singh SP, Khilnani GC, et al. Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study. Thorax 1996; 51:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/25\">",
"      Fern&aacute;ndez-Villar A, Sope&ntilde;a B, V&aacute;zquez R, et al. Isoniazid hepatotoxicity among drug users: the role of hepatitis C. Clin Infect Dis 2003; 36:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/26\">",
"      Patel PA, Voigt MD. Prevalence and interaction of hepatitis B and latent tuberculosis in Vietnamese immigrants to the United States. Am J Gastroenterol 2002; 97:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/27\">",
"      Bliven EE, Podewils LJ. The role of chronic hepatitis in isoniazid hepatotoxicity during treatment for latent tuberculosis infection. Int J Tuberc Lung Dis 2009; 13:1054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/28\">",
"      Wu JC, Lee SD, Yeh PF, et al. Isoniazid-rifampin-induced hepatitis in hepatitis B carriers. Gastroenterology 1990; 98:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/29\">",
"      Centers for Disease Control and Prevention (CDC). Severe isoniazid-associated hepatitis--New York, 1991-1993. MMWR Morb Mortal Wkly Rep 1993; 42:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/30\">",
"      Reddy KR, Schiff ER. Hepatotoxicity of antimicrobial, antifungal, and antiparasitic agents. Gastroenterol Clin North Am 1995; 24:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/31\">",
"      Maddrey WC, Boitnott JK. Isoniazid hepatitis. Ann Intern Med 1973; 79:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/32\">",
"      Saukkonen JJ, Cohn DL, Jasmer RM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 2006; 174:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/33\">",
"      Farrell FJ, Keeffe EB, Man KM, et al. Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation. Dig Dis Sci 1994; 39:2255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/34\">",
"      American Thoracic Society, CDC, Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep 2003; 52:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/35\">",
"      Centers for Disease Control and Prevention (CDC), American Thoracic Society. Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/36\">",
"      Centers for Disease Control and Prevention (CDC). Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001. MMWR Morb Mortal Wkly Rep 2001; 50:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/37\">",
"      Centers for Disease Control and Prevention (CDC). Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000. MMWR Morb Mortal Wkly Rep 2001; 50:289.",
"     </a>",
"    </li>",
"    <li>",
"     Bass NM, Ockner RK. Drug-induced liver disease. In: Hepatopathology, Zakim D, Boyer TD (Eds), WB Saunders, Philadelphia 1996. p.962.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/39\">",
"      Girling DJ. The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide. Tubercle 1978; 59:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/40\">",
"      Bailey WC, Weill H, DeRouen TA, et al. The effect of isoniazid on transaminase levels. Ann Intern Med 1974; 81:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/41\">",
"      Maddrey WC. Isoniazid-induced liver disease. Semin Liver Dis 1981; 1:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/42\">",
"      Preziosi P. Isoniazid: metabolic aspects and toxicological correlates. Curr Drug Metab 2007; 8:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/43\">",
"      Nelson, SD, Mitchell, JR, Timbrell, JA, et al. Isoniazid and iproniazid: Activation of metabolites to toxic intermediates in man and rat. Science 1976; 193:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/44\">",
"      Sarich TC, Youssefi M, Zhou T, et al. Role of hydrazine in the mechanism of isoniazid hepatotoxicity in rabbits. Arch Toxicol 1996; 70:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/45\">",
"      Mitchell JR, Thorgeirsson UP, Black M, et al. Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites. Clin Pharmacol Ther 1975; 18:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/46\">",
"      Mitchell JR, Zimmerman HJ, Ishak KG, et al. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Ann Intern Med 1976; 84:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/47\">",
"      Timbrell JA, Mitchell JR, Snodgrass WR, Nelson SD. Isoniazid hepatoxicity: the relationship between covalent binding and metabolism in vivo. J Pharmacol Exp Ther 1980; 213:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/48\">",
"      Timbrell JA, Wright JM, Baillie TA. Monoacetylhydrazine as a metabolite of isoniazid in man. Clin Pharmacol Ther 1977; 22:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/49\">",
"      Ono Y, Noda A, Zaima Y, et al. Determination of isonicotinic acid in the presence of isoniazid and acetylisoniazid. Studies on isonicotinic acid formation from isoniazid in isolated rat hepatocytes. J Chromatogr B Biomed Appl 1996; 677:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/50\">",
"      Delaney J, Timbrell JA. Role of cytochrome P450 in hydrazine toxicity in isolated hepatocytes in vitro. Xenobiotica 1995; 25:1399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/51\">",
"      Sarich TC, Adams SP, Petricca G, Wright JM. Inhibition of isoniazid-induced hepatotoxicity in rabbits by pretreatment with an amidase inhibitor. J Pharmacol Exp Ther 1999; 289:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/52\">",
"      Ellard GA, Mitchison DA, Girling DJ, et al. The hepatic toxicity of isoniazid among rapid and slow acetylators of the drug. Am Rev Respir Dis 1978; 118:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/53\">",
"      Pessayre D, Larrey D. Acute and chronic drug-induced hepatitis. Baillieres Clin Gastroenterol 1988; 2:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/54\">",
"      Yamamoto T, Suou T, Hirayama C. Elevated serum aminotransferase induced by isoniazid in relation to isoniazid acetylator phenotype. Hepatology 1986; 6:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/55\">",
"      Gurumurthy P, Krishnamurthy MS, Nazareth O, et al. Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis. Am Rev Respir Dis 1984; 129:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/56\">",
"      Huang YS, Chern HD, Su WJ, et al. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatology 2002; 35:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/57\">",
"      Huang YS, Chern HD, Su WJ, et al. Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Hepatology 2003; 37:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/58\">",
"      Furet Y, Bechtel Y, Le Guellec C, et al. [Clinical relevance of N-acetyltransferase type 2 (NAT2) genetic polymorphism]. Therapie 2002; 57:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/59\">",
"      Huang YS. Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injury. Expert Opin Drug Metab Toxicol 2007; 3:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/60\">",
"      Vuilleumier N, Rossier MF, Chiappe A, et al. CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis. Eur J Clin Pharmacol 2006; 62:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/61\">",
"      Lees AW, Allan GW, Smith J, et al. Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy. Tubercle 1971; 52:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/62\">",
"      Emerit, J, Decroix, G, Chomette, C, et al. Donn&eacute;es nouvelles sur les h&eacute;pitites observ&eacute;es au cours des traitements antituberculeux incluant la rifampicine. Revue Fran&ccedil;ais des Maladies Respiratoires 1974; 2:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41943/abstract/63\">",
"      Israel HL, Gottlieb JE, Maddrey WC. Perspective: preventive isoniazid therapy and the liver. Chest 1992; 101:1298.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 477 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-83.177.194.223-D60132E406-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_61_41943=[""].join("\n");
var outline_f40_61_41943=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2810569\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MILD INH HEPATOTOXICITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INH HEPATITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Prevalence and risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Normal baseline liver function",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Abnormal baseline liver function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      MECHANISM OF HEPATOTOXICITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2810569\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/477\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/477|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/45/9950\" title=\"table 1\">",
"      Inhibitors and inducers of cytochrome P450 3A4",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/18/34090?source=related_link\">",
"      Approach to the patient with abnormal liver biochemical and function tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/44/19142?source=related_link\">",
"      Isoniazid: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/6/23651?source=related_link\">",
"      Patient information: Toxic hepatitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/26/24998?source=related_link\">",
"      Rifampin and other rifamycins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/13/9432?source=related_link\">",
"      Treatment of latent tuberculosis infection in HIV-negative adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/21/19802?source=related_link\">",
"      Treatment of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_61_41944="Blood in fetal stomach";
var content_f40_61_41944=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F67005%7EOBGYN%2F57271&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F67005%7EOBGYN%2F57271&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 532px\">",
"   <div class=\"ttl\">",
"    Intraamniotic bleeding and gastric pseudomass in fetus at 21 weeks' gestational age, 2 weeks after transplacental amniocentesis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 512px; height: 226px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADiAgADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3r4n+P9L+HOg2+ra3b31xbz3S2irZojOHKOwJDMoxhD39K8y/4an8Ff8AQJ8Sf+A8H/x6k/bR/wCSX6T/ANhqL/0RPXlfwJ+EHhjxz4B1XxD4m1LVbL7DeSwsbWWNI1iSKOQsQ0bHPzt36AcUAeqf8NT+Cv8AoE+JP/AeD/49S/8ADU3gr/oE+JP/AAHg/wDj1cV8LvhD8L/iRpl5eaDqfjCEWkwhlhu5bZJBlcq2FjYbTzjnPB4r5mXlR9KAPs7/AIam8Ff9AnxL/wCA8H/x6tzwh8etG8YalJYeG/DPii+uo4jM6LFbIFQEDJZpwByR35r4agieeaOKFGeWRgiIvVmJwB+dfcHwm8Mr8MPBkEL2k73dzMv9rTxhHMchA5BAOY0B4z6k96AOt03x9c6kkjWXgzxHL5bFXUTaeGUjqCpusj8qjsPiHPf3MltbeC/EpuI87onexjcY9muQah+3SvbQWcFxD9kguGma8EgAljyePY5bqM4xVy/0iPXdKCJHqMc0DgR3DN5d1E49TxvXoc579+wBSPxPUW5mPhPxAFVtpXzrDeD7p9q3fpUc3xUSEr5nhDxMA2MNmyK8+/2nFc79kmtppoNY0ptQEUbM13ZSETRNnJD+vP1rOg1q5hsRfWeoPPaiQQiG5RAFOcsrj+LPqOlAHdXnxJe0tWuJvBviUwqMl43sZB6/w3Jrmj+0FoCojv4d8TIr/d3xWyk846GeoE1+5tNRsZlgaKS5VkaJWDrGB0K5wcY7HmsXWLTw9rJivLm2MJkyAZEeYBgcZ2jBVTk0AdzJ8XYUthcDwd4rkhKht0UVrJx7hbgkVlp8fNEYOf8AhHPEqhDtcvHaqFPocz8dR1ri7bSdd0T7amkalYyyFN1tNbxnfgckHkc/WsZ4tYvLxE8RaLeJqN6C00o58xOgOR0JChSfpQB6vL8bdMim8qTw14iWTAOCbLgHoT/pFTR/GTT5IvMj8N680eSNwlsSOOv/AC8149FpVvKtx9kstXsY55NrE4cKAOBzjv0/Gq91ZanarKZtJkeSPCxh4MJ6Ejoc46ZoA9xt/i1a3EDTR+G9a8pXZGLXOnrgg4PW69vx7VGfi9Z7yi+GdekcKG2Ry2Dtj6C5Jrw7T9Du41W1mR1iELiTMKmRgxLNx1XPAGfSuk07TmsYriRbxI0g27dztu2t/CWHp6mgD0u8+MFrZuq3HhPxMpIzwLNgB7kXBx+NMtvjNp9zbvNB4b15kRthHm2IbPpt+05P5Vxa+HgBENW8QpcwXc7Si2SUB2XGVO7p/wABJA44rYnEemxpA11pVnZM3It4h5oXsWbsT9aAOoPxTRbdZ38IeJUjY4UubJSx9gbnJo0z4ppqcPm2nhHxIY8bt0r2MXH/AAO5FciuqR3umzrp+iT3FwkWYTFGQWOcBmdunHpzSaaNRlS5vZ0SBLGN9jBtr5AB4Lck9u/fFAHUR/F61dSy+FvEQQFhuZrJQSvXBNzg49qh034zWOp3ptNP8K+Jri53BPLRbQnJ/wC3j9e1cV5elwR29xq1zHPdSKZPJjlJEbPznPRee3Wrc+sarPdNL4Vtn0nTUtVjuL1gqIxzwwbHc8ce1AHba18VE0V2TU/CHiaFlAJH+hNgHofluTWanxv0x7d518L+JzCieYz7LTCr6n/SK8t03T/N8T3CateTybQrs8qs+9SeVK96qeJ55WW4tRaSeRIxG85DGEdFKg8ZPGKAPQL39pzwjZXBgutF8SxygA4MFuePXImwag/4an8Ff9AnxJ/4Dwf/AB6vCdf8Kx3+iXDQwSRXcDHyUJJwT1Qnvn274rylgQcMpUg4II6H0oA+zP8AhqfwV/0CfEn/AIDwf/HqP+Gp/BX/AECfEn/gPB/8er4yFFAH2b/w1P4K/wCgT4k/8B4P/j1d98KviponxMOqf2Faalb/ANneV5v22ONN3mb9u3Y7f88znOO1fnpX1J+w/wDf8a/Sx/8AbigDufEH7SPhHQ9e1LSbrS/EElxYXUtpK8UEJRnjcoSpMoOMg4yBVD/hqbwV/wBAnxL/AOA8H/x6vnTxBpcGufH7UtJu3ljt7/xTLaSvEQHVJLwqSpIIBwTjINei+KPhn8NfDus67p9x/wAJ9cjQ4oZ7+5t5bHy4klA2n5wrN1wQFJoA9G/4al8F/wDQI8S/+A8H/wAeo/4al8F/9AjxL/4Dwf8Ax6vE/j98NdC+H9t4XuPDl5qlzDq8c8r/AG50JAQRFcBUXGRIc59uleQ0AfZZ/al8F/8AQJ8Sf+A8H/x6k/4al8F/9AjxL/4Dwf8Ax6vjQdqXp0oA+y/+GpfBf/QI8S/+A8H/AMeqS2/ad8IXMyxW+ieJ5ZG6KttAT/6Or4wzjOa6jw/Ym1dzNA5uOGZg+wwD0J6896APrqX9oHQYmCt4e8SlicAJHatz+E5rX0n4v2erxPJYeGNfkVSAQZLFG5/2WuQT+VfJ+kyLHbF5hdRu8jF5FyRAhHOfUEDj613Ok3SXawPEzxyxooeROCqf3to56flQB7xqXxbh0xmF94P8UxFQCfktDgHPJxcdOOtV7L40adetttvDfiBm7AvZKT9M3IzXmSa1bQXS+RdXEV4v+rlaTzg2OhYHqvJGOlWZNSg1NFn1Gws0lETIt1ZqICfVpEPBHutAHoV98arGxfbeeEfFsQwCWaC22gHplvPwPxNQw/HXR5iwi8O+Imxxx9j5OM8f6Rzx6VzugWTz6H5eleJIrWEjY9nevsR+OMMQdwzzg1x03g9DEqwWkV3JFOy+ba3qhN/II2n8D15xigD1eL43aXNOsUXhvxE8jDIVTZnI/wDAirR+L0ISRj4O8WbU6nyrX9P3/P4V5Dc2RNtNaXmna7EZQUaXYpRpMdQMZByDxn0rn4tPsrK9t4vD974jR+TI0kJVV6ZDEHkY74zxigD3hfjPZMQF8I+KySu4Yhten/f+j/hc9ntJ/wCEO8XjBAINvbAjPTjz849+leT6DZQ3plmtptQvJ3YDCt5Rb2B6kfzrfstB1Z7qWGKz+yrIogZru4dihJyGzkfrxigD1CD4jSzWwnHg3xIkRAIMslhGcEZzhrkGobj4nrbpG8vhTXgJF3IBPp7Mw6ZAF1k1xej+HNNtknvda8RQREzmFMyru3ZwwCc8elLM9idTitojC7qm57+eYKGUdCp4AOO3tmgDpZPjHaRWaXcvhPxQlu83kKzraDL9MYNxn8elVZvjlpUMjpJ4Z8TApnJC2hU49CLjB/CuF8TJ4at9Okuj55ug/EcU3mROCcO5J64JzkAVy0kFneF5Z9euli+5DEF5jC46k8YAHFAHrcHx/wBDuGIh8NeKHIfy8LDbH5vT/X1cb43aWsUUjeG/EKxyAlWY2YBA6/8ALxxXj+p6tp0UMUWn6hbzWkMu4AW7oLpieM4Oc/0rH1ZLa5spJ9kEt7LcATLvOGz1WKPA24FAHtDftC+HlkKHQPEe4HHCWpH5+fiqFx+074Qt3CTaN4lUkbh+4tzkeoPnV4f4kmWKxO6ytrZSuY7eMA592bPPb1rzrXrZoJ2S4kjkuNoZirbip/u+n4UAfV//AA1L4L/6BPiX/wAB4P8A49S/8NS+C/8AoE+JP/AeD/49Xxtnn3o69qAPsn/hqTwX/wBAjxL/AOA8H/x6j/hqXwX/ANAjxL/4Dwf/AB6vjYUDg0AfZP8Aw1J4L/6BHiX/AMB4P/j1emfDHx9pfxF0G41bRbe+t7eC6a0ZLxEV94RHJAVmGMOO/rX519sV9kfsZf8AJMtX/wCw1L/6IgoAb+2j/wAkv0n/ALDUX/oieuP+BGg6z4o/Zz8UaH4duLS1u7/WHgkmuWYKsJht/MxtUkkrlce55Fdh+2j/AMkv0r/sMxf+iJ6+MdqnkgUAfe3gT4Zah4H+IUupaVqi3fh+70yKzuorrYk4lhAWJlWKNUKhAF555JOa+Ck+6v0oCr/dH5Vr+GdJfVtSSPy3a2jw0xQgYHYZPqf0zQB3/wAHPDV6tzbeJ0dYZYpSLISx5STqGfPbuo4659K9+8MeKb1Y/sl3J9qs5WdUto0Mbz54Kkr0GO/evJY7h9Li/wBHs4vshZI1RIvX7wUjhf0rotDm0+wknNvMl1sQj95LsZeeh/2gfSgD2W2n0jUUthcWkFidjtGJQcKwfJXI6jbnk8mttLDXZXkWPUrBI0jP2ZIwXIHG0MT94Yz+deCf2rNDbecjOI4F+YSS5ILHkEA569e9bouyUS5jvTFI3ylbctu6DneT909/WgD1eCZ9Ea5t7yxnRSfMa+iTeq/7RbjAHoffrXPXmi6dNrdxealawmKaYMFicq8RAyJSANrZHfrzXMWXjfX7C4WO8vZLq3lJES4DMoB6Z5Ljryck1ox+PTLNumksJmmkGWiPlsq424z3BHVTigDX1myt7+8R7vzvIjZFWTUoG+dACQVZOhGOtVbjw/a3VvYXGmXjs00bAnDENjONwOMLngE9ah1LxWbG4FpZzXaiM+ekpvM+fGOsWD0IyMH0rMtvET3LPJqMwh06YgSQRIu5zn0GAxX+dAG/rvhKyklkMOq2zagFD434AClSd6jIHPJPfpim3On28WlyX+s/2hLHEx2XOmbHhZegIB54PXtnpWtpeueF9Xjlg8myS53ssIuIfs3m9BuJA7/QVZ0+30G4iEEN/bWU3mhfsqXKSKsi/wB0e59c5oA4+ytr/RoLO8sLOG/ikJLPcktGwJ4O3OAV5/lWVqniDW7ppv7M0fTJEud0TQhWJbP8W05IIHOR06V2mmXMSzT2Woyw290JR9nZG8pAw77Bldw/vYrDutUsLzUmf7fcz3CNjzo3wuzOCwAwcHvyM0Ac9Ba63rOoTLNbaHaRQQKrtI6xoce4Oc1Xub2w0aC4tbU39/PhcuZA8OG5AAAPvXfXmkn7JcXEFlafY8ASyTQIz8d+R8wPTn1qnptjp28XU8tvbxPGJIsW2HEanCgoDtwMnjtQBX0bWJ7yZJ9O8Kz30LRmNJpIvMEZAxkFsA84BPtVnVtK1i6hlbVrXTbGMAOYDdIiMBzlurEZ5xWx4f0m21aMmGaRIYpGKwRI3lOvUA5O0d+OK0Bb6LCRqXktmefZGZyiIVHUDrhAR3oA89nk1HVre9vJdZ1O4sFiKqtigVXccKp9R9Oa3BozadDp9xNZJ9swRCl3OoPI6BR8zN1POK6TUtW0/TbdjLcTIvyzrbo4QjdyqjGM5P8ACOcHmsaHVUnluLyW9juL3ZmaBx5BilHCKjMMsCTggfjQBz3hrTPKtru2muLSCSebIuHtA8hJycAZ6k+g9a3JfDWnm3jWI3ct+I1gNvfsURy3QhR2GC3sOtZ+qeJoYZbO31VIE1aJ0uSYBn92GAP3RgHPXFa1vqd3f6rHe6TE8lqpmgiLbm2/KSZN7HJPt2460AYtzYRWM91bX17Z29mZFRksztMrBck5POPX1xxWjbaD4Yury3W1s55ppCrx3IYgOcctgnoR0qTxLa3k9rK97cwRRHEfnTfMHmAz8oGOSBj5hjiqOn2Vnf6PZ34m07RiGBBgbdcMG+6Tjqe+McCgDH8SzaDaxxadBZRG9S6yy7PugZ2xIASWYkjLV8+fGfw6LLVm1e1tRbRXDlbqIdFm7sBnOG78Dke9fR1vDBc28KaHbq2uQGQzXCvtYqcjc390e5Oa868SxHVLt0caNCjo8Dts3h8dc7sl2z39elAHzWaWtrxdoT+HtZeyMqzRFQ8UinOVPY/7Q7isU0AFfUf7D/3/ABr9LH/24r5cr6j/AGHvv+NfpY/+3FAHlx/5OcH/AGOf/t/X0N47+FGsa74y8X6rb2Phu8i1qzgtrS4v5pFn090jCmVAIW+bPIw69Bk9q+UfimAfib4wBH/MZvf/AEoeuW2J/dH5UAfSX7XlhNpWhfDfT7q7kvri0tbmCS5k+9MyrbAufckZ/HvXzgOtN2qDkAA+wpwPrQABeP6Ubee9Ln3qezg+1XkUG8RiRsM5/hHc/lQBe0HTTdmecq7CBd0aKAfMcEcYPYDrXovlyWvkytZ+VEYSLhGXbJKT/d7E07QtOsUW2+26fIILfOxt6ruAyCwB45zk5qzJDb29w8bRXMtnInmR7ZBL06YGeD2IH1oAg0GzdkdbiIwq42xTBhtUY6FfTB5z0NaOnedpztaho477b8nkEgx7Txk/0HWo0VJbqJbhgzSR4DD7se3++eCeOoqYu0ke1NPRkZi8ksgILJ/eA6/jQBHc3RmS1GoxpdTJIu12XZvjbkg4wDXQWsrzrCVW2niTdHGtxP8AMF/iQZOeR25rADI+mpItq9yNwEUbEqoAP3iPUVP8l1OtxBd5YJ5juSFeMqcZXjGOaANRYtO1KUgX89tZsrnyhuyP4do4xn6dqhOgiyEVul1D5Vx++Ejuy7sex53dznjg1XlOoWNnH9lhnm3OdxaRWVmOSTgfd7YI4rPt9QMm2bU5Wi3MVKP95h7J9cc0AXjNqNlejmWMxEMrO+4Y6YQA4Y988U4aleR3LKl1qLs+HuJSfKCZPB29847VWkui1m6zX8JeY7oMQbXKgY7fdHvUdhf20+m/Z7aK3XUlkWUzQl2cOO2CcgY6dqANKFLk3C3H2q+XbhWuEBZyo5OGB4XH61ZtdQPnzXFw8l2ZJCyvI7OUX0G44IHTvWZa65PZ2+oQxTSglvLa3EhAYZ+ba/bB/PpTYLmZdPs5ZYfPSdXaHkyGM9OnQD9aALdxciTyJ1QhwzmLz1Tax/iAUDt69q0zbSpOkksawp5WUgL7lbg5JbPU56CubaC4jm8xpSJpAXZTMMRDPLHvkDrS/bVsBDFcsJxgyMwYklecYxznnI6UATX0lz9k2xW8ZQIPOHmYypOR+I6VxWoa/PbGIQuRHltqR4CsrHjOeSR+FdHqE+zM0SSpA65IlcFyB1HA6c/lXIvcRfahbXjQNCjbixj27s8gAcfrQBDNePPLBbW8TpJKwkbAwCw6bMdsDrT1OpWslxO5kaEkkvuyhY8YyOlV7kWaQM6ZtpRhkcd2PG0YJwDVe6tbw26GR45UOHfbKCcD0U0AE12GuY5sOzL95kY7RjgAZ7VlXcvnAt/FuzgDpU9rcELJFKu61k52kgE46DOKhuIdjt5TBlPRVODQBUbLMWY8k9abtFWZYtsrKEYSDHyddv1qsxIbGelAC7T1GeaTbzQSTSZNACgc19kfsZf8ky1f/sMy/wDoiCvjjOeK+x/2Mufhlq//AGGpf/REFADf20f+SX6T/wBhqL/0RPXxkBX2b+2h/wAkv0n/ALDMX/oievjOgCS3iknnjhgjaSaRgiIvJZjwAK9r0Lws2j6PbQLbxy3BBeSVmLRTMfUdQVwB+tcR8P8Aw+biCXV5lZgny2qK2GYg/M49ccj8Se1eh2WowwyyRvPdhFJRrQJvBbH3gD1/CgDUsriWGaITslnbCbmLaXVm6Yz6d8VWgk0x9Ua0sbQzWzy4mlgYMAx6MjHkD1Har1zJNfqgeCa5aOPbsSII7Drg54zUF1qNnbxpb6Yg0+MoWI2cwuvYgcZPTrQBtf2VLem3vIpopEh/dNbswWZhkgscDBP15p8Gmyy2cq27JHH5bS7WO5CF4KD0Pf0rL8NW6tGkU97ILieJpVEhKPHjntwVP51uaXfXDRPPM1nJEgYQmEHZEf8Anm2QcjPOKAJ7GGMabAr2kMbTKU/dzfxjkbCBn/69QNDAiXSIQJGRpEWSIKd45ILn7w7461Xl8S6VmVUso2u1Qt8g8tYmHcDpg/ga3W12y8Q2ekQSWwhmicTTxzSAREqOx6/keaAMiPTbq4RprjcykLIjeSC0ZwMbR/dP6VHJGp1GwtnQ2ZmYuWkXf5LnuuDjJNdlfw6Rq2nQNZ3/ANhvZZViEhUBE57P/dx2PJrC1m2bSruX7X5d0XlCbbW5DSXCAfwkDgd+aAMuPT4DfzSX12t55Ct5so3BQSRtx/d9x0rTaytI7qJUw7vsuXkjkBDEchcrwPXPtzmks7u2dLiOBXs55F4SWZSDt6kqeMfzq7ZmVZXaL7Q9syqjvDbjsM4YH7vfgCgCA3ji5mkvr+TUFdDGi/ZwWicA/NnOWPbipIvEaRad8ltCs0gMavBlHQY6tngDjp2NZeuafc2ZS6TT7pIY8mSaYbPLU8blXscdaqWdjDC8lvDDc/Y4w7SPcSgrzyDj1z0oA7KTx9eiYWcURljiiVXi8wFdvGQcDJOO/vTNS8U2kdqsX/CPtBHO5UyG6EmAx5Ax0GPXiuNuJornzGsNPv0SyiCm4OEBcjJJI56ds1n26vcj7RZFYGYtGtxPEy8jk5Xuc8DNAHp9rcW19p9yVu9UtbZYlWJSoI2rkAMOByOlYa3X2nS5pbHTbf8AtExF98/zQoq/3B3PH0rItbq+lsgJWuT5sfMRQgA9iuQc5znHtUc2nodM2ywMs8TbIow7INpGCxPQfSgDei1a6TQZZGW2M6SJIst1JiWLPOUB7cflTl1MX/h43F7c2d9M0u57aH/W7Sez8kDjPqa4VdNcywRz2u9thV0iJYhh3LHgDGPrV630maaGW1uLm3sypDfuX/eyA+nTHuKAO6ttc0OO3i0+SCO4iVSrXHmCIQIwG4scbiQeB2NYXiTxSY7oNZRGC2+VooWUgMFIwuAMgsB6d6w9Xl0+w1SCyl07+0I5DtYOChbbjnjJYcDvVq61e9uJpjBHHpUMilx5kJbzMdFGcknOBQBl+LtR13xDevcy2sqkY8qGNguxuMgY4OP61z82papp9y4jSO2uehuIGy3Awcg8D8KZ4ivdal+0SyvJM0c+V+zqVIOPU8L9O9UIrS61i8hga5mSVE3TwqMkA9M45OeRQBsXfia/Ns80d/LaRTRpDJbqfKMignBYgdCfxNc6Gure6e8u7hGErbI1aMnaSflB/TrWpqMGnWSxxwTXOI3Vf3/BeRfQHkeg6VmXqfvGE4jeS5YkKr/6sd8DufegDB8TWy3NtFY3FzvuizyxyuflVscquPXgV5906g59PSuy1O3F7dKsLvlANsszD5Rnoq+n61ieIbJ4LhphAI4jhcDuf72PegDIr6j/AGH/AL/jX6WP/txXy53r6j/Ye+941+lj/wC3FAHg3xS/5Kf4v/7DN7/6PeuYrqPin/yU7xh/2Gb3/wBHvXL/AKCgAoFFHP4UAB/HrXoXh7QorHRTc3cLTXDygSKqhwnopz0I6n1zWT4M0JrmCbWJvKa1tm2bBKPMRscSFD1QfzrVEoFqwn1JkkAKzQRgBsg/LIo5Dr+ORQB12lkzC7i+zxzqi7Ht1cpkfxLtJ9PSnTrpscbtY2FxCY3AeOZBviPbaxweaxfBl/LrJMK6hB9vaQMrOoUZHGSPcdx+VV/Er6hb6n/p/k3dvEdzPbNvOR2/3eOhHFAGzY3kbK8HlNDdRMVRJQDgk5ByOTz1q9d6nGN67AYnTmWYn5ZB95cnjHt9K5TRzqMTHVdNe1u7eUFntkzuUH7wAPQjpwa6LRWstTt0sdOmeadyfOt5kCvuyMABjtJ469eKAJ3CbIzYXL28sce5jJwp3Dhef4j29RVWDTrdoLVN0puw+6PHIHdgQeM49K1bqOZrkQ3Glp5keCqkmKRwGP31PBPJ+lR75ItQuLVLSKNicRl5sNtI4Ug8fjnt3oAQX8wkELrYyKDtV4ZSnBHDFh3J6mnyFZAN+GuImSOORTnOM5wT1BFPtrOKSe4V4GWNUKyeU2BLnqqsePwp32OKdYTbApHCpcx7dwQj0BwPy5oAqx7ZzcW4kVwCVMk27Ma4z5mcdCeOaiNotvJAFwhcB8R9JhjqD1Ix2q5bRXcVzFDqEMZtJ2IM0DBlUduf6VN9jRGS1s4YpVYMqM8PPmZ4UE9OPwoAxriGSKWVXjkKhiqSMm+P5uq5zyMcY681mwK9lbQLDesqzMy+Qwxhc4YDtW1qEaxu1i12Zd7YjC/NtxgEnnsM4xnvVoQQwrOmyCFocOspLKrqeOOmeeaAMYN9j+0QWEb3EDqEbc2CxY85qaW6lGltJDvit4pNkgBQk5OOh69MYpdWiksrOztdjOzgzl3j2see5HUd8URyLbs95ayrcXZkQRwIBtyeGLqRgY7CgCJoneyit2ZdhzEImfO0NwcjtjpxxWVfWNpNHbuN7oxa2Cli3lY/iZz16V1L6YZL/wCx3kwjnjjMisj7wHzkqAvUY7VBqQRohLa2FvPKU278AKADzheMd/c0AcVcaPDpplvt7PEnyOsSnah6cEj5jz2qrpllLcX8kVtFCWjZjJcTfN2yMKO/9a6S0u0ur6f7QEtLdPl3Hoe52qc4PP1pdOiiNoHlacmAusETIA6kn+6eufzFAHEPpoS6lS5JilEhGZs8A4xkD69KkuoxZ3mIo7aSXGx2K7T7lR9O5rqNYtXMNxILUCSWMYZc5A45weBz75rHuNMvL9NtjDHH5LbZZS2JZMjqf8KAMTVrjbKYUWOGEKPLEIwNvv3JrKZQQAMZPA7AVupYRRN5E8kLFPmdMHLnHTd2FULzzmcQskIVSHEcYx17n9KAM09aTv8A/XqSQdSNnXGF/wAKjoATBHWvsr9jH/kmOrf9hqX/ANEQV8bV9k/sY/8AJMdW/wCwzL/6IgoAT9tD/kl+k/8AYai/9ET18keGdEn13U1toQViUeZNJ0CIOvPYnoPc19c/tlo0nwz0dEUs7a1EAo6k+RPxXhXg3TbaytTY290YruZA07tEQHbspzyAvQY9z3oA2LCO7tNSs7aAI2nXC+XFDINgh2rgHP0HX1rbs4JYt6ad896ECzo/3owvdc9Rz/8AXqhZWOoWPmSRrEWUqqRsfMhmDHHHocE5I9K2LuVrO5iW4VbaS1AUcErtPow/h+tAF7SobqTWLqLWTNbSPCAkxACyr2yvIz6EVTuobNXXNqZMtjenysR0yF9R+tLYvexRS/ev43ILlzmGLnqrdVrQW+ezl8kXZiuFcyETxhyVI5Cn3NAEQmhle1jtMG3tnEUl1K4wqvzt6ZU1uQtcyC5S2ZlsT8n2hDvilB6gnHBx3rNt/JTT7lrlrm2trhdvl7V2I5ydzZ657UmoP9jtbe1lnEMhRXE6cxHA43AEYJ9aAM64s7Z9ShUDzGaJUN/GFwxB6yKeh9+9V5EEeqak1xcJNDLABA4hwpJ9Fz068j1q9Os1tcqdTuFe4MbOsLY3OvToOM+1JfSXWlaJAkTpceaodIQo2qMgNgdRjPsKAK+bqGRJhDELVNsccbJgCT14P61QuLY3E+zUrr/SolMkqAldw5x8wyKvW0hGpwWtzCUuf9UUsmzHIDyC2flPv3FOmiuY7m7jksrS4uYW8x41kMewdhgcH1zQBn6bG7XCrZ283mdGeaNgRGAPuse3sPrXVWNzKtqjxM9rNK7NMnll0dV4zuPO4jHJFVp7eUahGBN9mUr5yxRSCUSHGWAY9CKruZvsFleXMUixYcvcXER2xjPTI6+3GKAJ9R8WX7/bbFWhWFU2rI0GTKBg7gx6EdPStPQ/EtkLG4u9esnfyipWZM5lXGCMjv7gYrNWazkTzYY2+wWuVkZWDLOGXJ25zgevv0rmdRupJLAOlvcALIr+eWYKiE5VCucnjv0oA6i11rSrpjZ2F1LYpdStcRswD7V6hdzdTx37Vdh1fQJxbyS6jJsyY5LhIginr6Zzz6VwMs1vdzRXqxW1rbRgtIsTHbKuMBwO3Pes+G7MX2iPT4ZJJwN/lQxH5hnoSO2O4/GgD1T7Xp9rDHb3V5Fd2ry/uztKS+5yedo46/hVF9QsbiJ4YIUt7oSbIkZnDT4Oc46Z965a9uZJrIq1pf29xOoCsUBD54DDuAPSq0UkaLF9pW4jkgIb7S0u4ynoNo6DHWgDrIY9VFk1xb21wIGkK+auwsTnkfNw2D9agurDTZ5ZJo4buPV8iMhnVmk3cAkDtWJHqcUd3e2zrc3jGLzLdixRFGfm5PAY+orK1LV/LhmZb9raSSPZEynJIz9zJGevU0AdHqtimn6vALqdsxSAjzQRlQvTA7E9OeaZ/aHlE3UckvnyBpEScA4KngKD0Xqc1xcmm3sUlx5+qXMj+QCWVsKr46bm9Ko6QLn+0bZ9RvXnWOMpbAj5VXackj05oA9DcvLNHf65eG3DKZEtbZQ2/P8AG+eh96y31a5t9TkOkyOtxs8iW4mC7I+c4Qr1Ncy63UyX89vBbXFuikGSWXAB9Qvcj09q09OspLDTlLajKsDyBgy4Y5PU5P8ASgCldo11qHnagihUl3qfKJfaByT0HJ7mtK6tLqy0CS8t9HtLOC6Yt9uvZQzMO5Vf8K0r2902wtTNeR2t4yHEcMiEfaG7MxHYelc1K8GuAzeIb6CCQZEdtGpO3H8KDsKAM2eGCS5tPPmgaUt8ryfdwO4A71kauiveyvMEEdydsfmEj5B1Oe34V0Wk6PcLazG2tVcRk7XfChF6/Mx7+wrCnmEl7L9sIkum/dlwuFhT/Zz1Y0AcReQG2uHjyWUH5WxjcOxr6d/Yf+/41+lj/wC3FeJT+HTfaXPdRrHEoYi3diWedh2Ht2zXt37EAIk8bAggj7ECD2P+kUAeDfFP/kpvjD/sM3v/AKUPXL11HxT/AOSneMP+wze/+j3rlweKADtVixtmuZWwG8qMb5XAPyr/APX6Cq4BYgKpYk4AHf2rpkeHTdPezQBLggGWZWJWQnoOnAHTB+tAGdqGrSXKQRxxLD5EYhRkyrFP7retQWtv9sOxnMbD7jOPk3ehPanWVo+o3cVtBGI5pGO1t3y/rXVz6YvhayurDxNp8zpcYltry2Y7cj+Fgeo9uooA53XfD+q+HZYf7QtzF5q74p4mDo49mFUXvLmRQsszlc+tS3F1PDJJHbXUr2oIKqzEr64weKgtbeW8uCkS843E9gO5oAn0fU77S72O5025khuFPylT19sd66W41W91qZGvbGG2uy4WS9gj8tiD/fUcE579ak0Xw/GYIlV3+2S4OwLuJHUEf3frXRXeha9NJHcXNutrclwoMqcMR90e1AHUeHru7+xi01/QjqYK+XHI9y6yKT3Vu4747VLrOlxWOmrFqMGsaZG68XRYTRIAenHJH1wajE2pQ2sflXkCJBhpE6lGPUrjpTPEXjGe701LKO6nmhLHdFNEFDEcY3dcH3oAo2T3NsUXTtSfU5vMACGLywEHfJOM49a1p76yitVLW08brIVO0EqSf7xHQe3SuUt9Ri1JDbPD5II2IRkj04J71eTUbjQbUQ2rveQ7lR/KXAXnv/iKAOis7iLUop44Zrd5BGE2RphkI7kfrn260lpCJUmVdPu3SOPDOeEBHVuSeD0HqKzZRY6sTNYXpgnIKStGCZCxHGAByvaqV7rOr+H5xZ3TPKyqEMhjaNtn90A8NQBd05o9Q1CND5McIJI4wYMdAc9s1sSNKYmaKMyhW8zyU/1eFODlT90d+vNcrpep6df6ok1ll7wJseDYUDKDz611t5DM8V35aSJbuixzp5gLBDyNgH9c0Ac9qektPqcpmjSONCZmEMm8pIeQSBnC47VNbWTak7vOGhkXajxn5A+OdwPYD1qZoVtI5poFMMJfG7aBMQMY+UkDGOM96vWGjvNcE3MyQ+db5XcflcE529+cdqALLWd1boSiNIqHzI5IyCnJx0xl8/jVLV7W9aeOR4GR49xDxKFYD+I8cD8fwrY05Fg/0gMjJEV8yNjuyR0Vew7fSk8U3ZvjJIqsCR5Ryznj0AAH69aAOF060gm1lFjngklkkeRrgFlMYxjaueN2K6XRtF0+401v7PM8czxyF5pCzsW9C3p7CuS03SIPLlurqR57hHKwRvGS5AP8RU8Gux0m+nVdOCSuYbc4+VQY/Vvl7YHHuaAM3UYNQLwrd2Zb7TBldoDABRyzLnIHbmsaz0kR3weSONoyjH9y20J6nHb09zXc20StJc6hGbaFDkAbGcv3+YdB24rOs9OW81C3meW3tZZGLlmbauB1wpxg0Acd4gtLGU21xNFdMkQCunl5cDPXHr79hVVtBfV7mKCK3ijRQ0wS1UswGMAyP712evWNvd3UwtYrktbkBNjl9zt1LAcdO3SqAc2yzxX8v2XT2YLtgO1rkjsx7AH3oA8q17Q5tMlWIxM0hUlmjJZW+h9Pese+tGtJUV2Rt6BwUPHPavSvHUs1vdObUzI8yLEY1QvkDooPQY/KuHu9NkWwa8eNvK3bFLMdzt3PuBQBi49+a+yP2Mf+SY6t/wBhmX/0RBXxywKthgQR2NfY/wCxj/yTHV/+w1L/AOiIKANj9p9IZPCvhtLmN5IjraAqn3v+Pa4wR7g4P4V5bZWOkXM8F2l9cJFIfJlWZApQj+LPcetey/HzR217TPC2moyK02skjf0O2yumx+O3Ga+dtV0aTwrqYtr5CRNLlS8nML4xzk4P1oA7i/t7COJ7BdRV7MjzZCkikEgg/Keqnpx3pkOmiC8le+uEHyMMiEsnl4yMkf1FYVpOlvGlnNZQskCb5HXqyHvjv74rQt/EbaFJEWn+02zqCI5Fwwj7Y3feA+vSgDTtJDDGEtrW0CMMuLdmbzAO4XPp1FVr6FrnW4r24uJLNMKsbquVz2Uqx6H1q9pvinRNV1a2s9Us1s7mNGaK4g/dsRj5T1rtLPUItW0X7HdJp2pQJ3ChZIOeCGHQ/UUAefRRvBLdO8E9xLKxWaKRlZY8/wAaqecH8aS+jkMcUS2BntpFCyXcoO6P0O1v/ritrxPpVnLqfnRXri+SHBD+WGAHv91j+RrnBJfWlx9jEMVzbzLvdZ5SrsB1yM8+uKALlzNp6u8xtruURiPcTEC6kHqMnBB7/pUdpMbsq11Z3NwFGx2TACoeoIx6Y69ai00FZZYpPslzcbcEiXgsR8pH936VpWOorCR9rjvM4WMTsQBk8bWwB0PegCpNbrpwY6ZK6W1yVWa2O1ZIl6Djpz6ipVhtNPlu2vEZWcrA8j7CgUfdzj6/nVzUjHeiaeO0ibUYwIkYtsSXnGS3pxj0pty1vaauVlitBbXMYeWFzkBwMHDj/CgC1BZ202mXMsUVrbpACpO4YZT0ye59P51Xt7E6p4deGeSJ1iBQRylwq88DAzzis+W2a1tFMd8xynlIp2yx+TnIG3qSPWnwyXUuowCwtJ0tpEyoS4CnKjGQewz2NAFSfSrmKyhu4pYo4ZJQkQifCRqTzuzyV4NZ1zDZXM1zK9y7jZ5a20bZ2r2XnqCea3NZkks7aG4v7a3WdV2ywOuUmc9gQevuKzIEumgnd7O1s44TnYRiUk8/KTyR2oAx9HsRJbtHPprK0fzzEuQcD7q+mO/FaOlpHLCl9EloCkhVDCzCST6gEYH5+tNjaHVZJIrG2LIjAukczRSsw9R0Ue9Z11HBpw3Xb2koSQ5tdxaU56ruHAx60AbUrPaTyXFzflrhFEiwNJvXaT0K4z+dZusz20V3I1qzyXHmK37qDMaEjo4xgY68ClXUWsJ/MsrASwXce17d8SEIBwcjuMn3NZbTTC0jkhurjZtYEKMPGg5O72x9aALN9Ksd+kVzd5S6VVG0jYh6ln64Ge1YzpZCaSC7ee4mfcRcNCCjIOioPT3FU/tC2Nx/aHnW0SKyh4jEz71PRmOehqvqPiQBZfsE+JlyPlwVAPO1T2HtQBsWuvWUFvZpfaNHhcgRJKWYY4BcnufSsHUvFGnwQBbOyi805XzUlJZAT8w5HNcrd3F1cQmS6Q7HclV7iog6rCjgRrJGef7y4OPpQBuLrbhZbhLePeD5aSTZOc9yen4VoWOr2l5GqylLZMAICC6q3f5mPc9q49bpjvkdWJLcHoM+9PCJPFlZyqRD7snPJ7AUAdvpcEeqXMaTSyzLuIMwx8oH9wE96dqttYWl9b2VrNN5wYsJJVXJ9sj+QqhpOkalrtpEwtBDZW67zJuEeSO3PXNaN9YLqluL2S6BVF8qGNF/i9vXHrQBJPpt81qI3kkWDOWhMgVFUepz1NZLwvZF555AA2WXahPlj1ye5q8NQeDTDaPCYYQMOxUtI56fhmrUWkXb6arvYzF5ABumJKp/wHv+NAHO2Fxb+c7i4ldAvV84HsoFe+fsbNHJqHjiSJNquLE46d7jtXiVraPLLLZWgVlj5mckYc98n09AK9z/AGP4jFqXjUNGUyliR6EZueR7UAfOnxS/5Kd4w/7DN7/6PeuXHWuo+KX/ACU7xhkf8xm9/wDR71S8JaHJr2qi3UDyIgJJ/mCkqP4RnuecfnQBr+AdOsjI93rNuZraZWgi2t80JIH7zHcdR+ZFdlb3Olsn9ma1YMYvL/d3cUgZowOjbh1Hsazp9JaTVpDpZMO0YWJmADqOgGOuOmRWi1jLp8GzyfJXb88oAkUezr1x/KgCtr3h7S10ONtLvJPtSN81uw+Y5/iHHQ9aw5/HeqrpR0XU1t9Rtrdh5TyIA6Y7Z7/jXfaMmoXVgltMloy7SEcrhsDkLn6dDXlXilrca/IfLIZX2sko6/X/ABoAo+QdSvd9rb7ICw3mJcKo9cV2cmk2qpDY2yGSFyF88AMyqOT05zXe/CXwSbmzS7t722UXLLGEdM7SeCF/vfzrR8V+CY/D+oRC6uSsisSRGp+ZvUnqKAMmytJCFttPtdsUADRXjptkx6++KsuL2ZJri8NzfQMrDfEwyCO7L29sV2eiiw1N2sbmCQSeUWikhj+dzjlWOSMd+etbtn4JC2UclncXMN4oEs6MomSRTwCCp6DB4xmgDzbTNJtkeSS7huPKC7y0sxEjjGdwxwR2wayNU+w3EVrPbzxNp4bzCskO+ZBnv7fSu78R6IY7gW9rOTHboGe7t2DIXP8AAvt7EVzUsumSpB59q62shMayRSrw46My9gT70Acc9pHqlzJawMYbKUsV8sk+4O3+EntUWn2N5oZvC9y0Vq5HmLIVy+PXPau2sdPNlbTNDArG6zIrFwNrdMqB1FZN4L4232a4f92smFjlUEkHnOOp+lAF/wAPS28hNxGgsgjGWSZCqO7H0+vpWleadG9sL29uru7hDB4Vuj5vmf7LEHNc9eaG9vevdrgqgGUjUB4x7LgDNbtzdRvZ7LBb0mXAaJn6H/d6A+9AHnniWfR21hRpED6Z5iiORlfnPXKjOME8c1Ouv/2VqUaXQaACQNhZMFwRjK4yMVtalpaXaNp9zcQLCwCK0nLwNnoMdvepte+F2rwaNJeonmpbfP8AbI4iOMehGaAKt0JNaf8AcXq3MuSXUNjyv7u3p81WNKhDXX2q9W5i8t9ssaSZTPTHrnvjFedL9tjSGO8lu1kb7rI27afp2rvvDdkyG1srjzLq9uAZYmk/dtn/AGiT19uKAOvkgjkvl1CDbsXGwMvyxjGOSSBn2OafNBbSLJdpPdxIpw0xft646fgKsanp0senLH5ayMi7vMaVZHRh32is7S51W2SPUNOSZ4wHiLOojlycA47H60AV4YreN47y1U3Ms27C3EYjVuMDAB5J6jNWdNiSGCBbi8eO0MpEU0rFWA/uDt6jJq5q1msss8ciQ2sQdJY5oyWCMB/qxxgk1TYxf2jEj3FxL5ZDGO3H8QPYngAd+vNAHQWthbanqU9zBGLcqNqwtna5x94Buv8AvE96o6xZpJeyS31vavbrFuXDM2WBxwoAB/OtTQXnvZL77dPZiJo/kLycgtwuVUZJx26dzVjVLNriz8tJJvMchmvCQscManG7B7nsD+VAGVocWnLaJ5clxEkjlI/NiCgMeu1eSfy4Fc9fxSyXl8fslsbSNtgaTJOf9hM9fc12mj2AU3VzG0c9qmEjM0ggZnPVcdTnqcYpNVTTdOlnu54YjDFCHle3YCJvbg5P8zQB5T4kSzu1jtbOyuZhESWkGd5IHJJz0/SuCurpNZuI4bMNER1IBIjUdh/eP6V2XiIah4suZ4dCinhsmwJHcbWkz/DgcAe1LYC38PTRaY5hN0UC7UILu3YcdB9aAPLL7TnEMs0WXWEne7/Kzc+h6mvrP9jE5+GOrf8AYZl/9EQV4Vr2nWtkHlVxcXkudqRR5AY9SM8cepr3j9jdSnw21lWABGtS5A/64QUAd38VpmgufBjpIsTf20wDsu4DNjdjkfjWT4r8L23jTTVtdOns4r+zUqy4Dru7gA8jn8sil+P+pvo+leFr6NYWaLWukwymDZ3SnP4Gs3wx4gtLPRp3F9p9whcyeWpKOrkclG6g/WgDwnWfDGt6Nqnk3RuLLy5CrLGN23jAI9j7VsJ4YkubW2E73d7NCRJB5UZKHPfnIUjuDXbanqCeI9Nkk1CFr+0BLR3LHE8Qz0OOTirGh+FvFWiqureGpryY3Lh0QSB1kXHfPy4+uKAONtbWfV5Et4LUR6vA5jVpcBZB3CnjP4Guelm1fQvFrWc0dxp0wBVlB3p7MAOa9Q17V9Sv7xLXXtIS0WR9txIImVEP/PTP8DfjWbqN39jtYl1a0ttZ08HbBf8APmAd0Zx39DQBxlp42+xxTJrdnb3Dytt81/kfcp4LKOxHQ0nic2NxJHqGm3huIJMM8YYqYX7jJrW1Kx8I6tp/220vILadAUjWQksp6Yb157iuKvLe40V3lQKyFV2zF/ND+oIA6fhQB3NvfW8+nxXMrRSiX5l8uLyZAceoyentVzTrx72wmN/bQPDGpEFrK7GRh3Oe+eo9KxtElivrJbvRtOltZZFJeVZQWmxxnB5FXDqRvIVbU4bjdFGEUsC2eMHB4z9KANOzWC3tLOSYlxzG9qAGyx5IK5zj3FV5b630yZlu7JZbmYlYFZflwOgJPYVHp17Lb3sX2m2kBt48rIsi/d7jHrj8aki1a4urmQveCW1lmLIFUyFFx1yR+eDQBNZWthqCFIJ4k1MscsylRB+A4KkfSiQ2UkcsIjuZ0gxtaIEsTn5lB/hUHkirGotbi1SX7Y7mMndcoVjUYHRiBnHsawNVimEMTWNxEsEqAbVBwqnrtIyc+/WgDS+zRm58y5MIs7V90DLH5okkPqOpx+FYlxrtlb3F+NSigCtIY1e5jf8A0jPbGcADpU94l8dNkuIXRprUDyoHbYo7Eq3Un61yVzNLKjK8K2rPIEQ3E5Y7hydo6fnQBavbkWdtJfWsv2dp12qI3yVP0Hr78Vy7N5l/B9vkWOOQltzPgSnqQwUk5J70al4lhTO60tZfMXhI3P709Pn9PpVb/hI7BrYQrpUVrGpDkRqAWdTkYbr26UAb+mJaJbFU1KS1gt5CDJGgYRyN0Vcn5hj8qs3NyrzSrcM++Nd0YkO1WyMAlc859K5+LWbW8vIJLO3jUsxe5a4JVUbHQgdPw606+8SS290dltHJbplQ3lgD3IJ+9QBm6peOttLYW8jwr9+S3VAd7epI6L7VzayhNgKgsjbsg1PqDW8lwZ7YvEJPmKk7mH1xx+FUnlIAUKo2k/w8n60AWpbhXZJWXe78sN/yg+w7VX3hi2/cqcnavrUSELsJOR3AODTnZdzBeFJ43ckUAOQny8hiWYYIx0q7aSC2jR/JUSqciUHOfbBqjGSysqr8pIyecCnw7iz7GCnvjsKANy0126NyHkvpVGRhZOVH4Diuy0OdVlinuZEmjRt6yRsFRW98DA+grzaziRmLOyYXnYf4vavR9J+zv4YD2lrDbJyPNmZi8j57AdBQB0fiGws576C/ttRN1dKMtEsZMQPYKo6n3rmPFfiPV2tY9OnZbXPBCt87fl0/E1a1DUrzQLeC2tLhUlusK7Ll5Pfmm39pqNmgN9CqRynPlhR523suT93+dAFDwpBM1tIJVaGB2AL4y7+3stfQf7M8UUHiDxgkCMqi20/JY53Hddc//q9K+dLjWJWhiNqY7SAS4S3Q5wR1Z/71e+/snTz3Oq+MZrmQys0Nhtc/xDddf1zQB82fE6Npfil4tjjG6R9bvFUZ6k3D4qO11SPS7CO0jgjkZX3yZXa4cdHB+nGOlaHj+6Wy+J/jWRreKZn1a9VfM5C/6Q+T9e2a45iC2VUAf3c5oA988IWsF7pkF3YuktszBnkX70T99w7Gt290C+k1CG4ub7Lc4TiMSL2we59q+e9H8Q3+jO0mm3DRu33m/vexHQiuzsviVqp05YbmZJcODGrj5Ij3x3AoA72516z03TrhLyINKjmMBYyDjtlh/OvItamjuNRkDYuC7npgdemG9a0PFviubU5Myx5bBQ8rt/HHWubsUWe+jXYRG7AbSfU44NAHvPgx7vTtN0xEUzxxyC4aOJiCxHQkdM/Wm/EPxkJoJLw/abqaSUK8UyFHVRxtOfQ89a9N+EukGbw/d298IpvIiKl/L5U4+XPofpXg3jae3ja8tLm0EzTlpYbkvt8tl4Ybe+RzmgDJsPHuuWupm4S9eInAicAKAB/PFd54a+LZku5o9VW4j1KXAiv7SUwLI3+2On1rwq6KSofssEqoh6Md238aSJ8QCJo2ctyCHPy/hQB9Uz6hd+JbmCXUrqWaRI8gIiqSPXgYYVna81vp9lIbWa1uoVTyo4Gty8hdzhdoHViTge5rlPhvqy6h4YWHypFu7aQDzpY2KbDxk47CvZPhd4OtrrVxrskUJ02ykYaeqAFZ5uVe4B7qOVTtncw/hNAHmrRSeH9Yk0zXA0esyeWkVtZI0r5dFk2IBksw3bcjglScYrRvtGgs5j/wk8l7K6L5segWbK96ynkNdTL8sCH0DZPZicrXqvxP01rRJdW0a+03R7+dPKvL1wiXckIHCxSuQFAPUcEjkEEDPjujLpcmmsYr8xM8hnS4YZjck/eLZJZiRyW5z1oAwLdWmhlihVAiyOVjjVmSFCSVh3tgttHAJAOAK39Gje7sVitxHhBsIjYqWwe5PcelXmkjfUhJbzPMZeHniC7C/pycCr2nx21mZHUpKQCxBfBXP44x74oA5610xLh5EgFzIEJZBNGSI2HVQo59wa9KsvF9vqfh46NcJLdSxwmEsFPD4+UEZzn6iuQMkWmGfUN08BuXCQPCwZgpHJBPUH2rM0LVLXT9dhkc3coVis6DgyZPyrx0POeaAOc8QaculWsF/EkH2tHIL+QGEeM5LZqt4ev01uwaGa6sXmExIwoRs5+9jgAfjXoOqQxTa5qOnWyNaRXieYqyRh2JA6BuPxNeK+LdIktLgzbWO1ikbSSLtY+wUetAHqU2yO3+xC7tY4y+Gmjh3E8dsHGfzpIkgtYppyoMsbLh5kUlCDw2PftivIfDr6Xd3DLrN+9hDEMbwSxJ7hcdOa7vTPEXhe0hNrpvmuwz5lzfOTGfQj+LP8qAO/mFxrMhkmnuLiV9ohjZNoT0bGO/rWNcBbfUvs0DIzISc7/s5lIPKqeSee/FTWHiKefUoIJ7prhPK3R4kK7eOigAD8WqO6nn1G9Bs7FZXVwxj2iZienzDoOO1AG94ZSeZbq4Ie3tWwqIpYMMHtgfdz371t3n2i71H7IZGu4oo1d1MOyPI/urnLHHrz9KxZNSvbfyQb+3RfNxJbxDbIvHAJxgfrUF3qOm2NjIJ7iZbpiChEwZlJPQscYB/wAigC54smNksc+l6fGGZwGSRAyW+e5weXb0NcVrDX/iEw2VxNdffEk8eB8ijuSK0rbxzpOmyiSZ5Lu5jLeTZgBoy+OXPOB+Oa8j8WeLtW1O9lkdobVZS2ySI4AU9Rgf4UAejeM/GOg+F9Fg0/RZEvtW2lmZEaOCE+/d2/SvNfBU0lxqV3czz4Rv3km3G929Cx5A+lcZcSNLKzGUyHONx7+9dZ8ONNj1TV3iuJjHuxnaSWP0FAG34wV/scBwY5rhtiLuy23rjHbP519BfsnwSW3gfXYp12SLrL5X0/0a3NeO3P2G21a5uZvNhtrZfKDSDfJgddo6Amva/wBmC6hvfCniK4tYjFC+tPtRjkjFrbDn34oAf+0zZHUPDHhy1DBC+tL8x7Ytbk5/SvKIbWfSjJa6k9vPcHaYtijp2cMO49K9k/aBhuLjR/DMVnKIbhtYIRyen+hXVeZ+G7U2Zhvr6ZL8oPLmVNrOD0JKHGR9KALfhbQmK3MdtcM2qxMLlLSSTy2m7kJngnGeK9y8Hatb3unQQwW09uI024dQBnuOOM+1eY642nT6asCRNFOq7rO5jOGgPoN3O091PTtWR4O8TTeGRNbgTTuMvKJCyqfcOOn0IIoA+h65nW/BGj6rDMghNm0vLm1wgc+pXGCffGfeuY8N/EWW4lEd3aNJFIC8LhwWx/dyBtY+nSussPF+k3caObgW4dSQk52vkdRtoA8K+IXwYbR/Lv8AQbb7UmdsjbiWQk/f2+/tmvOL/wAJ6ppVvcR3KajBBG2S8SHaufYmvs/T9WsNRi8yyu4pV9mwfyPNSXSWd7ZyLcrBcWv8asA68eooA+FbGK70iWOW9jkaGAb0liDEsM9T6fQ1v6terevltb+zwOnmxhG6DuAfWvVvif4S0zT0Wbw8t1ZJdOsslvajdDKD/eB5Un06V5x4n0LTriCVdDhvPtMkYV0e3VfJb2IPQ/SgDLmZ49PFybuGSIsoDxtuYDtntk+lWbi+tjHEJI3jIbzmuYwyhWA6MlcxcXieHYIrW70ixILbjGk5J3D/AGeOc81He68dULPvuYg3zRhyvyn0wTlgaAO00W8ZrKaRNQNw1yp3eWhUOTwMA/ypy6Df2dlHBbGXzXLMLe5ZQcZ6g54PfiuTspLLSrW3u5YIrS4Z/Mw7OqMe/wB3NOuvHdjeYa8ieOdCQqxsZQpHoWI4NAGhrWo3OjXkUF7fJbosbF45JjK0vpggYB9q8/1rV4LwmCKa5ECkuWYBiX7AHrineJ/ED6uUfykhVDwA3J98dq5+Ri4ydq9+mM0AKzB4lQqqkfxjgn61GH2NgkkZzwaa7g8AHNNHbJ+tAFlbkCOQFQ+4YG4kH68U1p3eN1kzKAPlLEnb9KhZ8qACMdemDSBuCCTjrQA5nBjCjKjvz1po2nk7h2yO1KOhIxSg8DgflQAkkcke0uMbuRmjIJw5xnqetTKriJ5UTCD5S2OB7VGChG35h7gc/lQABioYBuW6kDtTmYZ2RJjHQ9WNMG4txwTxzT843DcM98Z60AT2pZJYjE4eRjjYoyQfx716f4ZmWzsXt73gxfMkOMufYDpn868vsVladRCuX7DGa9f8JaLcNZWBv4nub1m228QIDrnucGgDo7DSkubuC4lka1gixIyiMNIf9kE85PrjiqOtG2vxsstJuTcEtLLPcszlR/sgdfqa0P7GvPC99dJqruLi4QsqRSl2lPo3QKo+tZk2p6pdWrx6deLbwv8A8fEirwQB91fQfiaADRtJ0TRtG+0z2itqFwSIxNhsZ/uqOv1OK9Q/Zq02bTPEPjBLgpma2sJlVBjapa6AH6frXk/hNbeVJbjUkuZCSfLZ0wrAdyT29AOterfs1XZvfFHjeQh8LDYKC5GSA1zzgdPpQB8w/E8f8XM8Xkngaze/+lElcqAcdOldZ8VomT4j+Knw2JNYviCR2+0yDj24rkwMDg9fSgAUE8AFuasRRqCQxz3wKhTh+xz6VNnY2Q3B/SgBzDLA/MccAkdq0/DiBdctXnjeRUkGUjGTnrnFZqNhRuHyk45rR0I7NSt5tzK6vgndswD0waAPrb9n3UZr6+1HzJJIh5fCbCA3PBbPGQP51498coY4vEN7IsdozS9TF/rImLHqOnPtXa/B65ms9UksZL65tftAx5pk2MpHQZ6MDXT6/wCE7XxZqF9a6mIJNQRmQSR4UM/Yk9yfSgD5O0rT7m6ecwBWdB84zkge4r0v4W+GvDPiTXbez1qGWNNu57i0m2c444571g67pM3hS5awaOWG4DFZZAuN5Ofl561V0x7RUtp47qGyvifn2BoyB0OM8UAejeLbPS/DOszWuha/J/ZZVoJ5I8pMoYdNwGD1I3Y+ldZfWF5Hptqk9xrX2FrZFt4ItRlMWwLgHYGCgYGMba83lsPDsbq1pq8mrzbR5i3QBAbrjOQPyNdZog1OOziiBxH5gYwhmcoh6gE5wKALtnoEE1tcypb6fpkyxkh3hG+Y4/iYA4OPU1jaj4KudWs7ddFiubm5IIkaV8D6ZzyK7vTTqkdtfm0jjNvJgEXhDYX13Ywv4Gs2zSVv3CWS+Sh6wsVDH2Y8frQBx3hzwvrnhi4ubHVIYY49nnrH54kHJxnaOpzXd2ls1vY28+tWdxKpLRlhH5S7ccbsc10mi6fZnT/tAvrcyt8gWQZO49AzZwD9KoXralZCKC5m8uFcqS65MrE8EN29KAMHxEWS1gRIxGxQ7JOQmB0wQDnPtXCa/aT6ZdLPcXcs1xP86ovCqQOxzn8DXqc8usNHAs1rdpKFb5DIAjf7XTp+Fef6415MGnuzGroxAmCEALjBIH6EigDO0XVfO1GBPsmozkjGIWAcn1Ldvp3qh8StJvWn3w2N8VfDeTcSHevodvYVq+CUsYJGlu21Pywd8U0SFUT6MDzW5rOq3GpSXNgLG+vVdP3M0m0yMB6sQOKAPnnU7WSzk2zYWUNjCNwKjiupY/LxKo2nKsecfjXQ+KodSnlb7baLBLCxB+ZRgduBXKY+brnnPNAG/beJdSgLslwZGHQsMjgcH3q7B451eIKq3csaBfuREDee5JPU1yYIDdSe1SZCcomR157UAdgPGmpW8MhtZSkbkFj/AHvY+prOv9fa+ndpSxllI3SO+9gPbsK52Qg+uO5zU8kTW8cYkeMB8EiPDMB7+lAFn+0J4botFIRvBBUE9PciqJfe4Dn3OD+tNdfmJjL7M8E4yaWNFPzPuz6CgCxp9uLm4CvIsaZ5baWP4AV674OtYrS2W8tpbqGxjXbJdNGEDH0UAZx71x/w70o3N484CJCincZAefoQK9Wv7lZ7KGwgtphK+AsbQkBV9Qvb6mgDB8aa7o1tp6Ja3QvbhBnZHF8gPqfU/WvW/wBkUP8A8K/1syJsZtZdyPrbW5/rXj/jbwda6P4cjvblmtxO/wAvmt883rtTso9TXtP7K2f+EK135t3/ABOCAcjp9ltsdOKALf7Sl21j4b8N3McXmtHrIOzfsz/olyOvbHWvIzpd9f753uYIL9QLi384DLjrwRww9a9Y/acfZ4W8ONskbGtLny/vD/RbnkfTr+FeJ2urRXWlvp2p6nb3luxKoz4Uqe20j7p9jQBa1DxFqOqZsZrRpEVP39vbTZDj+8h6gj2NMsLy3R207TmkcSY8xJ0Ybc/7fSshojpaMbd0ureBeGjk8uZPYH1/Stbw5cLqZV7GZGlK5MNxICWH+z6/SgDu9M1K60W0EbWNvPZY2SQquNvowYcr+VUr37NfGSS2luZsYaSzDq0wHYqehrIu7vVTLFs3iOBseYkgV1HoQc7h7Vm3c0cWsrdOBEcB4xbp8p9SSDkH17UAd9p+svNp8lvBc7LSFg6vN8sm70+Uce+a6fwvax+ITMLm9CPEcgRpujyBkknIJNeOaTqs2vXd2trBHFqUJIWUHazDuD2z3rtPD+o61ZSTSairGSZQkLyQfJx05XOWH60AdZ4v0bUtFEc5u1u452JFxtJbdjKjaTgD8ea83vdRtNRtX/tSfyNV4VzHHsX2HHOK9x0/xPpcumWdpck3kcilZ/MQ8Ef7LdRn8uK8l8ZQaMt3dSWUssZiicjzowzgjpljnFAHJa94f0ifQri/mEjNGu15gyy4wOozzXl82mWYTOl3KTyFMbXLbifUgjg1694Y0rTNT0OVJ2M8jodyNNjr+X5815NrFjHa6lewoFhSFthDEvKvoQc4I96AOZvoLiAQwtcyNIuQYiGBT8+KqiIySxxIo3twVDdx61PPK6OCC8yBSD5uev8AOqxZAwaRcoOAE4Gf50AMeIhmUHzAnUgcE01Gdg2AWbHbrihHMbmQMe44OM1GGYMW5BPTnFAAirn5sAYzjrmlK/NhSuMZ69qCTjjkc0zGTgcUAHOPb3p3L4CLyB0A605WGwgjn36U5GK42kgZ5weKAIyCrEEbSOxFL1GSTjFS2s/lXIkOw4P8a5FOnbfIzRYCMMkDigCAA5AyQpqRosRmQBsdMnjNA2NGQSfMB4A+7ikJ3AAAcfgKAGlSDjIJ64p3lHKlmChj164FPdAIN4dODjryff6VNYQTzTBYEU5AByMj2oAt6TCUmZRJtLDAIOCfoK9l+GGm6lcRD7C1uLggqk7sVVF/vHPf3zXI+C/AGo6prYhaDMpAKI65XHqcdK928JRWngC5YaiLGFioUqsZuCh/6ZgHgk+tAHPy/Dkyyy3R1CbUCP8AXzGTAPqETrisbV/Dttoc74UzdB9leYqqf75HA+ld5q/iiLU1urq2N5JNI+xQVVSx6AFhxx6DpXl+r6cLK6Z9VnE0obLBZy6hvf8A/XQBovbT31m62UqscYURArDbp/vt/Su//Zk0waVr3i+ATGXdb2EhbBxkvddM9Rx1rm9NsppNHEkMfm27qAmehJ9zxXb/AAFaZvFfixbmUySJZaev3gVXD3fC46D/APX3oA808U6BY+JX1m1u0SKaPWNSEd0U2tHm9m/iH3l9QeleK+LfB2p+FpxHqkS+U/MNzCd8Mw9Qe30r6p0TSNMv21a5Kp9qt9a1MThHzvH26cgSL2OMYYdsDtV7xH4esdb0SSwgt1bSZ49yKLfc8D92Rs9PagD4mRVLgFto9WqVlKJtlwDn5T1H516F8QPhZrnheUSpaSXWmFd63UKcY/2hng1520bDpgj2oARg4Abdkdh/hWn4fZ01OCZVLbGGcrv49l71mqpCg8AfXjNauk3jWtxFc27hJo8EDGd3PTPagD374caRLrt/IEdPsgYbhM2xovdcfyr1XW7qPwvexW2sTNNHMi7LpI9pYjgFsjBx615V4Xu4b+xj1XTy63OAjCPCGJvVh0x+Ve22kg8W+GjYO0smpWyB/tE0KhC46cjI5oA4/wAbaJp3imzXzLPbdEFhdm4A+h2jIP4V5Fq3wv8AEb2DW9vpyX0EWJIp7eFncg9P/wBVe2MHsZDFrUF5b20PaCFCivnqB/d9639N8QT6fJ59yW+wyqFjhkwGGOjDbkAH05oA+SNG8C6tc6iI3sbjMT/ODBz7/Lx+Ve0+FtavNFEiIz2xjT54hLseRB6Bs4NeheINVtbzULaWRYhPIhEcVwpTzF9A3Q+vrXN3kNstsJVY27BySiqrfMeo5OSDQBT1HVfiNpmlyzaBpktzo848yN5PLlaNTy3yj5sfhVLTtRjvtMC3rRxTDJlbaFWI46BQMn8a9k8BCzg0C3htb37TIRvk3NyGPUAdgK5z4laPbLcRX0Qga4lO0wHC7vVj6j60AeeS6nNbLayzXLWtmowMopXPY4PBB/Our0nxbDbwLJ5mn3V2vEYXf5antj0P0rmbu4tLm3Fpd2oa4aQIjRypwOxCnoKhurK7S+TT9JvPMaMB5BEAO/8AEM5NAG5qF8dUM+p6nqE/nRgRxkqYkVM5IC4+bH4ZrivFyWt5EDZz30rXDBI5ZV2KT3zzn+ldBfyy3LyJFY2dgYQN0+92kY+hUnvT9VsLbStOtpLywdb26BeF9+9nxzkD+EAUAcJc+DdV/sto/tcdxGTu+Sd0SMfXpn2FZcVpKZI1i1K9Eyfuy5kPltj+YrsfEAtorI29lDA+oyrkE4Bye/PA/KuQ0+81XwbFLfvm3uHGBCdrtK3qDggfhQB5v4m0q6g1S4MUcrREkiUIxLHv15rmyApUEc9xnOK6bxL4pv8AVtRnvnurnz2JVstgKPQD/GuakBAUtjJycbuaAI8Z6dzingDfnPHp6VGGwAdv1JNKSMBipA7HdQAp4UgY5PUmkQAc54+lIGBHCgH3PWlLkgHA4wBzQA9t7hHJXHQAen0q5p1lLf3MVvbgDcfvP/OobO2kndFWMtuOOuK9p8L6TZW2hwpamCa+kXmOKMtM3tk9B78UAaXh/TUsdESRJHHlgIJ5sgyN2Ea+nuaNW8S/2fZMIZ2kvDgSuoJVvUbjyR6n9KYYNUglgsWjSS7kfiAEvIR6KozzWJ458P3OmPEJ45YJbg7VtFkDyk+hA+770AcP4w8S6h4mvmM0vmIB8uTzge57e1fTf7H2P+Fdaxgkj+2H5Ix/y7W9eTeAfA2nlftWvCPAODbRjO7HOC3QCvoH4FtA1l4r+xrEluNZCosQwqgWVqMD8qAOe/axBPgXQwsvlP8A2ym1w+zB+zXGOe2TxXyXJcT+YUktWaSFssc4Zue/+NfVv7X8Uc3w80WOdzHG2tRgsBnH+j3GP1r5KNurkN5zefGcEnkOO2O9AHZjWGlESfJHcgA4liA81D2z6iun8KrZxEIFtypO85TjP0HKn6V53pl+80lurwPHJE/Jb7gPYgH9Rmuks9b/ANMS1khjtr45BMSqMn2JPQ/WgDp9aOjpdzK9zPHLIud6TEqPcdvwNY63Zns5Fsr2W5aAfuyvzDnsQeR/KscsY5p4bm3llE7Fkdm2lW7gHp+dToJ41hMFqIE+7I8ThZXA7bc4z9DQB6T4ITTNckttNlNrbyzYCtLG0biTuCRxz717jd+B2i0hYdI1K7hnjAZIpn86EsO2G5APqDXzh4V8Qw2sMUWkXq7EOHhuIiJR+YOee9eqaT4zWTR0sbKNpL+Y4JnjUqM9QCeaAOX1q81Iajdsi2yeWMSSwcrnuOTXIXXiWTUWtjIboRWUnzFQAzL0IJ7rXpdh4W/t6G+0yLUrUIi53TQPGDnrkdBz3qXTfhzoOnaPNHrMjRRAlRJbTrIhP06/pQBwV2bC1NrLbXcZBOTHLGBLj/eHDCvNPHK28Xindbnz4plDSKrMuT716tK+jMJbcSq8NqcFWUgEdmB6g+1cT4k0aaUTX1jb5tyhGWfeHx054wKAPNLq13zOiDbgFyS43EfUdazbiFkyeOOOoNXhdSwTsu1YmyT+7XJB9PpVGZw77my2R3PU+tAEQ644OfU01hhsZ/GlJycnGfQCmnjHH60AKeDk4z09qBzQjmNwVJB7cClOeeffAoAAcZAANK20gAAj6nqaQcHtijhm5zz70ASQR+c2wyJGAOSxxSsqrnymJXP8Xf3p3lvHbrIUjKZ4z1NR/MRnbgsccdTQBJHvdSFACjk+9NMYJG1slvWrNvcRRRFXt1eUfdZz93/gNdT8IvDemeMfiDYaFrF7PZ294JNrwKu4uFLbcsCBkA44POKAORiIRo98Ubnr83NdHoJtYJmNzGGkyBGYm4z6ketfYNp8D/CGg6LenQ9EtL7Wvszi2m1YmdDLtOwuh+TG7GcLXyfP4O1C11SXS7+1ltdUtzi6inQZXJ+8uD8wPZhkHtQB3fg6+s9P1S8dptQDrGGZEkCgj1JHQV6d4ImguNNn1OSALBIxx5ycP7L3Ncevhj7HawTSiGIQqGdUGGdcfxluD7CuqS60q8tbEyXEtzLHyYY0JSEf8BGM+9AHJ+N9Ru9T1AWunCQzAFUit4RHFCDxxjv7ms7UdPTQrdGnd2KAeYrfvGJ9PQVr634q0T7UIfCGngOh2Pcux5JyNyseG5BGRkAg+lcSj3V6LuO5ZGggcqHZySW9v8eaANW41fV9cuVs7TMaiPIQ5baPcngfhXrP7Otr9l8ReKl+0RTs1lp7M0RyAd92MfpXm3hjULaysJPMabymT5oo4xulPoWPQV6X+zxcx3XiPxVJBpyafB9i08RxIuAy+Zd/N+eefagDM0byF1nUPOjeSCTWtTjnKgNszfTYzjBx7H6ivR7+wuLPTki0YxXdkGBeAk74s+nQ/wAj9a+dbq61fTPGniafT5mt/M1q/MRIwkmLqUFT2PToa9L8LfFGzv2tbfWfO0PWoDsWUJ5kMg6cg8gH0zj6UAdhaXNhcrLFPYtKwUl4WDZx3IHf3BH415l8R/gvoWvQLqfg+8bTL2YFxbXSEQTH+6Hx8rfXOa9ts107UcS3Vxatclt0c9opjKkjG5WzkZ7g8ZrkvFqalojyrqN5De6fJliUTZMn+0VHB98cH2oA+Mta8Panol8bTV7OW1myRlx8jY9G6GpIoVdliQM+zHzheQO+R/hXvyWljqkosvEEs8thOS8NysJAB7BlPQj1Fc7qPwYkGlSX+gatbXqROVngOQ6H+8g646cdaAOK8Mzw6YJZgzyJNhXiVCcY6g4r3v4M+KIEWWG2ndUkYb43PMIz1wx+6fXtXzVqmharoFx/pttJB83ExyUlH1HQ/WtTQdSezk8xlCcBQqDcuO4/+tQB90appK6ltlSQEkKrBsEEA+3f9D0rhdU0iayvvskBEKyMSXeMrGx9QTwMVi/Dv4hquk29rLPvdeY40iGHHcev6/nXo0vjLQwywXM5DSDlGiY4z/eGMj8RQB5pd6RLd3yWKLfXVwx+9DuRR/tI5GBjvzVfxV4cvv7UsNG+1fY1nILSKBIRz94+hr0m48daPp8iQSK0asMQ7Cu1vpzwKxI9YJ8U3Gp3ln5kYTESRkPhcfez60AYN3pmh+EdQS21vWdTnu5NpBtHwVPbd6Z9K1de8LaPc6adTfxHfRDrEZmDYPoVwGJqHxc+lai1pqdvPLHLL8rJAQdh6bmY8DHuBWr4Y8RafpFmbK6vLi9Y8AFN7E+hPf8AM0AcGnw91K+0iTVo1+0zSnEaJKGIUHqByCf1q1D4I1FZI1k065Uldxlf94XPpleg+tb9nf6t4a1DUr2HQrqHS7mTeI1Csqn16ggfSrmrfEr7DCZREnmFcLB97B9WOcj8qAKOn+DNR0mK3uDbWcSI26WLzizOPrjr7Cuc+JviG5l1E2RlkNmpyhaLLKe4DY3Y7VH4z+Jc2r6StqLO3jmQbml3kxhvYjkV4/qWutNbul1dr5nKFWViD+Xb3oANQ8TtFefaJY1d4GMMaEtgAdua5Pxb4lfW2VdqRKB9W3exrNv9StXuHHkR/LldyMx3fiaxg7nEgdQE+7u/oKAHNtCbldWGMAY5/Kq7ZB+X8/SnyHGQ/wB48npSIUVxvGR3B7UARLgHd1Hp604hXzj5R0xTpX8xyQqLngALgUJEec8f1oAaQM5HI7Ve0zTLnUZkjs4JJGYhRsXIzWr4d8K3+rXiRR2s7qe4Tp9fSvbfDvh+502BJNEFvHfqqqIUUmU+pI6CgDL8MfDqPQktZ71rZdQmHKGTzDGMdT2Fd3Z+EYJNMmmt9YYTIRJPcONiqP7qgfzJrR0yOznfyboS3+qhgGEsiqsR9lUf1rM8Zf2jc3X2LQoXuJoxmRULSKuO5/hGKALuk3w0SG8GgG2W6ucL9taEtcSeoXJ4X8B61y11YWGrXnAmDR5Er7gzyt3BboB7Dj1rC1W312ziuL24uVy6/vIkJ3svoT/Cvt3qn4e159RtxbmwQSsNuyGMuRz0Hb8TQB2d3Y6X9lLpfxiRF8oCP96I/wDZXOF+pr0X9ne3S00PxNDFjYus9Rnk/Y7Uk8+9eW3diTDbp/ZdxHGzAKfMVAT6/T6fnXrPwFgkttN8VRTKVkXWeQWLdbK1PU0AYf7WUTTeBdDRArH+2FOG6HFrcn+lfJ95DM1sjIU8qVcrG/BHupNfVP7X0ssHw90SSB1jlXWo9rN0H+j3FfKF5eGVWM5AuCcnLfKP930oA3NKvrk26nULWVoIxhbg9V7c9mWuksr6AX8f2rTIHt2TbJKsWd49ePSuS8M3ZiL+ZO4jcYSMYZD7H0NPkvru8vBBZJJD5RJYRN8x/wBoLn88UAdRHY6Y1/OrQXN7p03zZWMsqezDv9a5q7uoP7QuI7P7SqWw3RfLxHjsQw5H1qa41C605BPbSEljiaK4UsPqO4FJLqavGsk8ltC0fZQCxX0DEcj2NAE2katFdMpv9PEEy/8ALwqsDj/d9P0rvdEY6pdRR/2haWsDLtEiwkuwHQ8dq42C2tzDBc219cGYHcrpjhT29MV3vh4WouUuLfUbf7UyhY7e6XCSN9QMe3NAHpuk3kuiXOIr+IXMx2i4LAq49MkfMPbqO1afiXXBa2hDW9jvmysv2VEcTcep5U/hWTqEs1lCDc+FJNNkc43If3Bb1wcgV5/rN59oku5NSnurZ2ASKW3GUU+4HegDA8VX8XmTC3SMoflKSxKjKP8Ad6n6iuce0kWwe0XVfs9o65+RvMdieue/5CrV3oupS3cck95qEDxn93PdkCN89gevPoaLwQW9iE1LegU4FxbyKdrevtQB53dW6200otLuG477wp3f7uKyAPnPmK4z129jWzf+U2tSbi1yFbl1bDOPyGazbicyXDGMGNScDdwQPTAoApsWA5P4UgHfB/CnlTllyDjr6GljKBSrxlm7MG6UANRHwWVHIXqQDxT1TewBYYP8XQURu5GwzlVPbJwfY0IrM5Uck8cUANdAsh+6Rjsev0p2xFjJdj5h6AY/U0hDBjuBJHvTonBfOB7HrQAfdXaoV2I+9nNPTy15lLlhwAgx+tMkLOQzZ29s96mtoUc5ZxuJ4QLkmgBkrRNJ+6jIA7Mckmr3h+/udF1iw1i0+W4sLhLiPJ25ZWBAPtxg1UZUVsLICc5+n1rRsbTEiR/uWaQ4Z2bOwHvjt9TQB9cWH7RXhubxjLp1zDLFojqgttTTLguVBYOgGQoJxuGenPHI9P1DSNA8Y2VpfBorraC1pqNlPtljz3imjOQPUA4PcGvj7wr4Kie5WSW9GHAMZwFLH/Z7V6Xa+FLzQtQeexupNGkZBI0enXbK4H96UKcOx/ukH8KAPS9c+GuqahcF4/F1w4Khc31hFO4A6DcuzOM9SCemSay7rwD4a8K6Q17458RT3WnIcvbybbeCZvQxoN8pP9wswPTbXFXvizxUk/2O38T63cyMMiEQW0ewerS+RuH0Bz71jtoVjqNyuoeJfETDUE4UzvJdSkdwu8naOPYewoA5jxzrA8XeLLu+0yyFtYDyoba1YKuyCNQFVgOFydzbR0yBWJZ2cz3ZOpXWzL5j8vKqD349K3NevdO03UALdEvogcgMQpP1CmqEesz39y8wtrRYCCWJ4A9snoKAOr0C7g0h/MtrRNSuCRl7rcUA9ecDFeo/AvWLjXPF3i26u/K3rZafGFiTaqgSXZwB+NeI2UUJkSTyknkbB4kIiX6e9e2fAZmPinxSHktXIsdOG22Hyp8938pPc+/vQBg2U39lvrU11BHLZ3mtakPLvU3QyEXsw+Vhyjcdfar2neEtF11bkpcwW8xOGtrnDL+DDBU+/INRQXskNpqtrcxTf2fNrOp7xKC0Un+nT/MpI+VgeOOOOayZVgOozG3mSwgePagky0ch+uePp+VAEmuaZ4n+HuoJd2DM9hsI2KvmpIO4P/6hWRr/AIzTXbCG61iwvoniOEiSbzEU9j/eX8zVuL4gazoVylvp9xFIVOx7WZw6sP8AYJ68dq0NPvPCnjK+Ed55+j6hlmjkiwAPUFSMMM9jQBQ8B+JPDzXItfEn2mFMZhlk+ZQSejDHI+leg/a9Kt5Lxbc2rWjx5zHI3J9VcA4PfDDFc/qXw91kKVjhttQsIhuint9u2ZfdM5Df7pIrkbW1iGrT6dHcR20wIx8zwsrA8o24Yz7GgDotWisp7VII1Ae4G15ZQDG/sfRq5C88F6LCUngiuEuz/FBIZIWb3XGR9RXRa3qss0kdhqlrbI8RCpcW+2LzBjjLDg1a0dhbHzY5baMk4b/SNrY7j+7QBxGmabq2n3r4spnijO8SQozFfp0/lUup+L7iaaCRdRuba+jcKyygIzp7kdfoa9WTWrCxvYBYS3i2xP79Lq380D/dYdK07yXSdUkEU2jJeWwHMkixk4x1VSN34ZoAwfDOkx+OTEzyQtbxYaZiyOwYdOAQcGuo8f6UdK0OKa3e7KQfKgic4Q+pHXH415/L4Xh07XUufCuof2ZN99/s+6PcPdTkfkaoeNfFHja3tVtZdVt5IJPkLRsodgfYYzQBk+DNH8R69rVy62scgDblYuoVh3yhIyfpXoOhafdteyWl7DJbyxnDYmWFOPZgT+teMTWU8AiE3iG+ikfkJJBwPXBFb3hrxL4p8PTRzWfiE6pbqdq27ElVB9jkfnQB3uoRWplkSy11/tCkh7Sd2mhOO+9cAH2ritXv47W58qJxI7v+8a2j3BD757VF4t8XeIPEc7+faW+8jaDEuxvYc9frXH6xofjG/wBiJpE7oGBYQRgcf7RGKALviXV44I7lLeWHcwziS3WNT/n1FeXaxqktzcAsFBC7CY84H0rV17R9ftLljq9herHzhn6AfUVhnStRmkLRWd1Icbt2xjx60AZ8kgOdi4HGec5ojJHIUcjHJzW3YeEtbv3UW+nXJJ7shA/l0rsNL+EOu3sUjBNroMncMLn0ye/tQB5sm9SduSfp1p/l7wowM569Sa+jPA/wI0ye0ju/EN9MxU5a1T5GPtnrj3r0eLR/hX4duRY2mhW1zfIBu8uJpXBH+2x/lQB8keHvCOra9cKtnaS7MjdLIpCAV6X4d+GsOl3jz6kftP2blkVdwyfUHnivoXVdcfUbWOIaTFBYRDMcFwSjynoAoA6c9vzrmrfRbmLVLi6eFRdR8pbGQ7pB/dGcKPr1oAydJt4pXkk0+0v4ldQg8qAQK2PcY6+5qS+sri2OX89DHGXVbZG2r/vvj5jWheeING0aV3e4jtdUDAtG9yWDE9lUd/0rL8S/FvXILEQW+kCKArt8xWBDA+uR/KgC74OhubCCW6lt7jy2+aS5vJUWJAfTbz+A5rEvfH2h6Xb6pa2DX+r6hMSHVJvItoR22gHJ/wCBZrij8RdV1FjYbjH12xMuQfXAH+NM0f4WeKPFd1NcNZ/ZLJyGe7ncIoHf5c9hQBm3OoHWl+zxwoj3J2FllL/gO2fU816b4Q8DaToGiGW9ke4kK/OSW8pM9hjl27YzS6N4Y8DeGGUXWpNrWqQDCpZjekX0bhRVjUNTk8Raja29vazSadbsCsKT9W/25BxjPZaABUb+0oJGhlVY/wDVgIrLEOwJ6bvbtXp3wvlaa78YyO24nV4+cAf8w+z4wKxn0KOw0ox6pJYpdtz5KEt5Q9AOg+vJq98Gp0uE8XSRpsT+2VUD6WNoM/pQByn7XB2+AtC+eOMHW4wWkXcoBt7gHIr5kXw68l20kElpM5GBGRtU+m09Pwr6k/amaJfB3h83CRSRf20oZZVyrZtbkYIr51vtAMUb3OkxyWjbPmjPKsPTB/z70AY39m30lu4bS44LmI4wHxuH+6eoqro8MUM07zwLb3MTcb3KkH2NV/P1E3jebKT5a8ROcfgvvWomrtNPBJfWyXNsibWfhn/Pvj35oAs399b3gDajHL8o2l1YED/eUHkVi6jpdykasuGiZvk2puUjtgjPHsavXemz6zJJJphg+yJ0DAB19RgckU9NEl0+1Sa11l4pByEDFQ3tigCpZQ3ziKQI0Fr0AhBIB91612tpBrWm2EbW9xcz2+esUQ2kH68g1laXqJliWSe2uruVflkhC5Le4YdPpXrPgrV9Ommh02UC2hxlsuZHT6DqRQBRh+LPiDS9M+w3OnXl/Y4Kb7q3X92B2JzyPQ5rEaS28RxStaQC3n++wt5MA/7ymu41/wALxwzzXWja1aXpk6wJcKpJ7Zjboaw49D1C2tzLc2VrbzueSj7f8n6HFAHIavFqNnaKuqvc2sA5ilAZ0/4EDkUKdG/4Rv8A0azPnvkecAUQse5//VW1PrUtmZLK4lJHRobhsx/XHp9DWLrt9px0l/8AQ7W3d/lE1vIZIvqe4oA818UWot7hFmuY3uQm4yIchz3xjp+NYAL5Z1ySByTWtqSoQyefGz45CvvB5/hxWQ6bVwR8x7Z6UAI2Qg3r97kHOaQlQuADvPU0qxu2cITj2oUtGd2Bnpgj+YoAQMcMoLEHkinCFtu9mCr9etN4Zs4GPQGlXBDcD1zigCVFhABLcjk5GR7VGyhnztOT0xSAlOy5PUEZzSqGDZGOfSgBxUbBliG9COlPjiEg4k+f0zjFLFGsi7VRt46kc5/wq3b2mZYkgZJpGPIA6D3zQAafZtc3aw+WXOOFjYEfUmu18FeH7e51KGK9EflSPuKli2cdAVHb61PoXhm/1BjhIli4j3GMKcdyCK9u8B/D2S4hWOwnTyF+87qxUfVjyx9hQBP4K8G2a60hhuGCREFN43BT/sY6fWutv7G1XWWit4YJrkAlLmaIgH1IJPPpmtPQ/Cml6LqTZun1C+lwohICQrjplRn9SfpWD45W7S+kF5cxXN35e1bdY9kSr6Ak/wAzQBj674sudMtzYaRp2nRtKCkt604aWUnjCDH+OO1cSfBvijW5mvb6OKwtQPkaWQIqj1OeTT9XjezuYJS2n20iuGAYiWRmxxtC/dx6Cm3j63qAYIn2yRRuw+7j3YZwo+tAHPajY2FvfXFpeT2c0US7t8ScE4+7u7mqmh6a8+nkQW0S2kpz5StuGD2Cjk/jVxtMCWyvqUVkb12y8cZ3H8T0H0rXutbgW2EMNx9jjVceVHgOfbjpQBzurC5065hjlt4o4345KkovqEHT8a9e/Zvhih8Q+LPJRlV7TT2O7qxL3XNeM21zZXd3K0al5AwQ+Y3U+pzz/SvZ/wBnGNk8ReLd1wZy1pp5ztwF+e7GB6jjr9aAOr+HeuWrQappV19mKJrOqhhIcZzfzkdeD16HH41D4o+H3hiS5kK3txps06FwFJaNvoCOvtmvJpZ7SHWtfeSaS0nXWdSAlC7lb/S5uorQ0/xJqljFG1zA8tkkgkiuVgLop916gH2oAwvFXwu1XTU+3wTvNYM2ftMMRKgZ4JUcr9eKteDtV1DSmuIfENlFrlkOcoQs8Y/vKeufrXocHxD0S6heSO1eC9dlDPbsVVm/2kPBH1Bp/iyXwxqunG51NBYauy4S6t04kI75Hf1oA861DxzHpc4n8NanfeUDlra5/dyx/iOGH4Zq/F41/wCEnBvZ4pXu41CNgKoYDpnjn61x3ifSrZEDrclnY8OD976g8qf0rnYJ9U0G7MlncM0hGWhMfDD1x0PvigD029h0bUg00ou7TVFX5o3fchHtn/69Y1rdzQTq0dos1sDgt5Q4+orJsfGsEpjFxpMazjH7+3lZQ655Uqw4/Diu2SLTTLHcG7vJbSZQfs8uFZfo3GaANyx1fyY0lgvJ7Heu3Z5e6Fh7qeP5Vjap4hkiv0mZ43kiOC1qpwB9Ca0NJtGCm40+Zf7OJwYrl2AP44wfwp2rrp1zBIq6fNbvFy7QXAeIn2yMigCpF40t4pZJLhLtS67Vd8nnsQM8Vyfi7xLfXYjCO1zFE480vhSo9iO49a2GaZrHiG8jtwcZjCHI9+hrh9Qt5X1NYrYTMGb5dvGfqMnH1oA6iNZ7rRGRdSW8wM+U77nA9M4607wxNDcxrDPbIlwD/rgnQA+5ANRWmjXjKBNbSK3/AD0glaJh9dvGfrVzTfC+sXGpuLhbuS2C/u5LhNw/Ejg/U0AbySxW+sIIjFBZjhpzt6+zMSoNS6tfpMS1tPPf2x4dHAYfXepxis6bw9e2b7JEW5iI4hcM8ZHp8nT8acutvY2w0l9Jk07fwGhChMf8CyaAKKm1edvtEiRWkS/KsXzAH0rltQ1KwN3K9vLIqrypDAhz+HA+lX7iVIp5xFdGQZ2srkwkn0965PVb/wDs1m8zTbdcn5TKSyt+PegD0TwFf6w4hniivUA+UvGyoGGfeveNHJvLKBNQvIIYI8ERNJG7lvUt2NfHWk+I9WsyY7a5DwSNtMaIJEGeyHHaux0PxTeWkaGHRUa5Z8kybmkf3AAAoA+lDosLXb/2fcz7nzvkkZGXHsw5FWIbjSdCH2Nbq3julXcQGRDI3fJPOTXmNv4p1jVtKRbrVZtI6ARQRDd7AseBUdr4Zj1K6WW78QyR3BO/e8e5h64egDc8U+KLOS5d4c2uolFH2mMn9yScAFz976ADrXMa4+q61JImpapMlwB+6jhU7GX1ZQSd3t1rpI/C2kRlN8lvciSTJuLhvnb0GN3T6VianDfwzySjU7CwhtCQgT+6e+0Z/nQBy2o+HZ4JY3vBFHauARMGSFif+BEt+lVo10mK5WK/vI7vI+R3UA/izH+Qpbnwhea6Jr2DWJrxyxy9shZgPQH+GnaT8PVtQj381xNdYwIGQFgT9MnNAGLqMMdndfatDtkQxuWNxI28fgCMYqSy0/xT4xuQt/qU6WQXHnOdqj/dj9fwrp5fBI8xZft62YhIHku5kfnj7vaupi0jRPCwF5rdzc6jIR8sNoTGi5/vHjJ+hoA5DTvBUcEMkA/d28Z4kkG7fjuVxz9KSeW90yCKOCE26RyFk3qETHqAD1Nez6RNZX+jpqNtZWen6agLedNmU4HoDj/PrXnXjy4sr/zbrTZpogD+9v7tSWc/3Y0wMfhigDl77VL0Sqot5YnnOd6MGc/XPAFeqfs/MW0jxQWk8xv7ZwW9T9jta8M1G3a0UzyPPBERkM5IaT6Kev1r2X9mRi/hbxE7b8trLH5yS3/Hpbdc0AM/agfy/Cfh1ysbAa0vEgyv/Hrc9RXhI1fTiEhNxJb3B5WONvMjP0zyPpXuX7VUrQeC9AljkMbLrKkMBn/l1ua+ZrrXzcFI59PtZuOTt2tn2OKALPl6e95JLe2wSFG3blbaW7dT/KqF7Y2qSpeaJfN9lkf545FAZG9T7e9RyCxKlSbmNJ/4UbeF9ivcfrSXkS6fboqRCeEjIZX2MPzoAdqNvKFQ3FwLaVhxIq/Ix7A9x9arzy3q6a0V5bW5J+46yYEg/lmp7PXUg3RXijUICMqksQYgfhV2a3stVsPNsbDylB3EDP6e9ACeGLOWG0e/F+baRsBEAY7fT611l7c3N3YwyzoIbtTsW8gKrJntle/1rL0J3ihM0dhc3lknDqgxKn0FdP5uj6jAktjNJG0XLQ3MXlsfbJFAFRYL7zY5NVmjubpRhhcwZZsehBqSHUYLyJlSWYEnYEUu0Zx2IPKmp7fSZ7su9jbM4k5EizK5RvoKkhRNHila/EyXzHDebbDypT2JPGDQAySCzuNMaK7s4bgRjDHLM358ZrktZtRLGh0ENazEbDG7bdyDqAGGM109xqctlZNc6dJDbXA+Zo7e54PttauC1jxFPqd8ZW3OwTJgmXbj3x6+4oA5m/gltLmWDcCicMduwknsTjrVKG383CDyYiT1eTkVruHurB1gimNxu3S/PhW/CsWRGjBZ2GQcEDgigAvEcTlInZ1GPm3cE9+naoIojI+0g9cZzUqRhmYCQdM/OelRpG7MNoBGfvCgAkhbkqpG04IpuzIIySe2KtbQHKLEgO3kkn5vzqe0wsuIUCy5GDnG0enNAFSKElvmB3DlV281q2GlXMsnmW0aXY/uqMfnV6y0eeeSW4mkeONcDcQXOT0A7n+leheFvhzNIqyXCJ5j/OGm3IoHvg0AcHoWgy3eqyQTxylvueXBFvI+g7V7F8N/hXZyG8fVBJGsRJzNgSYxngcCvSfhj4Ut9NU3H26ITHoghEhceoHUCvRtR0q2a0EmoE3WOVV1VB7DAH+NAHnlhpmhW9hHH9qVUJGyCeFnn+mBwPwrurDTGGlrbaTLLpW4YVWgXB99nX9axNR05LWL7TbX0slyzDdbIwDkegOAR+lct4m+JF3pEckVtaRxyphRPdXYmaInggAd6APV7bTpYbSKO4uIrmWHo/2fbt+iqetcb4k8IxXFtdXlzfXCXEhzHCVAUfUAk4/GuHi+JHiiztbd2/s4edlljXEjEf3jgDn61j+IPG2s60sZaedNx2MFYBQPZVoA3rXwTZxQNdpLc3t24xG0Y8tFHfnqatX0V1pfh1EfVdPt4UU5jlAy59W28n6Zrn28TtptgljYXl35rriZlmWNgPTHOB9TXG6nqeozGIx2kM1pCNxUEkK395jj5gKALk4luLjz3uYhGcnbDASWQdwp6A1zkyRamzPb4t38zIkf5cAdhmraSX915l21ysvmr94cDHQAe1R2fhyztZI/tF614SPmQfKoPoD/AIUAO0XTLm6uTDYQCVy3Mp/eAjufrXuPwT0+XTvFniWKcEM2nac+D/10vB/TtXCaNcahpttHBAk9oJORvjV5SM8AL2Huc16B8HvtB8beKzdyzSymw047pRzjzLygDmrD4fSa3Fruo6ffqLubWNUzayOCr7b2dR8p6Hj9eorzHULzU/C+pSWlxbajpkyPjcHxE31DdAfYkV2UHiKG11fXLC4kmgkTWdSaCeNc4JvJiQQeGH05rK8Va1qd/pk3zxT7AQGX5lYf7rcj6UAYCanp13eNa66JrRJwNs64IJ/AH8xW3d6jJo9kIhqqzWXVWaZZAw988/j1ry/T7gCXekz2zxtu3KmYif8Ad6ge4rqZtYt9Z0thq2gQX0kfAns3Ecy++Ojj6j8aAOq0vxJpGrWphu9OF0V4EkXyPj69Cf51BrGnWE0C+XcRNakZhm2FXX2bAxn3rySHVvsOoSrZwFrUnJiZzG8Z9Rg8GrkPinVDPJ9luvIeTk5ZsZ9wOP0oA9M0zw/Yy2pee9lcR8iS3YSAf7y9RSWc8ouWSR7Se1DAL5o+V/c+n1FeWw6xq8V85Jnkn3AmWAbWHtxXV6T4q1K0tZYLWJZ45CTLbyoMZPUgN3+hoA9Dg1XSbSfzYQLZAf3sSXJMYPqAf8K328YWlhcRz6LIzxSDL5YEOewIT+dfP+sXmprCznSZLSHccN5Zbr6H0/OovC7a2dREdqxVGILpI2AR+NAH0BcvpPiiZru9nu4ycq1tOoKL/wACBBx9aoaZotpYzPdWvh6e/sc43jIIP4Z4+tR6TplvcW/l6hAbeQjl1JXP0JyKmtPE1roU/wBhhnuipGFZo4wCfc8ZoA62z0fXZ5mm0jTrnT4jhgJdrBx6AMBx9a6DSPCt/eW5m1C3trd35zGXhkz64UgD8RXAJ44v9M091iZ2Uktue8bA+mDxUvhnxrqVzqUV1Ld31wrHDQiUiMD1BJP8qAPS4NI+wT+XNHfzREcyxKS5+rLgn8jWVq3hbTL24tN801vCWJKSRmVpfQD+KrNt45Uaz5dzI5tgpxFGoldm+qgcVJd/EO2W9QWwT7Pgho7hGil3e2eMfhQBwmv+H7WaSW3t9Ot4IozgNJbSxu3uOo/M15tfeHtCgeZZZGe8Yna7hiqH0Fe2+JPFQlsBLqlrbSxjO2NUd159TkA15Jr99A8rXNtCiq4xtt41Tyx7bjzQBj6L4Wt727iiS7eK5hPzpCnb1JNez6D8O50s43s2tirfeafOSO+CMkGvDLfWkm1aNZ7sosWdrFzub2KivQPDmsrKrWcUFzcQuMja5j5/nQB3z+DIZ77+zbK4iNuV8y4SJt+GB/iY9Pp1rVbwTaiOOa51V4rdBhRbkKp/xrhLaz1yzu3u9P0y9aMrgospl/lx+dRX154qmBt7qe5MCjc0Rfy3X/ZG0YxQB6VJaeEdJt4ry4sbP7SBuCzMryfiXPX6/hVPVPHeh6MYzDpmHlGAAsaMR9Bk4rw7V7XUryYSXCzrA3K/vRKRjrmsfQ7j7DcvPLHK7u5iVgquevYZ4oA9gvfijc6mGt9OtFsISSqu8XmgY7ntj8KvaSl5FpsWp3WqQCN33SY/d+ae20Abj+leapJd6dGZT5KQzN+7AYbj65UE1fl8R6bDJbQeZfDUJfnVowAfoFxwPyoA9i0y78M20hjVmmvGIdt6szM349RVDxf4finilu9S1BrYPyfNHmso7KkSjn8zXkd74xvLUyRwxuJh88gmcOz+7YOfwzT7/wAYm608Q6jrDRNIuTBCuDj0wP6k0AbvijxjbDRV0rw/FClvG215tRmJf8EBwDXltzf6hZXqSRObmWVgEkdSI4/9o+3tWpBbR3c+17SWOADfnzAqAf7TEdfYU6e0sbtGluLuV1APlw25Yrn1OetAGtFfafBbCS8v/wC19acYEkgyqn0VR2Fenfs586D4nOQ2dabJGMZ+yW1fN8urzwXUiW8TzOp2qgO1pB7nsK+if2ZWnfwt4ha7jjimOsEskZyq/wCiW2APwxQBH+1CGbwl4eCJvP8AbKnbz0+y3OentXzFf2CSMzo7eXnO123x5+vUfjivon9se4mtfhto09tK8Mya1EVdGwR+4n718lWfiW9ilL3J+0hvvZO1j+I4/SgDduPLljCywTRvH0lixIPrnrVeSO6ZPNgubieAfe3IWX8jSReJrJZg8FvJbuw2ucgKfqOlMkv4llZg2xn5zFI3NAD3Wb7Il3bMIgpyGjUIR+HpVy2uJ5Xif5pHzyoYRsw/SoFn2WaxbzNbyHLeZgFc+hrf0+0u7WASwmS5jx8jSBXVPxoA19OuL6xuo5tOspHRh8+9w7/QNnmtO6hh1DE5e8gun+9HkDn6HIxTbW00e6u4Hnd0u3ADoq7Mn1UjitHXNLs7d7cXF1PJGpBVZI8j8cc0ATeGLW1s7rydQd7KYcq7I6h/YMDiupubXw5qVjKi+I7mG5jHIkLMAfYtmsyw1S2vrSW0Z9ioO6l4z+Bzis620W5v7giwNqkG7BPmbC30zxQBj32n2SxywxRz364+aSIbhn15FchqunQbitrE8054ClMt9DnpXt+m+EpJJhH9lkjXbhpLlQF/Bl61U1LwlDBfqbia0jKnDPHJ5gHpwBmgDwO50+4ieKKeF43Yk7Cu1c/hzUU+m3MmEItSAcFIzk88+le/N4VtZbxUe+1JIzwHWISJn6dRRf8AgC0tbZ50s766jcYF0syqh+oHNAHz0ulLcXLQrazpJt3bRGMY9quab4YmunUJHd2+DyZiFP4V9BeHPAca6eL5DJZvjLOG3D8Cafb/AA9h1G/+13Ws2/2KA7omdsLu9Sc80AeO2HhCW48tjbM1ovDyMxWTPoAa7rw18OdI1GZ7YQ3HmrgyK1wUJH1Nej32j2VqYpNUmVpIhgSwfvIyPXZt5NdDY6npVt4ekEFxYyqQQn2mzIGfzyfyoA5zwz4JsEmzaLZQRxnYrvKpOfQNjJP0r1XS9O0zRrNmUxJkZlkeTdn1yTXm+oahZX0NsvkWkNxGMCSNWh5OOmDVGefUYIDZ/apDbOD5gjZizD6nigD2S0jgdfNt08uNuRtQLuHr60gtbeSYSMsxdDlC8j4z7An+lcFoPiG7jjhim1MW9sEAT7ZamSTA/wB3H61IdWtry/LX95BqCpxFtQwH6DgtQB1l7psV2zx3l7tkk/hhCRnb+ILH864eb4c2E6TSah9njtzLuE7Sgr5eeNoAAyeOSe9dLY/2zeRvaxQxaTbMCVdYMtj8TjPuQK4vxvp32KeytYfFGo7wSWjDBkVQPu7V+6T0BxxQBsWfgTwZp4bDxyyHjEcgZvyXJNYHim18MeHdNKaVoLm9lYbWulcZz3wf5cVWuPG9h4PW1iwBfXOQGMRkc98s5riPF/xNudWvlSKe6DICA4jX5Qeyr2PuaAK/ia6s7RNqafDEW5ZxbiMufbHOK5z+07aZ4rcSXMMcgyy/aiqY9W9qev2jVbiUzzIiooZjeTEytnpx2H0q9pvh5jdrc3S2+wH70q7t3phB6e9AElmlmYHazkF0sI5LnZEvsPWus02LTr7S7czwXMLqQxO4Aj6HoKHt7W5hYzL5MNuAzS3M0cEfseeK4PxD8QPCui3UZsL258QzL96NFKQr04Dt25PIB6dqAO8uri2xINKhcyIMM8TkufrIf5LXV/AmO4i8VeKRdtcGU2OnnE77mX95ecc8gex9a+ZvEvxi8SatCbbTRa6JacfJYpiT6eYefyxXrv7E00txc+OJp5JJZn+wl3kYszH/AEjkk8mgDzH4gRTf8Jb4lkhNyWGt35Cp0/4+ZOn+FcxDr2pW+UFwVB5BlHDD0Jr07xDp9lL4i8QuLoi6l1jUQ9vIw2vi7lxjPGcAVyUOhTi+ET2qyREZV3HBHpkelAEHh3VYUCW91BbzJKSTFLkKM9kb+H+VdJqQ+xWqGztmWBu06E4+hwQfwIrPs/DzxGSND5cBO+PeqtsPtjt9K1YdRurKIxMIreY4BkjmKxv/AL0Z4/EUAcxeeCdQ1VTe6QsN9GRuaJX2yKfTB5qHTfDMjSxpepJbyg4ZJkwV/wAa7eRw8kJke3t5if8Aj43lBj6ip/NnTVUt9Q1ETW8q/wAA3gnseeD+BoAbpvheye1T7TqNza3EQ4ubckgjtuHcVz2redp+oiZZv7RERx5yrgFfcEdfwr0rT9Rt7tzpWLeaEDh1Yp+WAdre1S6jonkwl7APccH50kVnPsRxQB5/PZ3WqPAY9UW1tpfvRo+0EfQ45qrqVhc+Hts0V8soT7kjKfl+uOD+Nb12i2NrJ9r02aS0Y5JkQ7kPqBXA6nex28rXEQXyXG1Ht3w4HoVOR+lAG5qfjOO40pIrhm84j78CGMH3IDf0qhol/JJFGZNXnjjOd2EBUfXcK4u+vA90J2maZRxiQDd+nBpbLUoo45FaN1jc9myPyNAHoF5cwq0Itr2GaZOd0SlCfr2Iro7L4iz2Vl5J0lZEHymRIf3f15HFeVWur2pTypXuOvAi6fr/AErpINe022jXzVugx6bA3P1zxQB1MniyNJlYvJayD5kdQQQfYLV2PxzeahBtnSSVOhZWVGcD1DdK8/vvEovmKO0kEa8gvApZvoQBiqDa0xzCqTtG38by8fgBQB6ZDqFhfIrD7OsY5EczZcH8xWD4muLgxEWs1k8XTaxDN9B6VxUethDHHbIjMpwGJ+YD24q2+pR3U7MjTxyEYkBCrke3agC+x1PTWS4hWEhxwS6uyf8A1qmg8Vaq1yjXJ82OPjERCcd+grnnnt1vPKikkkQjBMrAc/XvWvaaal2X+aTzFXgqq7P/AB3qaAO1i+It/BaiLT1aKEDBSV2fA+gIrJvfEGo6izN9lcSvwqK+wH6gDNXPDkEFuyC8S2dohncFIyfc9M16pp/iXTLez8mHQ7eW5C53SDnPsTQB5fY6R431azY2uk301uudxhTaoA9yc1rRfCvxTFHa32sWrQQkZ8uO6+c57NjgfTNep6Z49u7LTzGyw2qochFUOx+gzwK5jxV4t1TUwP8AicQbIyGcNHtVfQAHqfpQBzWqeGkDEXIMkyj5EVSyrjtnOKgghe2Ym20+cgLtwqDH88mq+t6jHdPsvdciM4G5I1yuB9BWfJ4gtY7ZkN3MQPlCxRkZ/E0ANL3VsZt0MVqo5SO4Zdx/rWFZT31hcvcTIkd053JlA6r7+5qgLa31O7mmtRLHcd3uTuHPoeldLaTw2lrBFOtpcSrwFifKg+pIH9aAL+i67b29wXvWfU9QbkG6UxRp/uqKsarqN08ZlvLdI/M/5ZwQNlvQDJ/WsVtUuLyR5NNR3li+UyRxDyovxPU1u+H9Nv7ubfcSpEWOTLO/zfrk/hQBq+Fvhxca2Fv7q4a1jwCVjUMwHpuPyr+GTXsnwUsk06DxbaxBwkesgLvbcSDZWhyT75rzmHWI7BhBdSPqbIMLCDtT8f8ACvRPgjfS6jbeLbq4hEMj60AYx0UCytQB+QFAHGfto/8AJL9J/wCwzF/6Inr4zr77/aD8Aar8RvBtjpOhz2MFzBqCXbNeO6IUEciEAqrHOXHb1r5+/wCGWvG//QT8N/8AgTP/APGaAPBelKjGNwyHawPavef+GWvG/wD0E/DX/gTP/wDGaP8Ahlrxv/0E/Df/AIEz/wDxmgDxmPW7kJsnjguFAx86cgfUV0/hvxhb2sAgu5polGNreVnb64KnOB7iu/8A+GWvG/8A0E/Df/gTP/8AGaP+GWvHH/QT8N/+BM//AMZoAyY9egvAph1m3uOrIXjCkAdeBz+OK37XWpmsBbOGvLNhyViLeWfVW9Kqn9ljxseupeGv/Amf/wCM1f0z9nL4laVIz6Z4j0W0ZhgmG+uFyP8AvzQBoaXcw20saSXMgkI2rHLDuVx6kitjUGuUsz9k0yVYG723KN+Gf1zTdP8AhH8VbQ7pdQ8FXb7sh5vOBX2G2IVrw/CzxyLvzp4PC+MklLfUrmMMPRswMD9QBQBu/Dy+kXSfLfSGuYQMNudX2/kc/pVi6urOO8a8TSLZLWM4Z2lYKv16YPsaz9M8FfEfS5CLD/hGI7cnPlvfSsf++vstbCeHvHYSZG0rwpJHNy6Pqc20n14tRQBR1fWZo4PPW3kTH+pex5Jz6gA8U3TtU1Ca3MDabJbxPl2uJ8xcn05AJ/Ckt/A3jK1Zja2Whwo3WNddudg+gNqcVatPBPiGO3aK60DQ7rLFt0niO5JB/G0NAGDPNdeXIsOppPDGx3ZuGDfTbjBqlp+hahM0uqSafLaW5b90yxEhl/2x/hXQx+CPGtpqpvNOsvD8C4AET6zPIB9CbUGtwaZ4/lJF3ZaEyHqIdduIyf8AyVI/SgDkNPeKxHmG7eKGRtrLGFlAPqM5IrVl0DQoLJ7nz7i8kk+cidQVHv8A5FXbjwt4xWAwaZpfh+xhPJVNalOT6/8AHmKzF8EePzhZTorJn+HWZg35m0P8qAKggsbGyV/tebe54QaZA7P9G3fzFWtLe5ggmiVk02IN+7LpI8jj+8xPANOtfBXxBguhKX0qZFOUjk1ycqo9OLUCujurDx9LZi2j0vwv5Z+8JtWmkz/5KA0Aed6pAtpftcTa69yzA5VGJYfQDpWj4W13w9YSGfUZrp5l+VF+y5OPYk0mufDDxfqoJaw8MQOejR6pOMf+S1ZZ+DPi1oArweHvMAxuGqz4P4fZf60AbOo+ItI124a20241u1KnJDAKgPqATzXL6jp096WtrO+ZypyWkdQyj1Yqf0qzF8GfG8UpcJ4WkHQLLqFyQPpthH60y3+FHxcssHS9X8G2Lq+8SRLIzY54O+BgRz6UAc9F8N9e1u822pkvEVsFgu1F/wCBcD9afrPh6w8OKtprHi7QNNA2tcRx3CvcRIcYIRQzMTkHAHTnpUmr/Aj4t6yqLq3jHT7xUVkVZtTumCq33gB5XQ96wh+yz43HI1LwyPpcT/8AxmgChqvi34f6IZm0R9e16+IZRPORDCSPun5ssVP0GB2rl7n4ta+tqYNJhs9MJJ/fxoZJsZBA3PkDAGMqBnJruD+y144/6Cfhv/wJn/8AjNA/Za8cf9BPw3/4Ez//ABmgDxHWNVv9ZvGu9WvJ7y4Ykl5nLYyc8DoB7CqYNe8/8Ms+OP8AoKeG/wDwJn/+M0f8Ms+N/wDoJ+G//Amf/wCM0AeDV9R/sP8A3/Gv0sf/AG4rlv8Ahlrxx/0E/DX/AIEz/wDxmvZ/2cvhZrnw0PiI69dabP8A2j9m8r7FI77fL83du3IuP9YMYz3oA+fvFUhl8b+LreRkES6zfE8kMB9pk5GK0fDzX9tdLHa6i7rgMqSZQkeoyMH867vxD8CfGN/4v1jU7e58PPZ3Wo3N3Est1NHIEllZwCVhOGG71I+tbOk/C3x3p8Xl7PDUqqcqTqM4I/8AJbGfwoA5PUdbS8tZINZ0+FGx8t3EhjIPvjiuZbVb7T7OSO7SC604nEUgiMgx79QP0r2C6+Hnje7tWiuLHwnvPBkj1GeMke4Fvg1zbfAzxWpY2w0iLeMMn9tXDKfw+zf1oA4q3md9glWIw9UVWA/Dn+hrSudd02F7cNDNbRFtr7YwVJ+vGDWsPgJ42BKifw80PXY9/M2D65+z1qJ8GPGDJsuYPDMinBYLqM67iO//AB7daAOW1aSzlRTpTlblzklBuLfXGCD9aqXX2KNdpuLn7Y2D5UjMMn/dPX8DXfp8I/F8U2+3t/D0Q27eNWnz+Ytv6VSvfg54/uleN7zQ/KOdqnUpjt/H7NmgDijrDQW7JieBud8TBiM/ia801+7trm6kiuIsKpz5sKlSfrmvZbj9n/4gXFuIptR8Ovgn5mvZycf9+KrWf7OHjSFSJ7zw/Oc8Zv5wMehH2c0AeATxRrNiNpCnbeuDRgqNxjJweo6V7ve/sy+L55C0N14dg9FW9nIH4eRVeP8AZi8cxg7dT8ODPpdTj/2jQB5Tpdtb3Cxy3VxBbxf3EJJce46g10axaPpkTt5MpQjlwCwP4nIrs1/Zi8dK2TqXhpv965nP/tGpV/Zo8eKoUan4aABzxczj/wBo0AeN65cAzEwSLJbtyoIHH5VmrMBgoGVgc5HevcW/Zh8csxY6n4ayef8Aj5n/APjNNP7L/jgnnUvDX/gTP/8AGaAPFzLGBv2bweuWJYVGJml3IGJUnIUnP5Zr2sfsu+N+c6j4a5/6eZ//AIzUifsw+Nw4ZtQ8NMB2N1P/APGaAPK9HtTLthkCxS9ckg5H513lpo8ssUcgsbiQov3rcbQfx5NdLp/7NvjO1uTNLceGZuMBDeTgD/yBXX6d8JfHllb+Uv8AwjOAMKE1CdQv4fZ6AOS0W1vb0C1h0eVoh/rXniESj33ng1vmwtrfEUMqzzpy0Y3OF/EcH8634Ph38RBF5d2/h24T0Op3AGPp9nI/Spofhv4vimEi2Ph4Edl1idQfytRQBlWt1DBaOLnUrFZJDxDDH8w+uOfzrMu7i18wQxIL+YfMT5JcD8OldePAPjJZt6ab4VQZyQupS5P1JtCa1IfCni5ImRtH8O7WHPl63OmfytM0AePaloi30U8rx5kbguGRdvsF7Vz6+GoLKzzeajbIzZYbgXKj09K9q1X4deK7u2222k+GYJx0lfWLhwPwFsP51y978FPG98my5m0Lyz1WPVJ1/wDbY0AeTTAXUZt7vW5BEP8AV29vEAxHqeOPqav6XPpsFs1s0UcgHAaRyWH1x0/Cu6uPgD41KMLS50G3YkcjUZjx6f8AHsKRfgL48W1eIXXhoM38YvZ8k+p/ccmgDjWvGsJ0itY9Ocs26ONS2xT6kDqa0E8TXEUQW9uYHv34ISEOU9lUcD6mtz/hn7x6IGjTUPD6s33pPtsxY/j9n6Ulr8APiFbgBdT8O46ZF7OGA74PkdaAOShurhdSaWZrpSfubYxux689PrXv/wCzS/meGfEjYcZ1puH+9/x6W3WvPIPgT41hx5cuge5Op3BJ/H7PXsXwY8Iar4O0HVLXXGsmubvUGu1FnM8qKnkxRgFnVTnMZPTuKAPQKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Transverse transabdominal sonogram shows echogenic particles floating in amniotic fluid (arrow) that were not present before amniocentesis. Until third trimester, echogenic particles in amniotic fluid should raise possibility of bleeding. Later in pregnancy, particles are most commonly the result of shed epithelial cells (vernix caseosa). (B) Transverse sonogram of fetal abdomen shows echogenic material (arrow) in stomach that results from fetus swallowing echogenic blood particles that resulted from recent amniocentesis. Gastric pseudomasses resolve on follow-up examination. To our knowledge, no gastric neoplasms have been reported on prenatal sonography.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Trop I, Levine D. Hemorrage During Pregnancy: Sonography and MR Imaging. AJR Am J.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Echogenic fetal bowel at 15 weeks' gestational age in 33-year-old woman with vaginal bleeding",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 367px; height: 310px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sonogram revealed subchorionic hemorrhage (not shown). Sagittal scan through fetal abdomen reveals hyperechoic loops of bowel (arrow) as echogenic as adjacent bone. Cytomegalovirus titers and karyotype were normal, and findings of prenatal screening for cystic fibrosis were negative. Normal bowel echotexture was seen on follow-up 2 weeks later (not shown).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Trop I, Levine D. Hemorrage During Pregnancy: Sonography and MR Imaging. AJR Am J Roentgenol 2001; 176:607.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_61_41944=[""].join("\n");
var outline_f40_61_41944=null;
var title_f40_61_41945="Cyclosporine and tacrolimus nephrotoxicity";
var content_f40_61_41945=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cyclosporine and tacrolimus nephrotoxicity",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/61/41945/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/61/41945/contributors\">",
"     William M Bennett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/61/41945/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/61/41945/contributors\">",
"     Daniel C Brennan, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/61/41945/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/61/41945/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/61/41945/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 25, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients treated with the calcineurin inhibitors",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    are at high risk of developing renal injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/1\">",
"     1",
"    </a>",
"    ]. Calcineurin inhibitor nephrotoxicity (CIN) is manifested both as acute azotemia which is largely reversible after reducing the dose, or as chronic progressive renal disease which is usually irreversible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. Other renal effects of the calcineurin inhibitors include tubular dysfunction, and rarely a hemolytic uremic syndrome (HUS) that can lead to acute graft loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/2\">",
"     2",
"    </a>",
"    ]. A similar pattern of renal injury from cyclosporine is seen with the use of tacrolimus, thereby suggesting a drug class effect. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Tacrolimus nephrotoxicity'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Attention must also be paid to drug dose, other side effects, and drug interactions to minimize toxicity and maximize efficacy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28090?source=see_link\">",
"     \"Pharmacology and side effects of cyclosporine and tacrolimus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ACUTE CALCINEURIN INHIBITOR NEPHROTOXICITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most data in this field pertains to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    although the effects of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    are thought to be similar. In the earliest clinical renal transplant trials using cyclosporine, a high incidence of oliguric acute tubular necrosis (ATN) and primary nonfunction was observed; the risk was greatest with prolonged ischemia time of the donated kidney prior to transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/6\">",
"     6",
"    </a>",
"    ]. Subsequent trials using lower doses of cyclosporine showed that these problems were dose-related, although there was considerable variability in the incidence of ATN in various centers.",
"   </p>",
"   <p>",
"    Studies have demonstrated that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    causes vasoconstriction of the afferent and efferent glomerular arterioles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/7\">",
"     7",
"    </a>",
"    ] and reductions in renal blood flow and glomerular filtration rate (GFR). The exact mechanism of vasoconstriction is unclear, but there appears to be substantial impairment of endothelial cell function, leading to reduced production of vasodilators (prostaglandins and nitric oxide) and enhanced release of vasoconstrictors (endothelin and thromboxane) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/7-10\">",
"     7-10",
"    </a>",
"    ]. Increased sympathetic tone also may be present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/11\">",
"     11",
"    </a>",
"    ], although renal vasoconstriction occurs even in denervated kidneys. In addition, transforming growth factor beta-1, endothelin-1, and the production of reactive oxygen and nitrogen species have also been implicated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There may also be an intrinsic renal susceptibility to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    -induced renal vasoconstriction. Experimental support for this hypothesis is derived from a study examining the effect of raising the cyclosporine dose in eight pairs of stable unrelated renal transplant recipients who had received a cadaver kidney from the same donor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/12\">",
"     12",
"    </a>",
"    ]. Seven of the eight pairs showed a parallel response to increasing the cyclosporine dose (four pairs showed an elevation in the plasma creatinine concentration while three pairs showed no change, p&lt;0.05).",
"   </p>",
"   <p>",
"    The increase in renal vascular tone induced by",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    may not attenuate with time. Maintenance cyclosporine therapy is associated with transient reductions in renal plasma flow and glomerular filtration rate, which correlate both with dose and with peak cyclosporine levels reached two to four hours after the oral dose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/9\">",
"     9",
"    </a>",
"    ]. These functional abnormalities are also associated with increased urinary excretion of endothelin, which decreases when trough drug levels are reached. Studies with an endothelin receptor antagonist suggest that endothelin mediates cyclosporine-induced afferent arteriolar constriction, an effect that will lower the intraglomerular pressure and the glomerular filtration rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Administration of a calcium channel blocker can prevent the renal vasoconstriction, although not the rise in endothelin excretion (",
"    <a class=\"graphic graphic_figure graphicRef65894 \" href=\"mobipreview.htm?37/42/38573\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/9\">",
"     9",
"    </a>",
"    ]. This observation constitutes part of the rationale for the use of calcium channel blockers to treat hypertension in",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    -treated transplant recipients. The role of cyclosporine in the elevation of blood pressure is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/23/16761?source=see_link\">",
"     \"Hypertension after renal transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The increase in vascular resistance may therefore be reflected clinically by an elevated plasma creatinine concentration and hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/2,11,13\">",
"     2,11,13",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     Cyclosporine",
"    </a>",
"    -induced renal vasoconstriction can cause delayed recovery from early ATN and, in severe cases, primary nonfunction. These complications are most likely to occur with prolonged ischemia time and high cyclosporine doses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/6\">",
"     6",
"    </a>",
"    ]; however, even patients with therapeutic trough levels may show signs of nephrotoxicity.",
"   </p>",
"   <p>",
"    It is also possible that repeated episodes of renal ischemia contribute to the development of chronic",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    nephrotoxicity described below. The continued release of endothelin after administration of a calcium channel blocker suggests that vascular injury may still be occurring; thus, short-term prevention of renal vasoconstriction (due perhaps to limiting endothelin-induced calcium entry into vascular smooth muscle cells) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/9\">",
"     9",
"    </a>",
"    ] may not necessarily be associated with long-term protection against vascular disease.",
"   </p>",
"   <p>",
"    Acute",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    nephrotoxicity is usually reversible with cessation of therapy, as both the plasma creatinine concentration and systemic blood pressure fall toward baseline values for that patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/10\">",
"     10",
"    </a>",
"    ]. The important clinical problem is to differentiate cyclosporine-induced renal dysfunction from acute rejection. The only definitive diagnostic test is biopsy of the renal allograft. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/13/12505?source=see_link\">",
"     \"Clinical manifestations and diagnosis of acute renal allograft rejection\"",
"    </a>",
"    .) Although there are no specific pathologic changes induced acutely by cyclosporine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/3,14\">",
"     3,14",
"    </a>",
"    ], the absence of cellular or vascular rejection as well as reversibility of renal dysfunction with drug cessation (over days to a week) strongly suggests cyclosporine nephrotoxicity. It is also important to appreciate that the presence of rejection does not exclude concomitant cyclosporine toxicity.",
"   </p>",
"   <p>",
"    Rarely, vascular lesions similar to those in the HUS are seen. This lesion is idiosyncratic and is presumably initiated by",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    -induced injury to the vascular endothelial cells. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36826?source=see_link\">",
"     \"Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/49/12053?source=see_link\">",
"     \"TTP-HUS: Recurrence after transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CHRONIC CALCINEURIN INHIBITOR NEPHROTOXICITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic calcineurin inhibitor nephrotoxicity is manifested by renal insufficiency due to glomerular and vascular disease, abnormalities in tubular function, and an increase in blood pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/2,15\">",
"     2,15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/23/16761?source=see_link\">",
"     \"Hypertension after renal transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Renal insufficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    has had a major impact on renal allograft survival by reducing graft loss due to acute rejection, a large body of evidence suggests that long-term cyclosporine exposure is associated with an increased risk of chronic allograft dysfunction. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34778?source=see_link\">",
"     \"Chronic renal allograft nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Incidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Support for the hypothesis of chronic calcineurin inhibitor nephrotoxicity comes most directly from non-renal transplant patients and patients with autoimmune diseases in whom the nephrotoxic potential of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    can be evaluated in the absence of coexisting acute or chronic rejection of a renal allograft. These patients have a 35 to 45 percent reduction in GFR compared to patients not treated with cyclosporine. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/28/34250?source=see_link\">",
"     \"Renal function and nonrenal solid organ transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although reviewed in detail elsewhere within UpToDate, the following is a brief discussion of the best data on the overall incidence of chronic renal failure (CRF) with calcineurin-inhibitors, which come from a cohort study of non-renal transplant recipients (mostly liver, heart, and lung) in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/16\">",
"     16",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     Cyclosporine",
"    </a>",
"    was given to 60 percent and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    to 28 percent. At a median follow-up of 36 months, 17 percent developed CRF (defined as an estimated GFR &le;29",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m2). The risk continued to increase over time with all kinds of transplants and, at five years, ranged from 7 to 21 percent (",
"    <a class=\"graphic graphic_figure graphicRef54972 \" href=\"mobipreview.htm?35/21/36190\">",
"     figure 2",
"    </a>",
"    ). These patients had a 4.6-fold increase in the risk of death compared to those without CRF. Risk factors for CRF included calcineurin therapy, older age, lower pretransplant GFR, female sex, postoperative acute renal failure, baseline diabetes and hypertension, and hepatitis C virus infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/28/34250?source=see_link\">",
"     \"Renal function and nonrenal solid organ transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some patients with CRF, 29 percent in the above report, eventually progress to end-stage renal disease (ESRD) and require renal replacement therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/16-18\">",
"     16-18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal biopsy reveals an obliterative arteriolopathy (suggesting primary endothelial damage), ischemic collapse or scarring of the glomeruli, vacuolization of the tubules, global and focal segmental glomerulosclerosis, and focal areas of tubular atrophy and interstitial fibrosis (producing a picture of \"striped\" fibrosis) (",
"    <a class=\"graphic graphic_picture graphicRef75082 graphicRef54131 graphicRef70064 \" href=\"mobipreview.htm?17/55/18298\">",
"     picture 1A-C",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/1,3,5,19-22\">",
"     1,3,5,19-22",
"    </a>",
"    ]. These changes are seen with both low-dose and higher dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    therapy, although they seem to occur earlier with higher doses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/19,23,24\">",
"     19,23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One histologic study reported the association of these changes with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    dose and over time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/25\">",
"     25",
"    </a>",
"    ]. Mild arteriolar hyalinosis at six months appeared to be associated with high doses and was reversible. By comparison, at three years, irreversible severe arteriolar hyalinosis and glomerulosclerosis were observed, despite decreased doses and trough levels.",
"   </p>",
"   <p>",
"    The factors responsible for chronic calcineurin inhibitor nephrotoxicity are not well understood. The development of interstitial fibrosis is associated with increased expression of osteopontin, (a potent macrophage chemoattractant secreted by the tubular epithelial cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/26\">",
"     26",
"    </a>",
"    ]), chemokines (a class of cytokines that are strong chemoattractants for a variety of hematopoietic cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/27\">",
"     27",
"    </a>",
"    ]), and transforming growth factor-beta (TGF-beta, a powerful stimulator of extracellular matrix production [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]).",
"   </p>",
"   <p>",
"    Support for a central role for TGF-beta has been provided by findings in mice in which",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    nephropathy was significantly diminished with anti-TGF-beta therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. TGF-beta appears to be induced in part by decreased secretion of nitric oxide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/32\">",
"     32",
"    </a>",
"    ] as well as increased local concentrations of angiotensin II, possibly explaining at least in part the beneficial effects observed with ACE inhibitors and angiotensin II receptor antagonists [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/26,28,33\">",
"     26,28,33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     Cyclosporine",
"    </a>",
"    is a substrate for the transmembrane pump P-glycoprotein. There is some evidence in animals and in vitro that decreased expression of this pump may contribute to increased cyclosporine levels, leading to nephrotoxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Altered protein pump expression has also been observed in association with several polymorphisms in its gene. As an example, the TT genotype is associated with decreased P-glycoprotein expression in the kidney. In a case control study of donor and recipient pairs, the TT genotype in the donor directly correlated with chronic cyclosporine nephrotoxicity in the allograft recipient (odds ratio of 13.4, 95% CI 1.2 to 148) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/36\">",
"     36",
"    </a>",
"    ]. This suggests that underlying genetic factors that increase cyclosporine concentrations in the kidney may contribute to chronic nephrotoxicity.",
"   </p>",
"   <p>",
"    It has been proposed that the arterial lesions are the primary abnormality, with secondary ischemia being responsible for the tubular and interstitial lesions. Some animal studies, for example, have shown that the vascular and interstitial findings can be dissociated:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A report found that inhibiting angiotensin II with an ACE inhibitor or an angiotensin II receptor antagonist (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?25/35/26168?source=see_link\">",
"       losartan",
"      </a>",
"      ) minimized the interstitial fibrosis without affecting the glomerular or tubular injury; this beneficial effect was not observed with the combination of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?14/57/15254?source=see_link\">",
"       hydralazine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another study had somewhat different results [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/26\">",
"       26",
"      </a>",
"      ]. Both",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?25/35/26168?source=see_link\">",
"       losartan",
"      </a>",
"      and the combination of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?14/57/15254?source=see_link\">",
"       hydralazine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      minimized interstitial fibrosis while only losartan protected against the arteriolopathy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Increased apoptosis (ie, programmed cell death) occurs in kidneys exposed to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/37\">",
"     37",
"    </a>",
"    ]. This finding may help explain the interstitial abnormalities associated with cyclosporine toxicity: the loss of cells and renal tubules accompanied by fibrosis. The expression of specific apoptotic genes, such as p53 and Fas-ligand, is enhanced in rats administered cyclosporine, thereby favoring the induction of apoptosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Cyclosporine dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whether there is a \"safe\" chronic dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    that is effective immunologically but does not cause progressive renal dysfunction is difficult to answer because of the lack of well-controlled prospective trials. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/43/43706?source=see_link\">",
"     \"Maintenance immunosuppressive therapy in renal transplantation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Short-term studies suggest that low doses of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    may not lead to renal dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/6,39,40\">",
"     6,39,40",
"    </a>",
"    ]: As an example, the CEASAR study found similar kidney function at one year among a group of 536 first time kidney transplant recipients randomly assigned to low dose cyclosporine (target trough level of 50 to 100",
"    <span class=\"nowrap\">",
"     ng/mL),",
"    </span>",
"    low dose cyclosporine and cyclosporine withdrawal at 6 months, and standard dose cyclosporine therapy (first 4 months at 150 to 300",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    target trough level and 100 to 200",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    thereafter) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/39\">",
"     39",
"    </a>",
"    ]. In addition, although acute rejection was similar at 6 months at approximately 25 percent, it was significantly higher at one year in the cyclosporine withdrawal group with a one-year rejection rate of 38 percent.",
"   </p>",
"   <p>",
"    Overall, however, there is a strong association between chronic renal allograft dysfunction and long-term continuous exposure to maintenance doses of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/4,25,41,42\">",
"     4,25,41,42",
"    </a>",
"    ]. Perhaps the best insight into the time-dependence of chronic calcineurin inhibitor nephrotoxicity was provided by a study of 120 kidney-pancreas recipients who underwent sequential renal protocol biopsies over a 10-year post-transplantation period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/41\">",
"     41",
"    </a>",
"    ]. Triple agent immunosuppressive therapy consisting of",
"    <span class=\"nowrap\">",
"     cyclosporine/tacrolimus,",
"    </span>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    , and",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"      azathioprine",
"     </a>",
"     /",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"      mycophenolate",
"     </a>",
"    </span>",
"    mofetil was administered.",
"   </p>",
"   <p>",
"    Early damage, which was observed within one year post-transplantation, resulted primarily from immunologic factors, such as severe acute rejection and persistent early subclinical rejection, as well as from ischemic injury. By comparison, after one year post-transplant, damage was characterized by progressive high-grade arteriolar hyalinosis with vessel narrowing, glomerulosclerosis, and additional tubulointerstitial injury. This was thought to principally be the result of calcineurin inhibitor injury. By comparison, chronic immune rejection was uncommon with prolonged follow-up. At 10 years, severe allograft nephropathy was present in 60 percent of patients, with glomerulosclerosis being observed in almost 40 percent of glomeruli. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34778?source=see_link\">",
"     \"Chronic renal allograft nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Withdrawal of cyclosporine",
"    </span>",
"    &nbsp;&mdash;&nbsp;The replacement of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    with non-nephrotoxic immunosuppressive agents may ameliorate renal dysfunction among patients with cyclosporine-induced nephrotoxicity. Benefits have been observed among kidney and non-kidney organ transplant recipients with decreased kidney function due to calcineurin inhibitor therapy. The CEASAR study, however, questions whether cyclosporine withdrawal is safe in those with adequate renal function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/39\">",
"     39",
"    </a>",
"    ]. A detailed discussion related to cyclosporine withdrawal in renal allograft recipients is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34778?source=see_link\">",
"     \"Chronic renal allograft nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Hyperkalemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;An elevation in the plasma potassium concentration due to reduced efficiency of urinary potassium excretion is common in",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    -treated patients; it may be severe and potentially life-threatening with concurrent administration of an angiotensin converting enzyme inhibitor, which diminishes aldosterone release. Cyclosporine may reduce potassium excretion both by decreasing the activity of the renin-angiotensin-aldosterone system and by impairing tubular responsiveness to aldosterone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/43,44\">",
"     43,44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Urinary potassium excretion is primarily derived from potassium secretion in the collecting tubules via potassium channels in the luminal membrane (",
"    <a class=\"graphic graphic_figure graphicRef60693 \" href=\"mobipreview.htm?12/31/12797\">",
"     figure 3",
"    </a>",
"    ). This process is stimulated by sodium reabsorption (which, unless chloride follows the sodium, creates a lumen-negative electrical gradient that promotes potassium secretion), aldosterone (which increases the number of open sodium channels in the luminal membrane), and by the basolateral Na-K-ATPase pump (which removes reabsorbed sodium from the cell in exchange for potassium, thereby increasing the size of the potassium secretory pool). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/24/11657?source=see_link\">",
"     \"Chapter 12B: Renal potassium excretion\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In vitro studies suggest that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    may directly impair the function of the potassium secreting cells in the cortical collecting tubule by affecting each of these steps: reduced activity of the Na-K-ATPase pump [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/45\">",
"     45",
"    </a>",
"    ], inhibition of the luminal potassium channel [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/46\">",
"     46",
"    </a>",
"    ], and increased chloride reabsorption, which prevents generation of lumen-negative potential that drives potassium secretion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     Cyclosporine",
"    </a>",
"    may also have a second effect on potassium homeostasis in patients concurrently treated with a &szlig;-blocker. In this setting, there is often a modest (less than 1",
"    <span class=\"nowrap\">",
"     meq/L)",
"    </span>",
"    and transient elevation in the plasma potassium concentration due to the movement of potassium out of the cells into the extracellular fluid [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/47\">",
"     47",
"    </a>",
"    ]. Why this occurs is not known.",
"   </p>",
"   <p>",
"    Issues surrounding the management of hyperkalemia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/54/17258?source=see_link\">",
"     \"Treatment and prevention of hyperkalemia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Hyperuricemia and gout",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     Cyclosporine",
"    </a>",
"    via its glomerular and tubular effects can decrease urinary uric acid excretion, leading to hyperuricemia in most patients and occasionally symptomatic gout. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/14/3303?source=see_link\">",
"     \"Hyperuricemia and gout in renal transplant recipients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Metabolic acidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tubular injury induced by",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    can also impair acid excretion. This may be manifested as a normal anion gap (hyperchloremic) metabolic acidosis that may also reflect decreased aldosterone activity and suppression of ammonium excretion by hyperkalemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/44/9930?source=see_link\">",
"     \"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Hypophosphatemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    develop hypophosphatemia due to urinary phosphate wasting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/2,48\">",
"     2,48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Hypomagnesemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal magnesium wasting is common in",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    treated recipients presumably due to drug effects on magnesium reabsorption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/49-51\">",
"     49-51",
"    </a>",
"    ]. Hypomagnesemia has been implicated as a contributor to the nephrotoxicity associated with cyclosporine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/52\">",
"     52",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/41/15000?source=see_link\">",
"     \"Causes of hypomagnesemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Hypercalciuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    are associated with hypercalciuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/51,53\">",
"     51,53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     PREVENTION OF CHRONIC CALCINEURIN INHIBITOR NEPHROTOXICITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In view of the utility of calcineurin inhibitors in transplantation and autoimmune diseases, there has been a great deal of interest in developing therapeutic strategies to minimize their nephrotoxic effects. Although multiple agents have been evaluated, including cold water fish oil, calcium channel blockers, thromboxane synthesis inhibitors, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/28/13765?source=see_link\">",
"     pentoxifylline",
"    </a>",
"    , none is clearly effective.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Fish oil",
"    </span>",
"    &nbsp;&mdash;&nbsp;The fish oils, which contain omega-3 fatty acids, may act by competitively reducing thromboxane synthesis, thereby diminishing",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    -induced vasoconstriction and hypertension, and by direct immunosuppressive actions, such as decreasing the generation of cytokines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/54\">",
"     54",
"    </a>",
"    ]. Swallowing problems, a fishy aftertaste, and impaired hemostasis are potential complications.",
"   </p>",
"   <p>",
"    Conflicting data exist concerning the efficacy of fish oil in renal transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/54-57\">",
"     54-57",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When compared to a control group of 33 patients treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      , 33 patients also ingesting 6",
"      <span class=\"nowrap\">",
"       g/day",
"      </span>",
"      of fish oil showed a higher median glomerular filtration rate (53 versus 40",
"      <span class=\"nowrap\">",
"       mL/min),",
"      </span>",
"      a lower mean arterial pressure, fewer episodes of acute rejection (8 versus 20) and a tendency to higher one-year graft survival (97 versus 84 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A second controlled trial in which 50 patients were randomized to the same 6",
"      <span class=\"nowrap\">",
"       g/day",
"      </span>",
"      dose of fish oil or coconut oil showed no benefit of fish oil at one year in terms of the glomerular filtration rate, blood pressure, or number of episodes of acute rejection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    To better assess the efficacy of fish oil in renal transplantation, a systematic review and meta-analysis published in 2005 was performed of 16 studies enrolling a total of 812 patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/58\">",
"     58",
"    </a>",
"    ]. Cyclosporine was used in combination with prednisone",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    azathioprine in all but one study, which evaluated cyclosporine alone. Among the eleven trials reporting effects on GFR, there was no consistent benefit of fish oil on renal function, with only a modest benefit being reported in a few studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/54,56,57,59\">",
"     54,56,57,59",
"    </a>",
"    ]. Meta-analyses also found no survival benefit or decreased incidence of rejection with fish oil. Similar findings were noted in a 2007 meta-analysis that largely analyzed the same studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/60\">",
"     60",
"    </a>",
"    ]. These data suggest that fish oil is not associated with a consistent clinical benefit.",
"   </p>",
"   <p>",
"    The long-term administration of arginine and canola oil, which contain both omega-3 and -9 fatty acids, was associated with a decreased incidence of calcineurin-inhibitor drug toxicity in a randomized prospective three year study of 78 renal allograft recipients (9 versus 35 percent in controls) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/61\">",
"     61",
"    </a>",
"    ]. Additional benefits with this diet, as noted in this study, included decreased incidence of first rejection episodes, post-transplant diabetes, and cardiovascular events.",
"   </p>",
"   <p>",
"    However, a longer term evaluation in a larger number of patients is required to better understand the role for this diet, particularly given that a large number of patients stopped taking or were noncompliant with the agent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Calcium channel blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Animal and human data suggest that concurrent administration of calcium channel blockers may be protective against",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    nephrotoxicity, at least in part by minimizing renal vasoconstriction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/62\">",
"     62",
"    </a>",
"    ]. However, there is at present no proof that these agents increase graft survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. In one report, for example, 113 cyclosporine-treated patients were prospectively randomly assigned to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/16/12554?source=see_link\">",
"     diltiazem",
"    </a>",
"    or placebo after renal transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/63\">",
"     63",
"    </a>",
"    ]. At two years, there was no difference between the groups in blood pressure, plasma creatinine concentration, the number of rejection episodes, or the frequency of graft loss. The patients treated with diltiazem did have a lower incidence of primary nonfunction and fewer episodes of severe rejection, particularly vascular rejection; they also required 35 percent less cyclosporine due to the diltiazem-induced slowing of cyclosporine metabolism.",
"   </p>",
"   <p>",
"    A similar lack of benefit on long-term renal function has been noted with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/5/12377?source=see_link\">",
"     nifedipine",
"    </a>",
"    in two studies of hypertensive transplant recipients receiving",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    &mdash; one prospectively compared nifedipine to the ACE inhibitor",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/58/937?source=see_link\">",
"     lisinopril",
"    </a>",
"    and one retrospectively compared nifedipine to treatment without a calcium channel blocker [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. Neither study was able to demonstrate a better outcome with nifedipine in terms of blood pressure control, the directly measured glomerular filtration rate, or the plasma creatinine concentration at two to five years.",
"   </p>",
"   <p>",
"    However, it is possible that some calcium channel blockers may have a small protective effect on the kidney [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/67,68\">",
"     67,68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A prospective study randomly assigned 109 normotensive renal transplant recipients treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      to placebo or nitrendipine (5 mg BID) and 146 hypertensive transplant patients to placebo or nitrendipine (10 mg BID) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/67\">",
"       67",
"      </a>",
"      ]. Among all individuals at two years or at the time of study withdrawal, active therapy was associated with a slightly but significantly lower serum creatinine concentration (1.68 versus 1.80",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [149 versus 161",
"      <span class=\"nowrap\">",
"       micromol/L]).",
"      </span>",
"      This effect was statistically significant only among the hypertensive patients, but the small benefit was independent of any antihypertensive effect.",
"     </li>",
"     <li>",
"      In a multicenter study, 131 renal transplant recipients being administered",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      were randomly assigned to lacidipine or placebo [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/68\">",
"       68",
"      </a>",
"      ]. Allograft function was significantly better with the calcium channel blocker at one and two years post-transplant (50 versus 43",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m2 and 50 versus 42",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.72 at year one and two, respectively).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    One possible explanation for the conflicting results demonstrating a long-term benefit with calcium channel blockers in patients treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    is that renal vasoconstriction may not be responsible for the chronic vascular and tubulointerstitial injury. This hypothesis is supported by observations in animals showing that administration of an endothelin A receptor antagonist minimized the fall in GFR and renal plasma flow but had no effect on the arteriolopathy or tubular damage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/69\">",
"     69",
"    </a>",
"    ]. Alternatively, the inability to demonstrate a better outcome with a calcium channel blocker versus an ACE inhibitor may result from inhibition of angiotensin II activity also protecting against renal injury, although by a different mechanism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/26,33\">",
"     26,33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34778?source=see_link\">",
"     \"Chronic renal allograft nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Pentoxifylline",
"    </span>",
"    &nbsp;&mdash;&nbsp;Attenuation of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    -induced renal vasoconstriction and nephrotoxicity in animal studies with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/28/13765?source=see_link\">",
"     pentoxifylline",
"    </a>",
"    prompted a randomized trial evaluating the effect of this agent in cardiac transplant recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/70\">",
"     70",
"    </a>",
"    ]. Twenty-nine patients received either pentoxifylline (400 mg PO TID) or placebo for one year. No difference was observed in glomerular filtration rate or plasma creatinine concentration between the two groups.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Thromboxane synthesis inhibitor",
"    </span>",
"    &nbsp;&mdash;&nbsp;A proposed role for thromboxane in",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    -induced renal vasoconstriction has led to the evaluation of thromboxane synthesis inhibitors. In one report, a thromboxane synthesis inhibitor was given for four weeks to stable patients with a low glomerular filtration rate of 45",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    that was presumed to reflect cyclosporine nephrotoxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/71\">",
"     71",
"    </a>",
"    ]. Despite an 80 to 90 percent reduction in the excretion of thromboxane metabolites, there was no improvement in either glomerular filtration rate or renal blood flow.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effect of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    on other pathways of arachidonic acid metabolism, such as the 5-lipoxygenase pathway (which catalyzes the formation of leukotrienes), may also result in marked renal vasoconstriction. Evidence in support of this hypothesis is provided by the observation that cyclosporine nephrotoxicity is prevented in transplanted animals by the administration of a leukotriene receptor antagonist [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     TACROLIMUS NEPHROTOXICITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute and chronic nephrotoxicity is generally similar with both",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/15\">",
"     15",
"    </a>",
"    ]. However, tacrolimus has less nephrotoxicity with lower doses without compromising overall outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/73,74\">",
"     73,74",
"    </a>",
"    ]. This was best shown in the Efficacy Limiting Toxicity Elimination (ELITE) Symphony study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/73\">",
"     73",
"    </a>",
"    ]. In this trial, 1645 kidney transplant recipients were randomly assigned to one of four immunosuppressive arms: conventional dose cyclosporine, corticosteroids and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil or daclizumab induction therapy, mycophenolate mofetil, and corticosteroids with one of the following three agents: low-dose cyclosporine (target trough level of 50 to 100",
"    <span class=\"nowrap\">",
"     ng/mL),",
"    </span>",
"    low-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    (target trough level of 4 to 8",
"    <span class=\"nowrap\">",
"     ng/mL),",
"    </span>",
"    or low-dose tacrolimus. (target trough level of 3 to 7",
"    <span class=\"nowrap\">",
"     ng/mL).",
"    </span>",
"    At one year, the low dose tacrolimus group had the highest mean calculated GFR compared with the other three groups (65 versus 57 to 60",
"    <span class=\"nowrap\">",
"     mL/min).",
"    </span>",
"    The tacrolimus-based regimen was also associated with the lowest allograft rejection and highest allograft survival rates. At three years, the low dose tacrolimus group continued to have the highest mean calculated GFR (69",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    versus 64 to 66",
"    <span class=\"nowrap\">",
"     mL/min)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/75\">",
"     75",
"    </a>",
"    ]. Further discussion of this study is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/43/43706?source=see_link\">",
"     \"Maintenance immunosuppressive therapy in renal transplantation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, long-term trials comparing",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    in liver transplant recipients found a similar incidence of early acute renal failure and late hypertension, while late renal insufficiency was more prevalent with tacrolimus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/76-78\">",
"     76-78",
"    </a>",
"    ]. In contrast, the registry data cited above from almost 70,000 nonrenal solid organ transplant recipients, found that tacrolimus was associated with less nephrotoxicity in liver transplants and similar nephrotoxicity in other transplants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/16\">",
"     16",
"    </a>",
"    ]. Another retrospective study of liver transplant recipients also found that tacrolimus was associated with relatively better renal function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, these data are confounded by evidence that chronic renal disease in nonrenal transplant patients is not necessarily due to calcineurin inhibitor therapy alone. In one renal biopsy study of 26 liver transplant recipients, for example, chronic renal disease was due to four different pathogenic processes: chronic calcineurin inhibitor therapy, diabetic nephropathy, thrombotic microangiopathy due to",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"      cyclosporine",
"     </a>",
"     /",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"      tacrolimus",
"     </a>",
"    </span>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    alfa-interferon, and tubular disease due to hydroxyethylstarch [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     Tacrolimus",
"    </a>",
"    can also cause hyperkalemia, hyperuricemia, gout, and rarely the hemolytic-uremic syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/76,77,81,82\">",
"     76,77,81,82",
"    </a>",
"    ]. The mechanism of potassium retention is similar to that described above for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    : relatively selective inhibition of Na-K-ATPase in the cortical collecting tubule [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/61/41945/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H122017\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute calcineurin inhibitor nephrotoxicity appears to be dose related. It appears to result principally from vasoconstriction of the afferent and glomerular arterioles, with the exact mechanism being unknown. Acute toxicity is usually reversible with cessation of therapy. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Acute calcineurin inhibitor nephrotoxicity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic calcineurin inhibitor nephrotoxicity is manifested by renal insufficiency and abnormalities in tubular function.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      There is a general relationship between total exposure to calcineurin inhibitors and renal insufficiency. Support for this comes most directly from non-renal transplant patients. Renal biopsy in patients with chronic calcineurin inhibitor nephrotoxicity reveals an obliterative arteriolopathy, ischemic collapse or scarring of the glomeruli, vacuolization of the tubules, global and focal segmental glomerulosclerosis, and focal areas of tubular atrophy and interstitial fibrosis (producing a picture of \"striped\" fibrosis). The strategy of substituting for or lowering the dose of the calcineurin inhibitor may ameliorate renal dysfunction. However, these strategies are associated with an increased incidence of acute allograft rejection, which may compromise allograft survival (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Renal insufficiency'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34778?source=see_link\">",
"       \"Chronic renal allograft nephropathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Metabolic abnormalities resulting from alterations in tubular function noted with calcineurin inhibitor therapy include hyperkalemia, hyperuricemia, metabolic acidosis, hypophosphatemia, hypomagnesemia, and hypercalciuria. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Chronic calcineurin inhibitor nephrotoxicity'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A number of agents have been evaluated to help prevent chronic calcineurin inhibitor nephrotoxicity. None are clearly effective. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Prevention of chronic calcineurin inhibitor nephrotoxicity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute and chronic nephrotoxicity is generally similar with both",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Tacrolimus nephrotoxicity'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/1\">",
"      Burdmann EA, Andoh TF, Yu L, Bennett WM. Cyclosporine nephrotoxicity. Semin Nephrol 2003; 23:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/2\">",
"      Kahan BD. Cyclosporine. N Engl J Med 1989; 321:1725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/3\">",
"      Kopp JB, Klotman PE. Cellular and molecular mechanisms of cyclosporin nephrotoxicity. J Am Soc Nephrol 1990; 1:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/4\">",
"      de Mattos AM, Olyaei AJ, Bennett WM. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis 2000; 35:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/5\">",
"      Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/6\">",
"      Novick AC, Hwei HH, Steinmuller D, et al. Detrimental effect of cyclosporine on initial function of cadaver renal allografts following extended preservation. Results of a randomized prospective study. Transplantation 1986; 42:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/7\">",
"      Lanese DM, Conger JD. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 1993; 91:2144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/8\">",
"      De Nicola L, Thomson SC, Wead LM, et al. Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 1993; 92:1859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/9\">",
"      Ruggenenti P, Perico N, Mosconi L, et al. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 1993; 43:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/10\">",
"      Lamas S. Cellular mechanisms of vascular injury mediated by calcineurin inhibitors. Kidney Int 2005; 68:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/11\">",
"      Scherrer U, Vissing SF, Morgan BJ, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990; 323:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/12\">",
"      Wissmann C, Frey FJ, Ferrari P, Uehlinger DE. Acute cyclosporine-induced nephrotoxicity in renal transplant recipients: the role of the transplanted kidney. J Am Soc Nephrol 1996; 7:2677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/13\">",
"      Porter GA, Bennett WM, Sheps SG. Cyclosporine-associated hypertension. National High Blood Pressure Education Program. Arch Intern Med 1990; 150:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/14\">",
"      Mihatsch MJ, Thiel G, Ryffel B. Histopathology of cyclosporine nephrotoxicity. Transplant Proc 1988; 20:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/15\">",
"      Williams D, Haragsim L. Calcineurin nephrotoxicity. Adv Chronic Kidney Dis 2006; 13:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/16\">",
"      Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/17\">",
"      Goldstein DJ, Zuech N, Sehgal V, et al. Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression. Transplantation 1997; 63:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/18\">",
"      Frimat L, Villemot JP, Cormier L, et al. Treatment of end-stage renal failure after heart transplantation. Nephrol Dial Transplant 1998; 13:2905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/19\">",
"      Myers BD, Newton L. Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury. J Am Soc Nephrol 1991; 2:S45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/20\">",
"      Bertani T, Ferrazzi P, Schieppati A, et al. Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients. Kidney Int 1991; 40:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/21\">",
"      Sis B, Dadras F, Khoshjou F, et al. Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients. Am J Transplant 2006; 6:1444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/22\">",
"      Kambham N, Nagarajan S, Shah S, et al. A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies. Clin J Am Soc Nephrol 2007; 2:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/23\">",
"      di Paolo S, Teutonico A, Stallone G, et al. Cyclosporin exposure correlates with 1 year graft function and histological damage in renal transplanted patients. Nephrol Dial Transplant 2004; 19:2107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/24\">",
"      Chapman JR, Nankivell BJ. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain? Nephrol Dial Transplant 2006; 21:2060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/25\">",
"      Nankivell BJ, Borrows RJ, Fung CL, et al. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation 2004; 78:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/26\">",
"      Pichler RH, Franceschini N, Young BA, et al. Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol 1995; 6:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/27\">",
"      Benigni A, Bruzzi I, Mister M, et al. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year. Kidney Int 1999; 55:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/28\">",
"      Shihab FS, Bennett WM, Tanner AM, Andoh TF. Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy. Kidney Int 1997; 52:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/29\">",
"      Islam M, Burke JF Jr, McGowan TA, et al. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction. Kidney Int 2001; 59:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/30\">",
"      Ling H, Li X, Jha S, et al. Therapeutic role of TGF-beta-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation. J Am Soc Nephrol 2003; 14:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/31\">",
"      Xin J, Homma T, Matsusaka T, et al. Suppression of cyclosporine a nephrotoxicity in vivo by transforming growth factor beta receptor-immunoglobulin G chimeric protein. Transplantation 2004; 77:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/32\">",
"      Shihab FS, Yi H, Bennett WM, Andoh TF. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity. Kidney Int 2000; 58:1174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/33\">",
"      Burdmann EA, Andoh TF, Nast CC, et al. Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. Am J Physiol 1995; 269:F491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/34\">",
"      Del Moral RG, Olmo A, Osuna A, et al. Role of P-glycoprotein in chronic cyclosporine nephrotoxicity and its relationship to intrarenal angiotensin II deposits. Transplant Proc 1998; 30:2014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/35\">",
"      Koziolek MJ, Riess R, Geiger H, et al. Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients. Kidney Int 2001; 60:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/36\">",
"      Hauser IA, Schaeffeler E, Gauer S, et al. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation. J Am Soc Nephrol 2005; 16:1501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/37\">",
"      Thomas SE, Andoh TF, Pichler RH, et al. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 1998; 53:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/38\">",
"      Shihab FS, Andoh TF, Tanner AM, et al. Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis. Kidney Int 1999; 56:2147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/39\">",
"      Ekberg H, Griny&oacute; J, Nashan B, et al. Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study. Am J Transplant 2007; 7:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/40\">",
"      Tostivint I, du Montcel ST, Jaudon MC, et al. Renal outcome after ciclosporin-induced nephrotoxicity. Nephrol Dial Transplant 2007; 22:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/41\">",
"      Nankivell BJ, Borrows RJ, Fung CL, et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349:2326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/42\">",
"      Boyer O, Le Bidois J, Dechaux M, et al. Improvement of renal function in pediatric heart transplant recipients treated with low-dose calcineurin inhibitor and mycophenolate mofetil. Transplantation 2005; 79:1405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/43\">",
"      Deray G, Benhmida M, Le Hoang P, et al. Renal function and blood pressure in patients receiving long-term, low-dose cyclosporine therapy for idiopathic autoimmune uveitis. Ann Intern Med 1992; 117:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/44\">",
"      Kamel KS, Ethier JH, Quaggin S, et al. Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporine. J Am Soc Nephrol 1992; 2:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/45\">",
"      Tumlin JA, Sands JM. Nephron segment-specific inhibition of Na+/K(+)-ATPase activity by cyclosporin A. Kidney Int 1993; 43:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/46\">",
"      Ling BN, Eaton DC. Cyclosporin A inhibits apical secretory K+ channels in rabbit cortical collecting tubule principal cells. Kidney Int 1993; 44:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/47\">",
"      Pei Y, Richardson R, Greenwood C, et al. Extrarenal effect of cyclosporine A on potassium homeostasis in renal transplant recipients. Am J Kidney Dis 1993; 22:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/48\">",
"      Moz Y, Levi R, Lavi-Moshayoff V, et al. Calcineurin Abeta is central to the expression of the renal type II Na/Pi co-transporter gene and to the regulation of renal phosphate transport. J Am Soc Nephrol 2004; 15:2972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/49\">",
"      al-Khursany I, Thomas TH, Harrison K, Wilkinson R. Reduced erythrocyte and leukocyte magnesium is associated with cyclosporin treatment and hypertension in renal transplant patients. Nephrol Dial Transplant 1992; 7:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/50\">",
"      Barton CH, Vaziri ND, Martin DC, et al. Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine. Am J Med 1987; 83:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/51\">",
"      Nijenhuis T, Hoenderop JG, Bindels RJ. Downregulation of Ca(2+) and Mg(2+) transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia. J Am Soc Nephrol 2004; 15:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/52\">",
"      Miura K, Nakatani T, Asai T, et al. Role of hypomagnesemia in chronic cyclosporine nephropathy. Transplantation 2002; 73:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/53\">",
"      Lee CT, Huynh VM, Lai LW, Lien YH. Cyclosporine A-induced hypercalciuria in calbindin-D28k knockout and wild-type mice. Kidney Int 2002; 62:2055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/54\">",
"      van der Heide JJ, Bilo HJ, Donker JM, et al. Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants. N Engl J Med 1993; 329:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/55\">",
"      Kooijmans-Coutinho MF, Rischen-Vos J, Hermans J, et al. Dietary fish oil in renal transplant recipients treated with cyclosporin-A: no beneficial effects shown. J Am Soc Nephrol 1996; 7:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/56\">",
"      Berthoux FC, Guerin C, Burgard G, et al. One-year randomized controlled trial with omega-3 fatty acid-fish oil in clinical renal transplantation. Transplant Proc 1992; 24:2578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/57\">",
"      Homan van der Heide JJ, Bilo HJ, Tegzess AM, Donker AJ. The effects of dietary supplementation with fish oil on renal function in cyclosporine-treated renal transplant recipients. Transplantation 1990; 49:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/58\">",
"      Tatsioni A, Chung M, Sun Y, et al. Effects of fish oil supplementation on kidney transplantation: a systematic review and meta-analysis of randomized, controlled trials. J Am Soc Nephrol 2005; 16:2462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/59\">",
"      Maachi K, Berthoux P, Burgard G, et al. Results of a 1-year randomized controlled trial with omega-3 fatty acid fish oil in renal transplantation under triple immunosuppressive therapy. Transplant Proc 1995; 27:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/60\">",
"      Lim AK, Manley KJ, Roberts MA, Fraenkel MB. Fish oil treatment for kidney transplant recipients: a meta-analysis of randomized controlled trials. Transplantation 2007; 83:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/61\">",
"      Alexander JW, Metze TJ, McIntosh MJ, et al. The influence of immunomodulatory diets on transplant success and complications. Transplantation 2005; 79:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/62\">",
"      Palmer BF, Dawidson I, Sagalowsky A, et al. Improved outcome of cadaveric renal transplantation due to calcium channel blockers. Transplantation 1991; 52:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/63\">",
"      Chrysostomou A, Walker RG, Russ GR, et al. Diltiazem in renal allograft recipients receiving cyclosporine. Transplantation 1993; 55:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/64\">",
"      Ladefoged SD, Pedersen E, Hammer M, et al. Influence of diltiazem on renal function and rejection in renal allograft recipients receiving triple-drug immunosuppression: a randomized, double-blind, placebo-controlled study. Nephrol Dial Transplant 1994; 9:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/65\">",
"      Mourad G, Ribstein J, Mimran A. Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants. Kidney Int 1993; 43:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/66\">",
"      Ponticelli C, Montagnino G, Aroldi A, et al. Hypertension after renal transplantation. Am J Kidney Dis 1993; 21:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/67\">",
"      Rahn KH, Barenbrock M, Fritschka E, et al. Effect of nitrendipine on renal function in renal-transplant patients treated with cyclosporin: a randomised trial. Lancet 1999; 354:1415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/68\">",
"      Kuypers DR, Neumayer HH, Fritsche L, et al. Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study. Transplantation 2004; 78:1204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/69\">",
"      Hunley TE, Fogo A, Iwasaki S, Kon V. Endothelin A receptor mediates functional but not structural damage in chronic cyclosporine nephrotoxicity. J Am Soc Nephrol 1995; 5:1718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/70\">",
"      Frantz RP, Edwards BS, Olson LJ, et al. Effects of pentoxifylline on renal function and blood pressure in cardiac transplant recipients: a randomized trial. Transplantation 1997; 63:1607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/71\">",
"      Smith SR, Kubacki VB, Rakhit A, et al. Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity. Transplantation 1993; 56:1422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/72\">",
"      Butterly DW, Spurney RF, Ruiz P, et al. A role for leukotrienes in cyclosporine nephrotoxicity. Kidney Int 2000; 57:2586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/73\">",
"      Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357:2562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/74\">",
"      Shihab FS, Waid TH, Conti DJ, et al. Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study. Transplantation 2008; 85:1261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/75\">",
"      Ekberg H, Bernasconi C, Tedesco-Silva H, et al. Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation. Am J Transplant 2009; 9:1876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/76\">",
"      A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med 1994; 331:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/77\">",
"      Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. Lancet 1994; 344:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/78\">",
"      Porayko MK, Textor SC, Krom RA, et al. Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation. Mayo Clin Proc 1994; 69:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/79\">",
"      Lucey MR, Abdelmalek MF, Gagliardi R, et al. A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status. Am J Transplant 2005; 5:1111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/80\">",
"      Pillebout E, Nochy D, Hill G, et al. Renal histopathological lesions after orthotopic liver transplantation (OLT). Am J Transplant 2005; 5:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/81\">",
"      Gerster JC, Dudler M, Halkic N, Gillet M. Gout in liver transplant patients receiving tacrolimus. Ann Rheum Dis 2004; 63:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/82\">",
"      Holman MJ, Gonwa TA, Cooper B, et al. FK506-associated thrombotic thrombocytopenic purpura. Transplantation 1993; 55:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/61/41945/abstract/83\">",
"      Lea JP, Sands JM, McMahon SJ, Tumlin JA. Evidence that the inhibition of Na+/K(+)-ATPase activity by FK506 involves calcineurin. Kidney Int 1994; 46:647.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7357 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-9C35C7E240-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_61_41945=[""].join("\n");
var outline_f40_61_41945=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H122017\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ACUTE CALCINEURIN INHIBITOR NEPHROTOXICITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CHRONIC CALCINEURIN INHIBITOR NEPHROTOXICITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Renal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Incidence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Cyclosporine dose",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Withdrawal of cyclosporine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Hyperkalemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Hyperuricemia and gout",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Metabolic acidosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Hypophosphatemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Hypomagnesemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Hypercalciuria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PREVENTION OF CHRONIC CALCINEURIN INHIBITOR NEPHROTOXICITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Fish oil",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Calcium channel blockers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Pentoxifylline",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Thromboxane synthesis inhibitor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      TACROLIMUS NEPHROTOXICITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H122017\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7357\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7357|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?37/42/38573\" title=\"figure 1\">",
"      Cyclosporine and Ca blockers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/21/36190\" title=\"figure 2\">",
"      Incidence of CKD after nonrenal organ TPL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/31/12797\" title=\"figure 3\">",
"      Collecting tubule transport",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7357|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?33/50/34594\" title=\"picture 1A\">",
"      CyA induced arteriolar injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?14/23/14708\" title=\"picture 1B\">",
"      CyA induced tubular injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?24/48/25347\" title=\"picture 1C\">",
"      Striped fibrosis with CyA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/41/15000?source=related_link\">",
"      Causes of hypomagnesemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36826?source=related_link\">",
"      Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/24/11657?source=related_link\">",
"      Chapter 12B: Renal potassium excretion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34778?source=related_link\">",
"      Chronic renal allograft nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/13/12505?source=related_link\">",
"      Clinical manifestations and diagnosis of acute renal allograft rejection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/44/9930?source=related_link\">",
"      Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/23/16761?source=related_link\">",
"      Hypertension after renal transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/14/3303?source=related_link\">",
"      Hyperuricemia and gout in renal transplant recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/43/43706?source=related_link\">",
"      Maintenance immunosuppressive therapy in renal transplantation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28090?source=related_link\">",
"      Pharmacology and side effects of cyclosporine and tacrolimus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/28/34250?source=related_link\">",
"      Renal function and nonrenal solid organ transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/49/12053?source=related_link\">",
"      TTP-HUS: Recurrence after transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/54/17258?source=related_link\">",
"      Treatment and prevention of hyperkalemia in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_61_41946="Old lateral MI tutorial";
var content_f40_61_41946=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F55529&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F55529&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1264px;\">",
"  <div class=\"figure\" style=\"width: 550px\">",
"   <div class=\"ttl\">",
"    Chronic lateral wall myocardial infarction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 530px; height: 179px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A chronic lateral wall infarction is characterized by the presence of initial Q waves which are deep and broad in leads 1 and aVL.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_61_41946=[""].join("\n");
var outline_f40_61_41946=null;
var title_f40_61_41947="Pancreatic diabetes";
var content_f40_61_41947=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F68883&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F68883&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Approximate frequency of diabetes mellitus in different types of pancreatic disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Disease",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total pancreactectomy",
"       </td>",
"       <td>",
"        100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\" rowspan=\"1\">",
"        Pancreatectomy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Distal pancreatectomy",
"       </td>",
"       <td class=\"sublist_other\">",
"        20 to 40",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        40 to 80 percent resection",
"       </td>",
"       <td class=\"sublist_other\">",
"        40",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        80 to 90 percent resection",
"       </td>",
"       <td class=\"sublist_other\">",
"        &gt;60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\" rowspan=\"1\">",
"        Pancreatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Acute",
"       </td>",
"       <td class=\"sublist_other\">",
"        2 to 18",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Chronic calcifying",
"       </td>",
"       <td class=\"sublist_other\">",
"        60 to 70",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Chronic noncalcifying",
"       </td>",
"       <td class=\"sublist_other\">",
"        15 to 30",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\" rowspan=\"1\">",
"        Hemachromatosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Primary",
"       </td>",
"       <td class=\"sublist_other\">",
"        75",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Secondary",
"       </td>",
"       <td class=\"sublist_other\">",
"        16",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carcinoma",
"       </td>",
"       <td>",
"        40 to 50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cystic fibrosis",
"       </td>",
"       <td>",
"        10",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Del Prato, S, Tiengo, A, Diabetes Reviews 1993; 1:260.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_61_41947=[""].join("\n");
var outline_f40_61_41947=null;
var title_f40_61_41948="Differential diagnosis of anaphylaxis";
var content_f40_61_41948=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F65677&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F65677&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of anaphylaxis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Common disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute asthma*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute generalized urticaria*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute angioedema",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Syncope (faint)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Panic attack/acute anxiety attack",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aspiration of a foreign body",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiovascular events (myocardial infarction*, pulmonary embolus)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurologic events (seizure, cerebrovascular event)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Post-prandial syndromes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Scombroidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pollen-food allergy syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Monosodium glutamate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sulfites",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Food poisoning",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Excess production of endogenous histamine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mastocytosis and other clonal mast cell disorder",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Basophilic leukemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Flush syndromes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Peri-menopause",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carcinoid syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Autonomic epilepsy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Medullary carcinoma of the thyroid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other non-organic disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vocal cord dysfunction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperventilation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Psychosomatic episode",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Shock",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypovolemic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiogenic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Distributive",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Septic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Non-allergic angioedema (hereditary angioedema types I, II, &amp; III, ACE inhibitor-associated angioedema)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Systemic capillary leak syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Red man syndrome (vancomycin)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pheochromocytoma (paradoxical response)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    The differential diagnosis in children and adults is shown. In infants, the differential diagnosis of anaphylaxis is unique.",
"    <div class=\"footnotes\">",
"     * Acute asthma symptoms, acute generalized urticaria, or myocardial infarction symptoms can also occur",
"     <em>",
"      during",
"     </em>",
"     an anaphylactic episode.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Distributive shock may be due to anaphylaxis or to spinal cord injury.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_61_41948=[""].join("\n");
var outline_f40_61_41948=null;
var title_f40_61_41949="Survival alcoholic cardiomyop";
var content_f40_61_41949=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79337&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79337&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 535px\">",
"   <div class=\"ttl\">",
"    Outcome is poor in patients with alcoholic cardiomyopathy who continue to drink",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 515px; height: 344px; background-image: url(data:image/gif;base64,R0lGODlhAwJYAdUAAP///wAAAACIAP8AAAAz//+IiIjHiO7u7rvfu4iIiESoRLu7u6qqqv9ERIig/xEREbvJ//+7uyKYIkRERFVVVf8iInd3d0Rp/5nPmTMzM93d3f+ZmSIiIhGQEczMzP8RESJO///d3d3v3ZmZmWa4ZjOgM2ZmZv9mZu737v8zM//u7pmt/93k/8znzBFB///MzO7x/2aF/zNc/1WwVf9VVXfAd/93d1V3/8zW/6rXqneS//+qqqq7/wAAAAAAAAAAACH5BAAAAAAALAAAAAADAlgBAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wsbKztLW2t7i5uru8vb6/wHIBwcTFvMPGycqyyMvOz6jN0NPUntLV2NmU19rd3orc3+LjgOHk5+h25uns7Wzr7vHyRAzNCw8BHB5CEwEBJk7gzRvIrl+zBwkAWMgAIAGHAxoeMGgikKBFcguQeQhwAEBGABQs8EvIpOLFk90+ekSWUcMEkhMAlkRJM53KjR0/hhxJxJ/P/58mawp1phIAQoUMHUKUSHGoU20GA4zwiE8fP38yZz7d6jQo16/pgg4YS7as2bNo06pdy7at27dw48qdOwBsWLtJ6uIl5xWAAKF694rr+7dmYMHeCC8hwLix48eQIwc7jFib4jIEJlf+dplMZmCUN1frPMaxr9Cip5HGfDq1ZSiFz3zmhdq1s9WeI5uWVbvdgAhMfisp0ABKgwJDIvReopwTbjezYS3/pmJAhSHCl2RHQhzA8Sbffzc30l3JeE3P20R/Nd1bgRQfgAPYnlc+9+JPvgs5T6R8Ev6YpMfGeq60100FBZxwghDC0TDWBwAUMFYKL8yXwlgbABDChQPYEP9hcd9JOFaFQzg4FnLi1bUBWSeEwOKGYy0YQQVkOQcbHbpJRoqB2SinQgQfqDBfBAVUEIIQLwxQ4QnFDYBckQDQQAMAL8TX3XFJ2jdEkUeGFwF/K6pQHg0LhvBBlcgBeImAeRD4CY/YnFBWhr8pOMQG1wEw45AA4AlABRl6t8GVBfhphJ3eofilihwOEEJ5NJK14pFqWsImHm56Aic1KnywgxDvDcklkkpG2SRwfkpJ5W+EZkleBSqogOCQzVXg4Q6OhhrlgkN88OSmjFx6R6adAAvNBhAK4aKrDTwY4YQVCucnjB1+mOizIw6hwoUfzJoitjSGUOUALTYawooDXGj/4xMCtOuuu3oQy4mxth2DRWzD5qjvvvzKCwe99erSFxL4huLvGwAHjMvARxQMysFuJKywLQwb4fAnELchcTr6teHfKBUXcbEnGbOxMTpeolHex6KETMTInZS8xsnndKwyfiyH4vIQMHMisxo0FzPjieiS+6GEIZjoJJ/NDtDAj9YN8IGJHs7a6Q5ASp1hAxwuWHSLLBZJYwoqMClEAx5usrMQPW/ycxpBE+OrEWEWCdyoXhYZawoFKAdcBcWt2Od1fs6NrAoNTJkkiX0OICbORna6gYshUL6uFW1r8jYacQNjuRAbmFseol4imuB43zXXaQQpTO4ogyHoN8AGoZP1/yjO+AGaqA28qn1vKZDV0TkwcwthKwC43g4qrLIqqnfzqKep13vJzl1AkN8lf3zyukKa4YxndrK2X6psLsbwv2TtpIjhlret1N4C1/TT0eupV3XI6fmB1t6R9WvU4trfCbwnhBTg53JVyBzJhDexIwBJSEewWRRWZ43fpcJ8YUBfTVKQtgjmbwo2SMEnxqfAmPELbg18BgltgUEqaDCFqVhhLVo4hRdOgz5KwKEyZEgLGkrBhsUgFIO0lEMi9gc/ErwFD2fhwyjQ5YlQjKIUpzjF/ORPh0jAIqgO2IslyqKJW6kO4wDgKeIUbUUcCtQQIlWBaKURADYgS5JiFJ43Uv9rQWJLl5BMBCH2jRE993pXCUfRr0Ia8pCITOQJO8G3EACqStaS3ZPyZITjLe168/nUFs+GoknuSkNn4pLkRkWl8NlgSoRIgD8eMBUAGCQrSxifyGCIBTAS4pQn2AGCpiREPhlKCGVjEZ+U8yganeBxnPTldSKFIe8hqnFkoWQgDhCAiViAAw15SEQmopUtDJKWSLDlIKp0HRpYD0Rpk5Y0wwSAFCxIODaQ5gcGJcJrqfOTW8rdoIyEpPAdggMUOEACKAASkbiSJLHswjfBaQRxDmJuybMWulaEKmlSqwLvHEsFItCpCalgXExS1OA0JDp99k9q2DJaKjMwAQ4s4KD//IBlEmT5MoZWwaE2dQJOVnKAncB0CEABikJzOgWcEnUJG5nICDiilG02hQsLPapRj6oEVQaAlVf5R0CGStUnTLWrYKApz8DqhK+StQtiZdtZmWDWtWohreRzaxLaKtcrwDWqRKVrXatw170eQa+BIAAEsgAB8wl2CA64ABUSaymu+pUIgMUUY1gAWQgUdgqXBUBmh3BYtlo2M4w1wgUcsITQbsOxjxVCZDE12MpWIbObjUJnAWBaIoy2tIqtRF9Ty1mMDZYFMmjMZwEAXMbogLYgcAEBZAADFjSGuSBgDAgKG1wX4AAAh70BY1xAhOIyZriMjUFjVrCC8UIgugRY/wFtG5Pb00KVt5xVpHznS1/dFCG7uRXsZW9wAwDgwAUQcAAIYAADEJBWCM7lAWwPe4EYYDfAIKBsEW6QX/C2FwAxkAEAbgsAF6iXB9Y9bG0lsVv4PmywIFDvgy+bYiFcYAWhbTAOLmDez2Q2Bg4WLI6P0OIVg1axDlAuAUCwYdI61zErIDJtL0xi1Jo4ZoPlr3/1mxkp40CwjGWBhzMMABikt7Aw0OxndozlCBvBylRecoIBoAMiX+C4HVbxlK9L4ca+98kkmywOohvc4Xr3uA5oTH8hoNzorgAGwZ3umHM8WBoTgLtD2PNy08xYR4OAyOX9MnqJLN7lMjkSJcazK/9GnBgni3oVpO5GqE/N6jOsutWwFsNdBUnrWtv61rjOta53zWu8mpjDbUj1CHvha/jedrZlCK2wK8iLYvMW2GhQ9qdBAVdQOJuW52WMAzJNAAcnNtAs0K62H7xhxlwABoWNrgvEfVwDd9kFClauhzcc3G4DgNsxOHK3BcxnGMQgt29GYC6uDUMXHJgI5YWBgAcrYMoeG8IEloEDCotixZb33pgmssHv7QIYXKC/V76uEBKu7AjDwMPOZUHKBY4Lgjdw5SOvNwFYENodF/nBNndADDJ728ueHAIyWAHMZ87h9K5A5jTPbWhbPFodOJjlt3B5AzcuBBAclwczLzmB3V3/5q1P/DM9/4wDZADpjQfZ46TFOgusDgC1j10IS1fvea0rPmKbmNDaDvSQs55bRD+a6402N7rBTtrMevnAeJ+3owlAWr1HlwX/3XdueyyDaa/J7rEGA6HDfARoR+HnzN6F1DNvBBnAufMHl4IONBx6XYye9Muo9ideD/tkyN4TtK99MW7fidzrPhi854Tvf/+L4G9i+MTvIuaTzw7jawL5zBfY8qN/DudnAvrUV+L0sz+Y7XO/1M3+Pl+8L/5sWB8T2C9/JkzgD5hgZavhV38uTGAVITSVKd10vfw5cYD++7//VEBNLzUEPvUSTyV6+6cJ9RBU1TQFGYEPAZAQBuhK/zKFBOd3CemXgHWwgEHFTVGwEUJQDxpQgAgFAAzoE+SngZLwf/9XBVhVDwKlTfiXUPGngpggUBaQgxagAVSwABxwVa30SvCHgDaICRQAFB6oBhdoCRlYhHPwABnAARNgAQ+wD++Qgk7oCNTEABNAUBmQhGmwhJXQhFn4BtQ0AlSYhm0ghpRAhmXoBhlAARvhD2CIBmw4CW74hm/AABZQh3aIhXroC3coCXkYiGlAASZghW8wiJFQiIZ4BhngDy/REWsIiI94CCNAAfjwAAO4BowICY54iWbgAVblh2bwiY8QiqIoBgkQiZLIg1dYg6uoCJHIARagiLFIhLOICB2RAP8J0IKVKIu7SAj1wACu6BOmWAao6AiqOIxaUIzHSIfBqIvOSAiUyIJusIyN0Gvc2GvV+AjaOHDfqAWIiIvTWBPNqIGuOInZ6BTpqIGZuImdqITuOI5bQIrSmIvoaI9Y0Io+MQGw6In1yI9WUIu3uIgDSZBUkACtBAfh2HIKWQUTwBBx8JBRF5FUYIzAqI808Y77F40NyJEo4ZHyB5LJSAYWaQskKX/YeI4diZEBuJECORQrWX4m6ZIjCZNScJMieRI1WX7+5wEPEJD0SJM6KQX+lxElGIYJeZRNAJJL+YdG6ZROEI0TQIkzKRQ/KX4ymZX7SJVMgJUMYI5FqZVguQT/RzgCB+CKBtWTF7GV1McBSXFVP0iWUKBKAyiEB/iVZ3kE1CQS/ZAAGhCBVbBUAfBS93eSQNWUfUkE1AQQ+LAAf5mREnGYBcUT+feSjXkEGfAA7PcAK9GWUJARCzCYLzWBMbGXmrmZRcCBImEBlikF7PcTC0CCPXGCKVkLcEl9fEgSOXgFpplNS6GYQpCbtLCb1RicrvR+qpmTrLkHxjkLyDlwCMAEAlCdSWAACgAFCmAAQ4AAvgaeUPeWW4ECAiABPIOdSnCdSqCdANCdTQCf1ymeRuCeSkCfgDSVTmEAJdAB2MmeSwCgSGCfTgCfQoCfRECgSICgAcKYNSEBBkAC/yTANtU5A+3SAQBgAO1SAi3gFyXQLhgAACLwoQJQAxm6nfCpoe3SoUNgoe3infP5FxjgLiQgAjQ6ou0yoQggAfDiO/opFOCJAgjQASjgFwhgABIgAkLQAgLQoSSwnQLgnUgKADMwAwDQAv7pnt3JpOo5BEiqpPKJAAg6oyhgnzMwoSLQAVjqnQx6eT9aEyTwLiF6nRI6BBiAngCwo0YKAHcKABIQou+JAVpqAH1qBHX6njAqpjJKogIgAvbJo+4yo0rapnZmlkOBAh2QA0LAn0b6pUvapFQKpdXZp1V6pdc5qFxanxKAAigAoUYqnhJgojnQqJxKpRM6BB0gpdMpa/8OehIYgKFCYKOpqgAXmqEb2qHs2ac4WqIniqjGuqJDgAIf2gGuGqPPyqMigKUCUKOMKgIzKgAfOp4WsavPGZ2yQK6saa6xgK6bqa6wwK6N6a6vAK+/YKBtoKAt06uiEaZoYJ/4qjP6uhn22q/b2aylIK+uQK+rsKMv+q3beqIaKgIuGqV7SqwCoABCep4C0AEuaqKuiqk5MKQbG6IKQKIT6rA1SqNIyqMlgAJPKgQKYKI+aqlDkatGQKZIWp2eGqZIyqolYADgWZ0SsJ0zyqfo2ac2+6sooABWyqQsyqcCUKYF+6WYigE2KgJXK64E0Y1c27Ve+7VgG7ZfqwRZKwT/GNCt9nmoYXqoEUqf8CmemIoAJWC1jco2ImCgAoABZ+sujjq1BfuniFoDtzqzz3kHNisEsQoAs9q3m7qqrZqoPfu4bsumhcGfwGqzBkCk8Lm4ibu4tfqoIbqjalp3hYsHIhulKoqt9imtG1ut1WmxGDu5eVoY5umdedoBI/ue7qKrGputuEsCoCsEJVCwWlu6lzCkRXoEAxsFcdt6xssJJSCzymu7U1ADJTBsz5t5CJu9J7G93CsyXaoFy0sx37sHg0qhUECpRTC+31kY6ksK3su9eBu+S/C+Q8C+B6qwCFm+cGCeTwsAmaqdDjujJBqiy2qiL+und9oueCoEcQqi/+9psnyKu1EKqRIgnisLrkXqoi0LntPaoSrapAybt44Qv2D5syLwp1jarHgrpehZqliKAAn8p+9LAtfLtKbaAjHbvvmboUlatfxZpD8btO9JAqkqBB0QojkArMHCv3FQA2eaAxBqpee7p30KuIE6wxjQppnLwM7qF1v8oQrQAvSJwX+LAQ+co/QpoYUqooKkpE3sxG+ApS+MuSgqs8n6wk17qug5pFsctURgo5paA+i5uXUrBGcapLNrsH8axDwMABJ6xAAMqOAox3Bgs4vbrN86o6OKngcsoiybxKzbwLp7noW8u6UsAS0wymaMuCE6sX/swBMawmRswSVsyXhmwv+4jA66vMvj58u81cvAzBnDnFrCXMyvgcx7dczKTAuwmQ9WqJeZ2cyCIYcgQVCJ2ZzUjBgWQFC2Oc3bvBf3wIOoWYFHwMzhDAsjUH/fXJy4mc6IMZFYmc3gDM9PMZg/Qc7MWc/2DE7o3M+7B9BU9c8CDQwEXdCCiNA5ddAKvQsM3dC58NAQrX0TDUMSXdG0cNEYzQwb3UAa3dGv8NEg3QoiPdKrUNImHUMpbRsovdKm0NIuDb8xLRowPdMAa9OIUdM47bw7/RU63dOEC9Rc8dNC3aBF7dNHjdRJvRVEvdST0NRODWpR3RVTPRRQXdWNcNVYvQhavdWJ0NVefQhgHdb/hTDWZB0H0kyDZ10N9KzWaz0N7awEZv3WbFDO2kzXyRDXuDnXeJ0GbS3XfT0NaQ3Ygd0OfF3YeHDYiK0Oi30XjV19jw3ZkT0Oij3ZDmnZ3YfZ4KfZlrHXnv3ZoB3aoj3apF3apn3aqJ3aqr3arN3arv3aJzgPyzjbl72/tu2WUmnVtd2Ot43bue3bp/gUtN3bXgncwc3byC0Uw53cxo2SFUncZancu42T0d3czs3cxU0Ty03dTAnd1f3d4N29023dvOrd3c3dv10T203eYbDe7P0F7o0S8X3e6O1qz43d4c3Z+r3f/N3f/v3fAB6R9wDNafDMVqEBrtiQZYCXAIDg//6g4GMwmwnh4FJhBlaFVRQO4WBQD0Mw4PU32FvA4UJg4NG8z14g4kPA4MupVQNxFAtxiPtAAd5MUDBoBob5UjIOADVOBvSniDm+42KwhQqBTT/OEWNgEEPg4kkhg8QpBUguBNac43+9BU8uBDcunE4lDztVFAVOUPgXm2PAAJX5Ul8+j2AggERQ5mUAUALl5dwE5mFwE0auEwY1gV3A5SPuzXUelVpQFGJeDzi+5/OgEi2hBuNsggNY4WNAmsEZm4ouBg/YfohenBr+Ba3YUi/l6JV+5yzR6S4BE+aMBXh+6Hb9BYR+mMFZ6vGw5Wy4zlao5hEOFPfw5mb+BSCo4/8BkOVwDgasfgCwDukaMefDENdbwOWuDuWCburIMJs+UZvJLg9KngbyTIA0buRmEJxFjpVi8IIcke1kkFQAsFQ9Ve3aDgZFEe1T3ufNMO32x+Tmfg3Bme7s4OF2GQb47BMakOFoEJz6XgY+CIQNnuAWvkpT0e9iEBVTQe9ZFepXgPD37g/6zOJegPBDoJwgHuAYn/Eav/Ec3/Ee//EgH/IiP/IkX/Imf/Ioz3/+UO8p7whHGJKRCJpQEIkJQU0BwPItzwgvzxCGKfNPQPMAYPM4n/OKcISRuM6baH8+YVCRSAGRmAE99RM2T4UBQFAN4RM+T/SGcIQL0X5XpRBVDwCo7CcSkUj2hAn0Ns8Avn6YqkSRWp8IXF8PFFAPoPmDU1EP2AT0XA8AaL/yRlFNhpkBB/n2Wx8AbUn3AGD3uJ73hLn3fX/zfz8RCcDsREn4gbD3Ifj1sElQY8/3jW/4y1nzfo8PHojPlW/5f4D5uC7zVgX6np8Qey/m/iD0kf/M+bDpqJ/7ur/7vN/7vv/7wB/8wj/8xF/8xn/8yJ/8yr/8zN/8zv/8hxAEADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Survival curves of cardiac deaths show no difference in survival between patients with an idiopathic dilated cardiomyopathy and those with an alcoholic cardiomyopathy who abstain from further drinking. However, survival is significantly lower in those with an alcoholic cardiomyopathy who continue to drink (p = 0.002).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Fauchier L, Babuty D, Poret P, et al, Eur Heart J 2000; 21:306.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_61_41949=[""].join("\n");
var outline_f40_61_41949=null;
var title_f40_61_41950="Metoprolol hospitaliz HF";
var content_f40_61_41950=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F60489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F60489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Metoprolol reduces the number of heart failure patients requiring hospitalization",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 394px; height: 555px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the MERIT-HF trial of 3991 patients, metoprolol CR/XL reduced the number of patients requiring hospitalization for any reason by 18 percent compared to placebo (p = 0.004), the number admitted for a cardiovascular cause by 25 percent (p &lt;0.001), and the number admitted for worsening heart failure by 35 percent (p &lt;0.001) (Panel A). There was an equivalent reduction in the number of hospital days (Panel B).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Hjalmarson A, Goldstein S, Fagerberg B, et al. JAMA 2000; 283:1245.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_61_41950=[""].join("\n");
var outline_f40_61_41950=null;
var title_f40_61_41951="Erythema multiforme";
var content_f40_61_41951=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F74095&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F74095&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema multiforme",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 237px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Characteristic target lesions of the palm in erythema multiforme begin with a central vesicle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lee T Nesbitt, Jr. The Skin and Infection: A Color Atlas and Text, Sanders CV, Nesbitt LT Jr (Eds), Williams &amp; Wilkins, Baltimore 1995.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_61_41951=[""].join("\n");
var outline_f40_61_41951=null;
